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Abbreviations	
	
BIR	 	 	 	 break	induced	replication	
BLM	 	 	 	 Bloom	helicase	
CDK	 	 	 	 cyclin	dependent	kinase	
CFS	 	 	 	 common	fragile	site	
CO	 	 	 	 crossover	
CPT	 	 	 	 camptothecin	
DDK	 	 	 	 Dbf4-dependent	kinase	(Dbf4-Cdc7)	
DDT	 	 	 	 DNA	damage	tolerance	
DSB	 	 	 	 double-strand	break	
DSBR	 	 	 	 double-strand	break	repair	
(d)HJ	 	 	 	 (double)	Holliday	junction	
gRNA	 	 	 	 guide	RNA	
HR	 	 	 	 homologous	recombination	
HU	 	 	 	 hydroxy	urea	
IR	 	 	 	 ionizing	radiation	
JM	 	 	 	 joint	molecule	
MMS	 	 	 	 methyl	methanosulfonate	
MRX	 	 	 	 Mre11-Rad50-Xrs2	
NHEJ	 	 	 	 non-homologous	end	joining	
NCO	 	 	 	 non-crossover	
nt	 	 	 	 nucleotide	
PAM	 	 	 	 protospacer	adjacent	motif	
ROS	 	 	 	 reactive	oxygen	species	
SCJ	 	 	 	 sister	chromatid	junction	
SDSA	 	 	 	 synthesis-dependent	strand	annealing	
SSB	 	 	 	 single-strand	break	
ssDNA	 	 	 	 single-strand	DNA	
SSE	 	 	 	 structure-selective	endonuclease	
STR	 	 	 	 Sgs1-Top3-Rmi1	
TALEN		 	 	 TAL	effector	nuclease	
TS	 	 	 	 template	switch	
TLS	 	 	 	 translesion	synthesis	
ZFN	 	 	 	 zink-finger	nuclease	 	






action	 at	 other	 phases.	 Two	 proteins	 regulated	 in	 such	 a	 cell	 cycle-specific	 manner	 are	 the	
structure-selective	endonucleases	(SSEs)	Mus81-Mms4	and	Yen1	–	repair	factors	required	for	the	
removal	of	DNA	structures	arising	during	homologous	recombination	(HR).	Research	in	the	last	
years	 thereby	 identified	 a	 variety	 of	 regulatory	 pathways	 leading	 to	 cell	 cycle-specific	
upregulation	 of	 the	 Mus81-Mms4	 and	 Yen1	 catalytic	 activity	 during	 M-phase.	 Despite	
accumulating	 evidence	 that	 the	 catalytic	 activity	 of	 the	 two	 SSEs	 is	 cell	 cycle-regulated,	 it	
remained	elusive	at	which	cell	 cycle	phase	 they	would	exhibit	 their	key	 function	and	how	the	
different	 regulatory	 mechanisms	 upregulating	 Mus81-Mms4	 and	 Yen1	 during	 M-phase	 are	
working	together.		
To	address	these	questions,	we	developed	an	advanced	toolbox	of	cell	cycle	tags	which	





circumvented	 this	 problem	 using	 genetic	 approaches	 like	 chimeric	 protein	 fusions,	 5´UTR	
truncations	and	out-of-frame	ATGs	which	resulted	in	a	toolbox	of	46	cell	cycle	tag	constructs	with	
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Elledge,	 2010).	 Nonetheless,	 due	 to	 the	 potential	 of	 evoking	 genome	 rearrangements	 and	
chromosomal	aberrations,	DSBs	are	considered	as	extremely	toxic	lesions.	Consequently,	even	a	
single	DSB	is	sufficient	to	block	replication	and	arrest	the	cell	cycle	resulting	in	a	window	of	time	






Figure	 1:	 Sources	 of	 DSB	 formation.	 DSBs	 are	 produced	 by	 exogenous	 or	 endogenous	 factors	 and	 can	 also	 be	





exploited	 during	 cancer	 therapy	 are	 chemotherapeutic	 drugs	 (like	 DNA	 alkylating	 agents,	





and	 generation	 of	 reactive	 oxygen	 species	 (ROS)	 (Ward,	 1988).	 ROS	 are	 highly	 energetic	
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molecules	which	can	react	with	DNA	to	form	oxidized	bases	or	SSBs.	In	contrast	to	ROS	produced	
during	normal	 cell	metabolism	where	 the	 formation	happens	 randomly	distributed	across	 the	
entire	 cell,	 the	production	of	ROS	 in	 response	 to	 IR	 is	highly	 localized	 to	 specific	 regions.	The	
consequence	is	an	enrichment,	also	referred	to	as	clustering,	of	DNA	lesions	and	SSBs	at	specific	




replication.	 Due	 to	 the	 yet	 unfinished	 genome	 duplication,	 replication	 associated	 DSBs	 are	




forks	 encountering	 single-stranded	 DNA	 (ssDNA)	 gaps	 (induced	 for	 example	 by	 IR	 or	 the	
topoisomerase	inhibitor	camptothecin	(CPT))	or	replication	fork	collapse	of	stalled	forks	whereby	
fork	stalling	can	result	from	a	variety	of	natural	impediments:	aberrant	DNA	structures,	sites	of	
chromatin	 compaction,	 DNA	 protein	 barriers	 or	 the	 transcription	 machinery	 (Aguilera	 and	
Gaillard,	2014,	Hamperl	and	Cimprich,	2016,	Berti	and	Vindigni,	2016).	In	addition,	replication	
fork	stalling	can	be	induced	by	extrinsic	factors	like	the	alkylating	agent	methyl	methanesulfonate	
(MMS)	 or	 the	 ribonuclease	 reductase	 inhibitor	 hydroxyurea	 (HU)	 (Mehta	 and	 Haber,	 2014).	
Together,	these	factors	interrupt	DNA	replication	so	frequently	that	even	leading	strand	synthesis	






programmed	genomic	 rearrangements,	 in	mammals	during	 lymphocyte	development,	 in	 yeast	
during	mating	type	switching	and	mitochondrial	intron	mobility	as	well	as	in	eukaryotes	during	
meiotic	 recombination.	 These	 DSBs	 are	 induced	 by	 the	 PiggyMac	 transposase,	 the	 Rag1/2	




of	 galactose-inducible	 versions	 of	 HO	 and	 I-Sce1	 allowed	 to	 synchronously	 induce	 DSBs	 in	
budding	yeast	and	monitor	the	subsequent	repair	events	(Jensen	et	al.,	1983,	Connolly	et	al.,	1988,	
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Plessis	et	al.,	1992,	 Jasin	and	Haber,	2016).	These	studies	gave	 insights	 into	various	processes	
happening	after	DSB	induction,	including	the	disentanglement	of	Holliday	junction	(HJ)	structures	




et	 al.,	 1995,	 Jasin,	 1996,	Donoho	 et	 al.,	 1998)	 and	 laid	 the	 foundation	 for	 the	 development	 of	
advanced	genome	editing	techniques.	Given	the	limited	number	of	genes	that	could	be	targeted	
by	 the	 use	 of	 site-specific	 endonucleases,	 further	 efforts	 during	 the	 development	 of	 genome	
editing	techniques	focused	on	increasing	the	flexibility	of	the	DNA	recognition	process.	Today,	two	
principles	are	commonly	used	 to	specifically	and	 flexibly	 target	endonucleases	 to	 the	genomic	
region	of	choice:	first,	 fusion	of	the	endonuclease	to	the	modular	DNA	binding	domains	of	zinc	
fingers	 or	TAL	 effector	proteins	which	 can	be	 varied	 to	bind	 specific	DNA	 sequences;	 second,	














adjacent	 to	 the	 gRNA	 target	 sequence.	 Binding	 of	 Cas9	 to	 the	 PAM	 coordinates	 its	 nuclease	
domains	on	the	DNA	sequence	and	 initiates	 the	gene	editing	process	by	 introduction	of	a	DSB	
(Deveau	et	al.,	2008).	
Overall,	DSBs	are	not	only	a	consequence	of	coincidental	DNA	damaging	processes	but	are	










process;	 see	 chapter	 2.2	 for	 the	 repair	 of	 single-ended	DSBs	 and	 ssDNA	 gaps).	 Since	 the	 two	
mechanisms	 are	 overall	well	 conserved,	 I	will	 focus	 on	 the	Saccharomyces	 cerevisiae	 proteins	









which	 results	 in	 high	 repair	 fidelity.	 As	 the	 homologous	 template	 usually	 presents	 the	 sister	
chromatid	(Kadyk	and	Hartwell,	1992,	Liang	et	al.,	1998,	Johnson	and	Jasin,	2000),	HR	is	restricted	
to	the	S-	and	G2/M-phases	of	the	cell	cycle	where	such	a	second	copy	of	the	chromatid	is	present	
while	 the	 template	 independent	 NHEJ	 pathway	 can	 act	 throughout	 the	 cell	 cycle	 (Figure	 2).	
Interestingly,	in	mammalian	cells,	this	cell	cycle-specific	initiation	of	HR	is	locally	coupled	to	the	









intermediate	 for	HR,	 it	prevents	re-ligation	of	 the	DNA	ends	and	 inevitably	excludes	repair	by	






















involved	 in	a	 typical	HR	process	as	well	as	highlight	 the	variety	of	HR	sub-pathways	acting	at	
different	DNA	lesions.	
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2 Repair	of	DNA	breaks	by	homologous	recombination	
2.1 Mechanisms	of	homologous	recombination	at	a	double-ended	DSB	
All	HR-dependent	mechanisms	 share	 four	 core	 biochemical	 features:	 (1)	 resection	 of	 the	DSB	
ends,	(2)	homology	search	and	invasion	of	the	resected	DNA	end(s)	into	the	template	sequence,	
(3)	DNA	synthesis	and	(4)	disentanglement	of	HR	intermediates.	As	HR	is	best	described	during	
the	repair	of	DSBs	where	both	DSB	ends	are	available	 for	 the	repair	procedure,	 the	 individual	






responsible	 for	 the	 endonucleolytic	 incision	 that	 initiates	 the	 resection	 process	 (Cannavo	 and	
Cejka,	2014,	Anand	et	al.,	2016,	Deshpande	et	al.,	2016,	Reginato	et	al.,	2017).	Starting	from	the	










5´-3´	 nuclease	 activity	 (Masuda-Sasa	 et	 al.,	 2006),	 the	 concomitant	 coverage	 of	 the	 3´ssDNA	
overhang	with	RPA	 inhibits	 the	3´-5´nuclease	 function	of	Dna2	and	 thus	drives	 the	 long-range	




























invading	 strand	hybridizes	with	one	 strand	of	 the	 template	duplex	while	 the	 second	strand	 is	
displaced	 in	 a	 D-loop	 structure	 (San	 Filippo	 et	 al.,	 2008).	 This	 D-loop	 tethers	 the	 two	 DNA	
molecules	 together	 and	 forms	 a	 joint-molecule	 (JM)	 structure	 –	 a	 typical	 recombination	
intermediate	linking	the	two	DNA	molecules	involved	in	the	HR	process.	
Starting	 from	the	 invaded	3´end,	DNA	synthesis	 initiates	and	extends	the	D-loop	 in	the	






After	DNA	synthesis	has	 initiated,	HR	can	differentiate	 into	 two	pathways	 in	case	both	
ends	of	the	DSB	are	available	(see	chapter	2.2	for	description	of	HR	at	single-ended	DSBs):	(1)	
synthesis-dependent	strand	annealing	(SDSA)	or	(2)	double-strand	break	repair	(DSBR).	The	two	










al.,	 2018).	 After	 reannealing,	 the	 remaining	 gaps	 are	 filled	 by	 further	 DNA	 synthesis	 prior	 to	
ligation	of	the	DSB	ends	(Figure	3,	SDSA,	gap	filling	and	ligation).	








enzymatic	 activities	 which	 can	 be	 grouped	 into	 (1)	 dissolution	 and	 (2)	 resolution	 activities	
















containing	DNA	 template	 or	 after	 the	 collapse	 of	 a	 stalled	 replication	 fork	 and	 initiate	 an	HR	
process	termed	break-induced	replication	(BIR)	(Figure	4).	In	contrast	to	the	repair	of	double-
ended	DSBs	by	SDSA	or	DSBR	where	only	 a	 short	patch	of	DNA	gets	 synthesized,	during	BIR,	
robust	replication	is	established	which	copies	a	large	fraction	of	the	template	chromosome	in	a	





























mature	 into	 a	 dHJ.	 Disruption	 of	 the	 D-loop	 and	 dissolution/resolution	 of	 the	 dHJ	 structure	
thereby	rely	on	similar	enzymatic	activities	as	during	DSB	repair	(Liberi	et	al.,	2005,	Ashton	et	al.,	
2011,	Mankouri	et	al.,	2011,	Szakal	and	Branzei,	2013,	Giannattasio	et	al.,	2014)	(see	chapter	3).	
Alternative	 to	 TS,	 ssDNA	 gaps	 can	 be	 filled	 by	 specialized	 polymerases	 in	 a	 process	 termed	
translesion	synthesis	(TLS).	Due	to	the	use	of	low	fidelity	polymerases	TLS	is	considered	error-











be	 initiated	 from	 a	 reversed	 replication	 fork	 (Figure	 4,	 (c)	 reversed	 fork).	 Fork	 reversal	 can	
initiate	 upon	 stalling	 of	 the	 replication	 fork	 and	 involves	 the	 coordinated	 displacement	 and	




in	a	single-ended	DSB	(Figure	4,	 (a)	single-ended	DSB)	 in	 turn	 initiating	a	BIR-like	procedure	
(Branzei	 and	 Foiani,	 2010,	 Saugar	 et	 al.,	 2014).	 Notably,	 the	 evidence	 for	 fork	 reversal	 in	
eukaryotes	was	sparse	for	a	long	time	and	detection	of	reversed	forks	exclusively	in	checkpoint	
deficient	yeast	cells	led	to	the	proposal	that	fork	reversal	is	a	pathological	process	resulting	from	











pathway	 implicating	 an	 overall	 similar	 mechanism	 for	 the	 repair	 of	 different	 lesions	 from	 a	
homologous	template.		








al.,	2014,	Gritenaite	et	al.,	2014)	and	 thus	underline	 the	 importance	of	a	 timely	removal	of	 JM	
structures.	
	 JMs	 are	 removed	 by	 different	 enzymatic	 activities	 depending	 on	 the	 nature	 of	 the	 JM	
structure.	 D-loops	 are	 usually	 counteracted	 early	 on	 by	 helicase	 activities	 during	 SDSA	 (van	
Brabant	et	al.,	2000,	Ira	et	al.,	2003,	Bachrati	et	al.,	2006,	Prakash	et	al.,	2009).	However,	some	D-
loops	escape	this	disengagement	process	and	mature	into	dHJs	when	the	second	end	of	the	DSB	
or	 post-replicative	 ssDNA	 gap	 invades	 into	 the	 D-loop	 (Holliday,	 1964,	 Szostak	 et	 al.,	 1983,	
Bzymek	et	al.,	2010,	Giannattasio	et	al.,	2014)	(see	chapter	2.1	for	a	more	detailed	description	of	
the	maturation	of	dHJs).	The	removal	of	dHJs	relies	on	two	alternative	pathways:	(1)	dissolution	
and	 (2)	 resolution	 (Figure	5).	 These	 two	pathways	not	 only	differ	 in	 the	 enzymatic	 activities	






of	 the	helicase	Sgs1	and	the	topoisomerase	Top3	that	act	 together	 in	a	single	protein	complex	
called	 the	 “dissolvasome”	 or	 STR	 (Sgs1-Top3-Rmi1)	 complex	 (Bizard	 and	 Hickson,	 2014).	
Interestingly,	deletion	of	any	of	the	STR	components	leads	to	an	increased	CO	rate	(Ira	et	al.,	2003,	
Wu	 and	 Hickson,	 2003)	 indicating	 that	 dissolution	 acts	 in	 parallel	 with	 the	 CO	 producing	
resolution	 pathway	 and	 limits	 the	 number	 of	 JMs	 that	 are	 processed	 into	 crossing-overs.	 The	
importance	 of	 counteracting	 crossing-over	 events	 with	 dissolution	 activities	 also	 becomes	
emphasized	by	the	phenotypes	associated	with	a	rare	genetic	disorder	called	Bloom	syndrome.	










































The	 picture	 emerging	 from	 these	 studies	 reveals	 that	 resolution	 and	 thereby	 CO	




In	 the	context	of	Mus81-Mms4,	mitotic	phosphorylation	affects	 the	protein	 function	by	
two	different	means:	(1)	direct	upregulation	of	the	enzymatic	activity	(Matos	et	al.,	2011,	Matos	
et	al.,	2013,	Gallo-Fernandez	et	al.,	2012,	Schwartz	et	al.,	2012)	and	(2)	incorporation	into	a	higher	
order	 complex	 comprising	 several	 scaffold	 proteins	 that	 might	 play	 a	 role	 in	 targeting	 the	
endonuclease	to	its	cellular	substrates	(Gritenaite	et	al.,	2014,	Princz	et	al.,	2015)	(Figure	6,	upper	
left).	The	first	evidence	indicating	that	Mus81-Mms4	activity	is	regulated	in	a	cell	cycle-specific	
manner	 was	 deduced	 from	 data	 derived	 in	 meiotic	 cells	 where	 Mus81-Mms4	 was	 found	 to	
undergo	cell	cycle-specific	phosphorylation	(Matos	et	al.,	2011).	Subsequently,	 it	became	clear	






protein	 from	 cell	 cycle	 phases	 where	 Mms4	 is	 unmodified,	 on	 the	 other	 hand,	 abolished	 the	
stimulatory	effect	observed	for	the	catalytic	activity	(Matos	et	al.,	2011,	Gallo-Fernandez	et	al.,	
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Figure	6:	Cell	cycle	regulation	of	Mus81-Mms4	and	Yen1.	Both	Mus81-Mms4	and	Yen1	are	regulated	by	cell	cycle-
dependent	 phosphorylation/dephosphorylation	 events.	 Mus81-Mms4	 gets	 activated	 by	 CDK-	 and	 Cdc5-dependent	













EME1	 (the	 human	 homolog	 of	 Mus81-Mms4)	 interacts	 directly	 with	 SLX1-SLX4	 in	 a	
phosphorylation	 (CDK1	 and	 PLK1)-dependent	manner	 (Wyatt	 et	 al.,	 2013).	 In	 contrast	 to	 the	
human	 SLX1-SLX4-MUS81-MMS4	 complex	 in	 which	 the	 interaction	 of	 the	 two	 endonucleases	
leads	to	coordinated	and	enhanced	activity	(Wyatt	et	al.,	2013),	the	Slx1	nuclease	activity	does	not	
seem	 to	 contribute	 to	Mus81-dependent	 resolution	 in	 budding	 yeast	 (Gritenaite	 et	 al.,	 2014).	
Instead,	 the	 exact	 mechanism	 by	 which	 mitotic	 complex	 formation	 enhances	 the	 resolution	





contrast	 to	Mus81-Mms4,	phosphorylation	of	Yen1	has	an	 inhibitory	 function	and	needs	 to	be	
removed	to	allow	full	endonuclease	activity	(Kosugi	et	al.,	2009,	Matos	et	al.,	2011,	Matos	et	al.,	




protein	 inactive	 during	 S-	 and	 early	 M-phase:	 (i)	 export	 of	 Yen1	 from	 the	 nucleus	 and	 (ii)	
downregulation	of	 the	enzymatic	activity	 (Matos	et	al.,	2011,	Blanco	et	al.,	2014,	Eissler	et	al.,	
2014,	Garcia-Luis	et	al.,	2014).	These	mechanisms	are	further	reinforced	by	active	degradation	of	










As	 a	 consequence	 of	 the	 establishment	 of	 such	 a	 clear	 cell	 cycle	 regulation	 of	 the	 resolvases	
Mus81-Mms4	 and	 Yen1	 and	 their	 specific	 upregulation	 during	 M-phase,	 the	 necessity	 of	 the	
observed	regulation	has	become	a	matter	of	ongoing	investigations.		
In	 this	context,	 the	development	of	genetic	 tools	 that	allow	prolonged	activation	of	 the	
SSEs	provided	an	entry	point	to	address	this	question.	The	bypass	of	the	Mus81-Mms4	regulation	












(Matos	 et	 al.,	 2013,	 Blanco	 et	 al.,	 2014,	 Szakal	 and	 Branzei,	 2013).	 This	 hypothesis	 is	 further	
supported	by	the	fact	that	the					S.	pombe	homolog	of	Mus81-Mms4,	Mus81-Eme1,	is	regulated	by	
the	 S-phase	 checkpoint	 in	 response	 to	 acute	HU	 treatment.	 Phosphorylation	 of	Mus81	 by	 the	
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as	 well	 as	 the	 S.pombe	 homolog	 Mus81-Eme1,	 show	 strong	 genetic	 interactions	 with	 factors	
involved	in	replication	fork	protection	(Noguchi	et	al.,	2003,	Noguchi	et	al.,	2004,	Bellaoui	et	al.,	
2003,	Pebernard	et	al.,	2004,	Boddy	et	al.,	2003,	Irmisch	et	al.,	2009,	Torres-Rosell	et	al.,	2005).	In	
addition,	 studies	performed	 in	mammalian	 cells	 have	 established	 that	 loss	 of	MUS81	 function	
leads	to	replication	perturbation	and	checkpoint	activation	(Hanada	et	al.,	2007,	Shimura	et	al.,	
2008,	Regairaz	et	al.,	2011,	Buisson	et	al.,	2015,	Fu	et	al.,	2015,	Xing	et	al.,	2015).	The	observation	
that	stalled	 forks	undergo	MUS81-dependent	cleavage	after	 long	 treatment	with	HU	or	CPT	to	
facilitate	replication	fork	restart	(Hanada	et	al.,	2007,	Shimura	et	al.,	2008,	Regairaz	et	al.,	2011,	
Pepe	 and	West,	 2014a,	 Fu	 et	 al.,	 2015)	 further	 strengthens	 the	 argument	 that	 SSEs	might	 be	
required	directly	during	replication	despite	their	potential	toxicity	and	non-matching	temporal	
profile.		
	 Taken	 together,	 the	 observed	 discrepancy	 between	 the	 temporal	 regulation	 of	 SSEs,	
specifically	Mus81-Mms4,	 and	 their	 implication	 during	 replication	 is	 still	 a	matter	 of	 ongoing	
discussions.		
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Aims	of	the	studies	
Publication	1	|	Bittmann	et	al.,	(2020)	eLife	
















terminal	 degrons)	 of	 cyclins	 and	 allow	 to	 restrict	 the	 protein	 of	 interest	 (in	 our	 case	Mus81-
Mms4)	to	different	cell	cycle	phases	(S-,	M-	or	G1-phase)	by	simple	fusion	to	the	protein.	Using	














system	 on	 a	 constitutively	 active	 version	 of	 the	 SSE	 Yen1	 (Yen1-ON)	 to	 address	 which	




The	 upregulation	 of	 the	 Mus81-Mms4	 catalytic	 activity	 during	 M-phase	 depends	 on	 both	
phosphorylation	 of	 the	Mms4	 subunit	 by	 the	 CDK	 and	Cdc5	 kinase	 (Matos	 et	 al.,	 2011,	Gallo-
Fernandez	et	al.,	2012,	Matos	et	al.,	2013,	Szakal	and	Branzei,	2013)	as	well	as	the	engagement	of	
Mus81-Mms4	into	a	higher	order	complex	comprising	the	scaffold	proteins	Dpb11,	Rtt107	and	





DDK	 cooperatively	 target	 Mms4	 and	 that	 the	 phosphorylation	 of	 Mms4	 by	 the	 two	 kinases	
additionally	depends	on	the	Rtt107	scaffold.		
Consequently,	 the	 second	 aim	 of	 the	 study	 became	 to	 analyse	 this	 interdependency	
between	the	kinases	and	scaffold	proteins	during	the	activation	of	Mus81-Mms4.	Generally,	one	
readout	 of	Mus81-Mms4	 activity	 during	 the	 resolution	 of	 recombination	 intermediates	 is	 the	
relative	number	of	COs	produced.	
My	specific	aim	was	to	establish	an	experimental	setup	(Ho	et	al.,	2010)	that	would	allow	
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Abstract Cell cycle tags allow to restrict target protein expression to specific cell cycle phases.
Here, we present an advanced toolbox of cell cycle tag constructs in budding yeast with defined
and compatible peak expression that allow comparison of protein functionality at different cell
cycle phases. We apply this technology to the question of how and when Mus81-Mms4 and Yen1
nucleases act on DNA replication or recombination structures. Restriction of Mus81-Mms4 to M
phase but not S phase allows a wildtype response to various forms of replication perturbation and
DNA damage in S phase, suggesting it acts as a post-replicative resolvase. Moreover, we use cell
cycle tags to reinstall cell cycle control to a deregulated version of Yen1, showing that its
premature activation interferes with the response to perturbed replication. Curbing resolvase
activity and establishing a hierarchy of resolution mechanisms are therefore the principal reasons
underlying resolvase cell cycle regulation.
Introduction
Eukaryotic chromosomes undergo dramatic structural changes during the cell cycle often referred to
as the chromosome cycle (Blow and Tanaka, 2005). In order to maintain the integrity of genetic
information cells need to adjust their DNA repair and genome integrity pathways to the different
requirements within this chromosome cycle. Accordingly, many DNA repair enzymes are regulated
by transcriptional and post-translational mechanisms or otherwise adjusted to act at specific stages
of the cell cycle (Hustedt and Durocher, 2017). While our knowledge of regulatory mechanisms has
grown over the past years, a question that often arises is whether a certain enzyme or protein has a
function, or not, at a specific cell cycle stage.
Answering this question usually involves cell cycle synchronization and sophisticated tools to
induce/deplete protein expression at specific time points. Moreover, not all phenotypes can be
investigated in single cell cycle experiments. A simple system that promises to overcome these limi-
tations utilizes so called ‘cell cycle tags’. The cell cycle tag methodology was initially developed for
budding yeast by the Jentsch group (Karras and Jentsch, 2010) and expanded by Kolodner and
colleagues (Hombauer et al., 2011) and Kubota and colleagues (Johnson et al., 2016). Cell cycle
tagging involves both the replacement of the endogenous promoter of a gene of interest by a cell
cycle-regulated promoter as well as the addition of a protein-coding sequence containing a cell
cycle-regulated degradation signal (degron), restricting the expression of the fusion protein to a spe-
cific phase of the cell cycle. So far, three cell cycle tags have been developed based on the S phase
cyclin Clb6, the M phase cyclin Clb2 and the G1 regulator Sic1 (Karras and Jentsch, 2010;
Hombauer et al., 2011; Johnson et al., 2016). These tags constrain protein expression to S phase,
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early M phase and late M to G1 phase, respectively. Single constructs, and also combinations have
been used in several studies (Karras and Jentsch, 2010; Hombauer et al., 2011; Karras et al.,
2013; González-Prieto et al., 2013; Gonzalez-Huici et al., 2014; Menolfi et al., 2015; Renaud-
Young et al., 2015; Johnson et al., 2016; Siler et al., 2017; Hung et al., 2017; Lafuente-
Barquero et al., 2017; Kahli et al., 2019; Lockhart et al., 2019). Notwithstanding, the current
three-construct-system has major limitations: (i) peak expression levels from the three constructs are
vastly different (Sic1 > Clb2 > Clb6, compare Figure 1C) and (ii) expression levels cannot be
adjusted, which can lead to under- or overexpression of the protein of interest. Collectively, these
limitations may confound the interpretation of cell cycle tag experiments.
To overcome these limitations, we have set out to generate an advanced toolbox of 46 cell cycle
tag constructs with varied expression levels. To achieve these variations in expression, we have used
additional promoters/degrons from cyclins Clb5 and Clb1 and introduced chimeric constructs with
new promoter/degron combinations (Figure 1A). Furthermore, in order to cripple expression from
specific promoters, we introduced 5’UTR truncations (Merrick and Pavitt, 2018) and upstream out
of frame ATGs (Araujo et al., 2012; Yun et al., 2012; Dvir et al., 2013; Figure 1A). This construct
toolbox will allow comparable and, within a certain range, titratable expression of the protein of
interest.
As a proof of principle, we applied the advanced cell cycle tag toolbox to study the regulation of
two structure-selective endonucleases (SSEs), Mus81-Mms4 and Yen1. SSEs are involved in many
DNA repair pathways and defined by their ability to recognize and cleave branched DNA structures
(Ciccia et al., 2008; Schwartz and Heyer, 2011; Dehé and Gaillard, 2017). While required for the
corresponding repair mechanisms, it is obvious that cells must also tightly control SSEs, as unsched-
uled activation of nucleolytic activities might lead to genome instability (Dehé and Gaillard, 2017;
Pfander and Matos, 2017). A number of SSEs have the ability to cleave Holliday junction (HJ) struc-
tures and are therefore involved in processing DNA intermediates arising during homologous recom-
bination (HR) and/or as consequence of replication stalling (Boddy et al., 2001; Kaliraman et al.,
2001; Doe et al., 2002; Bastin-Shanower et al., 2003; Ciccia et al., 2003; Fricke and Brill, 2003;
Gaillard et al., 2003; Ehmsen and Heyer, 2008; Ip et al., 2008; Jessop and Lichten, 2008;
Oh et al., 2008; Muñoz et al., 2009; Rass et al., 2010; Wechsler et al., 2011; Saugar et al., 2013;
Wyatt et al., 2013; Saugar et al., 2017). In mitotically dividing budding yeast three HJ-processing
SSEs are active – Mus81-Mms4, Yen1 and Slx1 (Matos and West, 2014; Blanco and Matos, 2015;
Guervilly and Gaillard, 2018).
The heterodimeric Mus81-Mms4 nuclease is known to undergo cell cycle regulation with the
Mms4 subunit becoming phosphorylated in M phase (Matos et al., 2011; Gallo-Fernández et al.,
2012; Matos et al., 2013; Szakal and Branzei, 2013; Princz et al., 2017). This phosphorylation is
mediated by the budding yeast cyclin dependent kinase (CDK) Cdk1/Cdc28 and by a complex con-
sisting of two kinases – polo-like kinase Cdc5 and Dbf4-dependent kinase DDK (Cdc7+Dbf4) (Gallo-
Fernández et al., 2012; Matos et al., 2013; Szakal and Branzei, 2013; Princz et al., 2017),
whereby the timing of Cdc5 expression determines the M phase restriction of Mms4 phosphoryla-
tion (Matos et al., 2013; Princz et al., 2017). Cell cycle regulation impinges on Mus81-Mms4 by
two mechanisms. While phosphorylation of Mus81-Mms4 directly stimulates its catalytic activity
(Matos et al., 2011; Gallo-Fernández et al., 2012; Schwartz et al., 2012; Matos et al., 2013), a
second layer of cell cycle regulation requires the engagement of Mus81-Mms4 in a phosphorylation-
dependent multi-protein complex comprising several scaffold proteins such as Slx4, Dpb11 and
Rtt107 (referred to as Mus81 complex hereafter) (Gritenaite et al., 2014; Princz et al., 2015;
Princz et al., 2017). The Mus81 complex forms exclusively during M phase and is likely involved in
targeting Mus81-Mms4 to its substrates or controlling its action by other means (Gritenaite et al.,
2014; Princz et al., 2017). Intriguingly, phosphorylation of Mus81-Mms4 and formation of the
Mus81 complex displays features commonly associated with switch-like activation (positive feedback,
multi-site phosphorylation), suggesting that with the transition to M phase cells might enter a state
of increased Mus81-Mms4 function (Pfander and Matos, 2017; Princz et al., 2017) (note that func-
tion in vivo will not only be determined by enzymatic activity, but also by targeting of the enzyme to
its substrate, etc). Notably, however, mus81 mutant phenotypes suggest that the main function of
Mus81-Mms4 can be attributed to the response to replication perturbation (Xiao et al., 1998;
Interthal and Heyer, 2000; Boddy et al., 2001; Mullen et al., 2001; Doe et al., 2002; Bastin-
Shanower et al., 2003; Kai et al., 2005). This raises the question, whether (i) Mus81-Mms4 may be
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Model of “High”/”Low” strategy
Figure 1. An advanced toolbox of cell cycle tag constructs. (A) Schematic representation of the applied strategies for improved cell cycle tag
methodology. Upper panel: conventional cell cycle tag methodology was limited by only one construct for each cell cycle phase. Lower panel: the
advanced cell cycle tag toolbox was expanded to 46 constructs. Therefore, we used new promoters and degrons from Clb5 and Clb1, chimeric
promoter-degron combinations and protein expression was crippled using 5´UTR truncations and upstream out of frame ATGs. Vertical bars indicate
Figure 1 continued on next page
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acting in S phase directly on stalled replication forks or repair intermediates, despite a non-matching
temporal regulation, or whether (ii) Mus81-Mms4 acts in M phase as post-replicative resolvase.
A second SSE with the propensity to cleave HJ structures is called Yen1 (Ip et al., 2008;
Blanco et al., 2010). Yen1 is also tightly cell cycle-controlled and becomes dephosphorylated in late
M phase, specifically at the metaphase-to-anaphase transition, when CDK becomes inactivated and
phosphorylation marks on Yen1 are removed by Cdc14 (Kosugi et al., 2009; Matos et al., 2011;
Blanco et al., 2014; Eissler et al., 2014; Garcı́a-Luis et al., 2014). Yen1 regulation consists of sev-
eral layers and involves phosphorylation-dependent inhibition of its catalytic activity as well as phos-
phorylation-dependent regulation of its sub-cellular localization (Matos et al., 2011; Blanco et al.,
2014; Eissler et al., 2014; Garcı́a-Luis et al., 2014). Furthermore, at the G1/S transition a degrada-
tion mechanism is in place to clear Yen1 from chromatin (Talhaoui et al., 2018). Altogether, a pic-
ture emerges whereby Yen1 is inhibited by CDK phosphorylation and becomes stimulated or
activated from late M phase to the end of G1 (Blanco et al., 2014; Eissler et al., 2014; Garcı́a-
Luis et al., 2014). The temporal windows of high Mus81-Mms4 activity and high Yen1 activity there-
fore appear non-overlapping (Matos et al., 2011). Experimental removal of the inhibitory phosphor-
ylation sites on Yen1 generated an allele (YEN1-ON), where Yen1 was found to be uncoupled from
cell cycle regulation and constitutively active (Matos et al., 2013; Blanco et al., 2014). This allele
allowed to study the consequences of unrestricted activation of an SSE and showed that ectopic
nuclease activity has adverse consequences in presence of replication stalling agents, suggesting
that unscheduled cleavage of replication intermediates by this SSE interferes with the response to
replication stalling (Blanco et al., 2014).
The control of SSEs in human cells involves additional features, such as the presence of two mutu-
ally exclusive MUS81 regulators (called EME1 and EME2), but the principal mechanisms of control
appear to be evolutionary conserved (Matos et al., 2011; Wyatt et al., 2013; Chan and West,
2014; Duda et al., 2016), suggesting that cell cycle control of SSEs is an intrinsic necessity. In this
study, we take advantage of the genetic tractability of budding yeast to expand, improve and apply
cell cycle tag technology with an advanced toolbox of cell cycle tag constructs to investigate the rel-
evance of Mus81-Mms4 and Yen1 cell cycle regulation. We show that several survival and genome
instability phenotypes induced by chronic or acute exposure to DNA damaging agents or other gen-
otoxic agents are rescued by M phase restricted Mus81-Mms4, but not by a version that is confined
to S phase. This suggests that for the conditions tested, the essential function of Mus81-Mms4 is as
a post-replicative resolvase. Yen1 can compensate for this function, if present in constitutively active
form in early M phase. We also employ cell cycle tags to reintroduce cell cycle regulation and find
that premature activation of Yen1 in S phase, but also in early M phase interferes with the response
Figure 1 continued
location of cell cycle regulatory elements in the promoter and N-terminal degron sequence (see Figure 1—figure supplement 1 for detailed
description of the tagging procedure). (B) New cell cycle tag constructs allow cell cycle-restricted expression of GFP at varied peak expression levels.
Anti-FLAG westerns of cells expressing Clb5pClb5-, Clb6pClb5-, Clb6pClb6-, Clb1pClb1-, Clb2pClb1-, Clb2pClb2-3FLAG-tagged versions of GFP after G1 arrest
with a-factor and synchronous release through the cell cycle up to the next G1 phase. Pgk1 western was used as control and DNA content
measurements indicate cell cycle progression at the individual time points below (see Figure 1—figure supplement 2 for G1 release experiments of
the corresponding 5´UTR truncations and for constructs containing upstream out of frame ATGs). (C) New promoters and degrons, chimeric promoter-
degron combinations, 5’UTR truncations and upstream out of frame ATGs allow a broad spectrum of peak expression levels of cell cycle-restricted GFP.
Western blot analysis of peak expression levels of cell cycle-tagged 3FLAG-GFP variants at indicated time points after G1 release (20 min = S phase, 50
min = M phase, 100 min = G1 phase). DNA content measurements below indicate cell cycle progression. Graph: peak expression levels were quantified
using Image-J and signals of the individual constructs were divided by the corresponding Pgk1 sample to normalize to overall protein levels (see
Figure 1—figure supplement 3 for an overview of all cell cycle-tagged GFP versions in cells arrested in the corresponding cell cycle phase). (D)
Schematic representation of the suggested cell cycle tag strategy using two sets of constructs with matching ‘low’ and ‘high’ peak expression levels.
‘Low’ expressing constructs (light colours) are chosen by matching peak expression levels similar to the endogenous protein but will show
underexpression at cell cycle phase transitions. ‘High’ expressing tags generally show higher expression compared to the wildtype protein with the
advantage of broader timeframes of action (timeframes in which protein levels are similar or higher than endogenous protein levels).
The online version of this article includes the following figure supplement(s) for figure 1:
Figure supplement 1. Schematic representation of the cell cycle tagging procedure.
Figure supplement 2. 5’UTR truncations and upstream out of frame ATGs do not interfere with cell cycle restriction.
Figure supplement 3. 5’UTR truncations and upstream out of frame ATGs cripple peak expression levels of cell cycle tag constructs.
Figure supplement 4. Clb6pClb6- and Clb2pClb1-tag induce similar peak expression levels for several cell cycle-tagged proteins.
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to replication fork stalling, suggesting that a temporal hierarchy of HJ-cleaving nucleases is required
for optimal DNA repair.
Results
An advanced toolbox of cell cycle tags
When we started this study, three cell cycle tag constructs were available to restrict target protein
expression to G1, S or M phase. The S-tag uses promoter and N-terminal degron (aa 1–195) of the S
phase cyclin Clb6 and restricts expression to S phase (Figure 1A; Hombauer et al., 2011). The
M-tag (originally referred to as G2-tag; Karras and Jentsch, 2010) uses promoter and N-terminal
degron sequence (aa 1–180) of the M phase cyclin Clb2 and restricts expression to M phase
(Figure 1A; Karras and Jentsch, 2010). The G1-tag uses promoter and N-terminal degron of the
G1 regulator Sic1 (aa 1–105) and restricts protein expression to G1 (Figure 1A; Johnson et al.,
2016). In order to overcome the limitations of these specific constructs and allow for modulation of
expression levels we generated a toolbox of 46 cell cycle tag constructs. Specifically, we used a
three-pronged approach to create constructs that at the same time allow varied peak expression lev-
els and retained cell cycle restriction (Figure 1A): (i) we used additional promoters and N-terminal
degron sequences from S phase cyclin Clb5 (aa 1–202) and from M phase cyclin Clb1 (aa 1–120); (ii)
we generated chimeric S-tag and M-tag constructs (containing Clb5 promoter and Clb6 degron
(Clb6pClb5-tag) or Clb1 promoter and Clb2 degron (Clb2pClb1-tag), respectively); (iii) in order to crip-
ple expression from some promoters, we either truncated 5’UTRs or introduced out-of-frame ATGs,
which have been shown to reduce protein expression levels by reduced mRNA stability and reduced
translation rates, respectively (Yun et al., 2012; Araujo et al., 2012; Dvir et al., 2013; Merrick and
Pavitt, 2018).
We constructed 46 plasmids based on the pYM-N vector series (Janke et al., 2004) that allow
the introduction of all variants of cell cycle tags by a well-established recombination-based strategy
using a single pair of oligonucleotide primers and the natNT2 resistance cassette (Figure 1—figure
supplement 1, see supplementary methods for detailed protocol). As test substrate, we subjected
the GFP ORF, which was integrated in the yeast genome, to the cell cycle tagging approach and the
resulting yeast strains were verified for genomic integration and expression. Next, we tested
whether all constructs restricted protein expression to the desired cell cycle phases. Therefore, we
arrested cells in G1 using a-factor, synchronously released them into the cell cycle and followed
them to the next G1. Notably, all constructs restricted GFP-expression to the target cell cycle phase
(Figure 1B, Figure 1—figure supplement 2). When comparing the different S-tag constructs, we
noticed that constructs containing the Clb6 degron sequence imposed a much sharper restriction of
expression to S phase consistent with the differential regulation of Clb5 and Clb6 (Figure 1B;
Kühne and Linder, 1993; Schwob and Nasmyth, 1993; Jackson et al., 2006), suggesting that
these constructs should be the preferred choice for an S-tag experiment.
We then took S, M and G1 phase samples (20, 50 and 100 min, respectively) from our cell cycle
release experiments in order to measure peak expression levels for the individual constructs. This
analysis showed that within different G1-, S- and M-tag constructs expression varied by up to 10-
fold, respectively (Figure 1C, Figure 1—figure supplement 3). Notably, none of the S-tag con-
structs tested gave peak expression levels in the same range as those of the previously used Clb2
M-tag and Sic1 G1-tag constructs (Figure 1C, Figure 1—figure supplement 3), emphasizing the
need for new M- and G1-tag constructs. Satisfyingly, we found that M-tag constructs containing the
pClb1 promoter or the 5’UTR-truncated pClb2 promoter showed much weaker peak expression lev-
els and tighter temporal restriction of expression at the same time (Figure 1B–C, Figure 1—figure
supplements 2 and 3). Similarly, for the G1-tag we found that upstream out-of-frame ATGs reduced
protein expression from pSic1 constructs and also led to tighter temporal restriction of expression
(Figure 1B–C, Figure 1—figure supplements 2 and 3).
Therefore, these constructs from our advanced cell cycle tag toolbox will allow to titrate peak
expression levels within a certain range and offer at the same time superior restriction of target pro-
tein expression to the cell cycle phase of interest. We also note that by introducing cell cycle-
restricted expression, one will usually change expression of the protein of interest from a continuous,
often constant expression regime to a dynamically, cell cycle phase-restricted expression regime
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(Figure 1D). Due to this dynamic expression it may sometimes be difficult to directly compare cell
cycle-tagged constructs with endogenous proteins, as well as the arising phenotypes. To mitigate
this problem, we therefore developed a strategy where we conducted experiments with two sets of
G1-, S- and M-tag constructs (Figure 1D). The first set (called ‘low’ hereafter) can be chosen to yield
peak expression similar to the protein of interest but may show ‘under-expression’ at cell cycle tran-
sitions (Figure 1D). The second set (called ‘high’ hereafter) can be chosen to yield peak expression
higher to the protein of interest (overexpression) but will avoid under-expression at cell cycle transi-
tions (Figure 1D). Most importantly, with the presented toolbox it will be possible to use constructs,
which give highly similar peak expression levels in different cell cycle phases and the respective
strains are therefore phenotypically comparable. Protein expression should be tested for any new
cell cycle-tagged protein, even though we observed similar trends for different proteins tested. For
example, we found that S phase levels of Clb6pClb6-tagged proteins were very similar to levels of
Clb2pClb1-tagged proteins in five (Xrs2, Rad52, Fun30, Sgs1, Yen1-ON) (Figure 1—figure supple-
ment 4, Figure 5—figure supplement 2) out of six cases (Mus81-Mms4 being the exception). Over-
all, our advanced cell cycle tag toolbox therefore offers titratable expression levels, which allows for
the first time a direct comparison of phenotypes arising from cell cycle restriction of a protein of
interest to G1, S or M phase.
Cell cycle-restricted expression of Mus81-Mms4
To showcase the cell cycle tag toolbox, we applied it to Mus81-Mms4. Deletion of MUS81 or MMS4
causes phenotypes that imply Mus81-Mms4 in the cellular response to replication fork stalling
(Xiao et al., 1998; Interthal and Heyer, 2000; Boddy et al., 2001; Mullen et al., 2001; Doe et al.,
2002; Bastin-Shanower et al., 2003; Kai et al., 2005; Saugar et al., 2013). In contrast, Mus81-
Mms4 function is specifically upregulated once cells enter M phase (Matos et al., 2011; Gallo-
Fernández et al., 2012; Matos et al., 2013; Saugar et al., 2013; Szakal and Branzei, 2013;
Gritenaite et al., 2014; Princz et al., 2017). We therefore decided to employ our toolbox to dis-
criminate between potential S phase- and M phase-specific functions of Mus81-Mms4. In addition to
the strategy outlined in Figure 1, we constructed cell cycle tags for both subunits of the Mus81-
Mms4 heterodimer, as we reasoned that this would result in even tighter cell cycle restriction of the
complex. Specifically, we found that Clb6pClb6 -80bp-tagged and Clb2pClb1 -150bp-tagged versions of
Mus81-Mms4 restricted Mus81-Mms4 expression to S and M phase and resulted in very similar peak
expression levels between 0.9 and 1.2-fold of the endogenous proteins (Figure 2A, Figure 2—fig-
ure supplement 1A,C). We therefore refer to these versions as Slow-Mus81-Mms4 (Clb6pClb6 -80bp-
tag) and Mlow-Mus81-Mms4 (Clb2pClb1 -150bp-tag), respectively. While peak expression levels are
comparable to endogenous Mus81-Mms4, we observed reduced expression levels at cell cycle tran-
sitions. For example, we observed that expression of Mlow-Mus81-Mms4 was below endogenous lev-
els in early M phase (see Figure 2B, 37.5 and 45 min time points). The same trend was also
observed for the nuclear fraction of Mus81-Mms4 (Figure 2B, right panel, Figure 2—figure supple-
ment 2). Consistently, the window of time during which we could observe the M phase specific,
hyperphosphorylated form of Mms4 was shorter for Mlow-Mus81-Mms4 compared to endogenous
Mus81-Mms4 (Figure 2C). Taken together, Mlow-Mus81-Mms4 peak expression is comparable to
endogenous Mus81-Mms4, but expression and hyperphosphorylation appears reduced in early and
late M phase. To complement Slow-Mus81-Mms4 and Mlow-Mus81-Mms4, we therefore also used the
Clb5pClb6-tagged S phase-restricted Shigh-Mus81-Mms4, as well as Clb2pClb1-tagged M phase-
restricted Mhigh-Mus81-Mms4 (Figure 2A). Comparison of peak expression levels in S and M phase
suggests that Shigh-Mus81-Mms4 and Mhigh-Mus81-Mms4 are expressed to very similar levels, but 2
to 5-fold overexpressed compared to endogenous Mus81-Mms4 (Figure 2—figure supplement 1B,
C). Both constructs showed expected restriction of expression to S and M phase (Figure 2A) and
when we compared Mhigh-Mus81-Mms4 to Mlow-Mus81-Mms4, we noticed that the Mhigh-Mus81-
Mms4 did neither show underexpression in early M phase (Figure 2B), nor a shortened window of M
phase-specific Mms4 phosphorylation (Figure 2C). Therefore, Shigh-Mus81-Mms4 and Mhigh-Mus81-
Mms4 constructs are expressed to similar levels, avoid under-expression at cell cycle transitions, but
show overexpression compared to endogenous expression levels. The two sets of S- and M-tag con-
structs are therefore complementary and enable us to follow the high/low expression strategy out-
lined in Figure 1D to investigate Mus81-Mms4 phenotypes.
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Figure 2. Cell cycle-restricted expression of Mus81-Mms4. (A) Restriction of Mus81-Mms4 expression to S or M phase of matched pairs of ‘low’ and
‘high’ expressing cell cycle tag constructs. (Left) Western blot and DNA content analysis of strains expressing WT, S phase-restricted (Slow (Clb6pClb6 -
80bp)-/Shigh (Clb6pClb5)-Mus81-Mms4) and M phase-restricted (Mlow (Clb2pClb1 -150bp)-/Mhigh (Clb2pClb1)-Mus81-Mms4) alleles of Mus81 (9MYC-tagged)-
Mms4 (3FLAG-tagged) during a single cell cycle as in Figure 1D (see Figure 2—figure supplement 1 for quantification of peak expression levels of
Figure 2 continued on next page
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Lastly, we also ensured that N-terminal tagging of Mus81 or Mms4 did not lead to inactivation of
the Mus81-Mms4 enzymatic activity. To this end we obtained Mus81-Mms4, Clb6 (S-)-tagged
Mus81-Mms4 and Clb2 (M-)-tagged Mus81-Mms4 by immuno-purification, phosphatase treated the
protein to exclude cell cycle-dependent stimulatory effects and found that all versions showed nucle-
ase activity towards a nicked Holliday junction (nHJ) model substrate (Figure 2D, Figure 2—figure
supplement 3).
Mus81-Mms4 restricted to M phase, but not S phase is sufficient for the
response to genotoxic insults
To reveal phenotypes of Mus81-Mms4 cell cycle restriction, we first tested cell viability upon chronic
exposure to replication stalling chemicals (MMS, CPT and HU). mus81D cells were hypersensitive to
MMS and CPT and showed reduced growth on HU containing medium (Figure 3A–B; Xiao et al.,
1998; Interthal and Heyer, 2000; Mullen et al., 2001; Bastin-Shanower et al., 2003;
Saugar et al., 2013). Restricting Mus81-Mms4 to S phase also gave a severe hypersensitivity to
MMS and CPT: Slow-Mus81-Mms4 expressing cells showed similar phenotypes as mus81D
(Figure 3A, Figure 3—figure supplement 1A), while Shigh-Mus81-Mms4 also showed pronounced
hypersensitivity, but compared to mus81D (and Slow-Mus81-Mms4) the phenotype was less severe
(Figure 3B). In contrast, restricting Mus81-Mms4 to M phase showed very little phenotype. Specifi-
cally, Mhigh-Mus81-Mms4 cells did not show any hypersensitivity (Figure 3B), while Mlow-Mus81-
Mms4 cells showed a small but detectable growth defect in the presence of high doses of MMS or
CPT (Figure 3A). Collectively, these data suggest that Mus81-Mms4 would exhibit its dominant func-
tion in the response to genotoxic agents during M phase and not during S phase.
We interpret the slight phenotypic differences between Shigh-Mus81-Mms4 and Slow-Mus81-
Mms4, as well as between Mhigh-Mus81-Mms4 and Mlow-Mus81-Mms4 (Figure 3A–B), to arise from
leaking of Shigh-Mus81-Mms4 into M phase (Figure 2A) as well as from underexpression of Mlow-
Mus81-Mms4 during early and late M phase (Figure 2B–C), respectively. This interpretation is sup-
ported by the facts that (i) the residual viability of Shigh-Mus81-Mms4 depends on M phase-specific
phosphorylation events (Figure 3—figure supplement 1B–C,M phase specific phosphorylation is
abolished by the mms4-14A mutant; Matos et al., 2011) and (ii) the MMS and CPT sensitivity of
Figure 2 continued
the Slow-/Mlow -Mus81-Mms4 and Shigh-/Mhigh-Mus81-Mms4 constructs). (Right) Schematic representation of WT, S (Slow-/Shigh-Mus81-Mms4) and M
phase (Mlow-/Mhigh-Mus81-Mms4) restricted Mus81-Mms4 constructs. Blue and green bars indicate location of cell cycle regulatory elements in the
promoter and N-terminal degron sequence. (B) Different constructs (‘high’ and ‘low’ peak expression levels) of Mus81-Mms4 lead to underexpression of
the Mlow-Mus81-Mms4 construct or to overexpression of the Mhigh-Mus81-Mms4 construct in early M phase and similar trends are seen in the nuclear
fraction. Western blot analysis of protein levels in whole cell extracts (left panel) and after nuclei separation (right panel) at indicated time points after a
G1-release (early M phase; see DNA content profile depicted at the bottom). While immediately with entry into M phase the Mhigh-Mus81-Mms4
construct reaches similar or higher protein levels than endogenous Mus81-Mms4, the Mlow-Mus81-Mms4 construct shows a 10–15 min delay in reaching
comparable expression levels and this holds true for both, whole cell extracts and the nuclear fraction. Expression levels were quantified using Image-J
and signals of the individual time points were divided by the corresponding Pgk1 (whole cell extracts) or Nsp1 (nuclear fraction) signal to normalize to
overall protein levels (graphs below contain normalized values for every construct). (see Figure 2—figure supplement 2 for control western blots of the
nuclear fractionation) (C) Different constructs (‘high’ and ‘low’ peak expression levels) of Mus81-Mms4 lead to different windows of Mus81-Mms4
phosphorylation in Mlow-Mus81-Mms4 and Mhigh-Mus81-Mms4. Western blot analysis of the phosphorylation states of Mms4 at indicated time points
after a G1-release (M phase; see DNA content profile depicted below the western blots). While Mhigh-Mus81-Mms4 shows a similar timeframe of Mms4
phosphorylation to endogenous Mus81-Mms4, Mlow-Mus81-Mms4 is phosphorylated and stimulated during a shortened window of time only (compare
red lines above the Mms4-3FLAG western blots: 15–20 min of phosphorylation in Mlow-Mus81-Mms4 compared to 30 min in Mhigh-Mus81-Mms4 and
30–35 min in Mus81-Mms4). (D) N-terminal tagging does not alter Mus81-Mms4 activity. Resolution assay using a nicked HJ (nHJ) substrate and
immunopurified Mus81-Mms4, S-Mus81-Mms4 and M-Mus81-Mms4 (note that WT and cell cycle-tagged proteins were expressed from pGal1-10
promoter). Myc-tagged Mus81-Mms4 was purified from cycling cells, dephosphorylated using l-Phosphatase and incubated with the nHJ substrate for
2 hr. Upper panel: nHJ cleavage assay with heat DNA substrate (HD) as control. Lower panel: western blot analysis of Mus81-9MYC IP after nHJ
cleavage assay (see Figure 2—figure supplement 3 for a western blot analysis of Mms4 dephosphorylation by l-Phosphatase).
The online version of this article includes the following figure supplement(s) for figure 2:
Figure supplement 1. Analysis of ‘low’ and ‘high’ S- and M-tagged Mus81-Mms4 peak expression levels.
Figure supplement 2. Nuclear/cytoplasmic fractionation.
Figure supplement 3. l-Phosphatase treatment leads to efficient Mms4 dephosphorylation of WT, S- and M-Mus81-Mms4 used for activity assays.
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Figure 3. Mus81-Mms4 restricted to M phase, but not S phase is sufficient for the response to genotoxic insults. (A/B) M phase-restricted Mus81-Mms4
is sufficient to confer viability to replication fork stalling drugs. Viability of cells with Mlow (Clb2pClb1 -150bp)-Mus81-Mms4/Slow (Clb6pClb6 -80bp)-Mus81-
Mms4 constructs at low peak expression levels (A) or Mhigh (Clb2pClb1)-Mus81-Mms4/Shigh (Clb6pClb5)-Mus81-Mms4 constructs at high peak expression
levels (B) is compared to that of WT and mus81D cells. Strains were plated in 5-fold serial dilutions on YPD plates containing the indicated amounts of
MMS, CPT or HU and incubated at 30˚C for 2 days. (C/D) Mitotic function of Mus81-Mms4 is sufficient to confer viability upon induction of RNA-DNA-
hybrids in the absence of RNAse H enzymes and mild replication stress (HU). Cell cycle-tagged versions of Mus81-Mms4 were integrated in the rnh1D
rnh201D background. Strains were spotted in 5-fold serial dilutions on YPD containing indicated concentrations of HU and incubated at 30˚C for 2 days.
(C) Spotting containing Mlow-Mus81-Mms4/Slow-Mus81-Mms4 cells. (D) Spotting of Mhigh-Mus81-Mms4/Shigh-Mus81-Mms4 cells. (E/F) Repair of Flp-
nickase induced DNA lesions requires the M phase function of Mus81-Mms4. Galactose-induced DNA nicking is presumed to be followed by
replication run-off in S phase to form single-ended DSBs and repair by BIR (Nielsen et al., 2009; Mayle et al., 2015). Location of the corresponding
FRT sites on chromosome IV and VI are indicated relative to replication origins. Cells were spotted in 5-fold serial dilutions in presence of glucose or
Figure 3 continued on next page
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Mlow-Mus81-Mms4 cannot be rescued by an additional copy of Slow-Mus81-Mms4 (Figure 3—figure
supplement 1D–E).
We next tested whether endogenous replication stress would require Mus81-Mms4 during M
phase as well or whether S phase Mus81-Mms4 could play a role in this context. Absence of RNa-
seH1 and RNaseH2 generates replication stress due to defects in the removal of RNA-DNA-hybrids
and defects in ribonucleotide excision repair (Sollier and Cimprich, 2015; Hamperl and Cimprich,
2016). Mus81 orthologs were first implicated in the replication stress caused by RNaseH-deficiency
because of the synthetic growth phenotype of a mus81D rnh1D rnh201D mutant in S. pombe
(Zhao et al., 2018). We observe a similar synthetic growth phenotype in the corresponding budding
yeast mus81D rnh1D rnh201D mutant, which was further aggravated by addition of HU in low con-
centrations (Figure 3C–D). Notably, presence of M phase-restricted versions of Mus81-Mms4 was
able to rescue these phenotypes back to levels of the rnh1D rnh201D strain, while S phase-restricted
versions of Mus81-Mms4 were unable to do so (Figure 3C–D). Furthermore, we studied the
response to a site-directed protein-bound single strand break induced by a step-arrest mutant of
the Flp recombinase (Flp nickase; Nielsen et al., 2009; Mayle et al., 2015). Previous studies have
suggested that single strand breaks generated in the Flp nickase system would lead to replication
run-off (replication fork breakage) and repair by break-induced replication (BIR) and that Mus81-
Mms4 and Yen1 would be redundantly required for survival (Mayle et al., 2015). Notably, however,
also in the Flp-nick system, we observed that M phase restriction of Mus81-Mms4 allowed survival
similar to WT cells (Figure 3E–F, note the yen1D background). In contrast, the Slow-Mus81-Mms4
construct led to pronounced sensitivity similar to the MUS81 deletion, while Shigh-Mus81-Mms4 led
to an intermediary phenotype (Figure 3E–F). Collectively, these data show that restriction of Mus81-
Mms4 to S phase renders cells sensitive to various forms of replication stress, while restriction of
Mus81-Mms4 to M phase does not cause a discernible phenotype, suggesting that in budding yeast
the dominant function of Mus81-Mms4 in response to replication stress is post-replicative.
Mus81-Mms4 act as a post-replicative resolvase
To reveal the temporal control underlying the activity of Mus81-Mms4 in resolving recombination
and/or replication structures, we turned to single cell cycle experiments. First, we used a single-cell-
cycle setup to show that even after DNA damage induction, and recovery, the cell cycle restriction
of Mus81-Mms4 expression to S or M phase remains intact (Figure 4—figure supplement 1). Con-
sistent with the fact that in budding yeast cyclin-CDK complexes are unlikely to be directly regulated
by DNA damage signals (Zegerman and Diffley, 2009), we observed restriction to S or M phase as
expected. When we next treated cells with MMS in S phase and measured cell survival, we obtained
a similar picture as in experiments with chronic exposure: M phase-restricted Mus81-Mms4 showed
sensitivity similar to WT cells (Figure 4A). In contrast, cells expressing S phase-restricted Mus81-
Mms4 showed hypersensitivity, with Slow-Mus81-Mms4 cells similar to the mus81D knock-out and
Shigh-Mus81-Mms4 displaying slightly better survival (Figure 4A). To have a physical read-out of
repair, we used pulsed-field gel electrophoresis (PFGE), which resolves linear chromosomes, but not
in the presence of replication and recombination structures. Intriguingly, mus81D deficiency has
been shown to interfere with recovery of linear chromosomes after MMS treatment in S phase
(Ho et al., 2010, see Figure 4B–C), but it has been unclear whether this represents a direct function
of Mus81 at stalled replication forks or rather a post-replicative function in resolving recombination
intermediates. When we released cells from replication fork stalling with MMS in S phase, we found
that cells expressing M phase-restricted Mus81-Mms4 versions recover linear chromosomes as WT
cells (Figure 4B–C). In contrast, cells restricting Mus81-Mms4 to S phase were strongly delayed in
the appearance of resolved, linear chromosomes, as were mus81D cells (Figure 4B–C). These data
Figure 3 continued
galactose (FLP-induction) and incubated at 30˚C for 2 days. (E) Spottings of Mlow-Mus81-Mms4/Slow-Mus81-Mms4 cells. (F) Spottings of Mhigh-Mus81-
Mms4/Shigh-Mus81-Mms4 cells.
The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. Residual Shigh-Mus81-Mms4 function in response to genotoxic agents is explained by insufficient restriction to S phase; slight
Mlow-Mus81-Mms4 defect in response to genotoxic agents is due to underexpression during M phase, respectively.
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Figure 4. Mus81-Mms4 act as a post-replicative resolvase. (A) Viability after a pulse of MMS in S phase and subsequent replication fork stalling
depends on the M phase function of Mus81-Mms4. Viability assay scoring survivors after pulses of MMS in S phase for one to three hours (upper). Cell
viability (%) was determined by colony forming units normalized to untreated cells (0 hr) and is depicted as mean of biological replicates (n = 3) with
error bars indicating standard deviation. Significance: n.s. p>0.05, *p<0.05, **p<0.005 as calculated by an unpaired Student´s T-test (see Figure 4—
Figure 4 continued on next page
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therefore indicate that Mus81-Mms4 resolves replication or recombination structures to linear chro-
mosomes in a post-replicative manner during M phase.
To further test if the dominant M phase function of Mus81 is that of a post-replicative resolvase,
we turned to DSB repair. Specifically, we used a genetic system to study the repair products of an
I-SceI induced DSB in diploid cells and score for rates by which recombination intermediates are
processed by resolution enzymes generating crossovers (Ho et al., 2010). Cells lacking Mus81-
Mms4 showed a strong reduction in the formation of crossover repair products (Ho et al., 2010;
Figure 4D). Notably, cells expressing M phase-restricted versions of Mus81-Mms4 were proficient in
crossover formation as WT cells, while S phase-restricted versions of Mus81-Mms4 as well as the
MUS81 deletion showed reduced rates of crossover formation (Figure 4D). This shows that the M
phase function of Mus81-Mms4 is linked to its role in forming crossovers, suggesting that in budding
yeast a major function of Mus81-Mms4 is that of a post-replicative resolvase.
A large proportion of recombination intermediates is typically processed by the Sgs1-Top3-Rmi1
helicase-decatenase complex (Gangloff et al., 1994; Fabre et al., 2002; Wu and Hickson, 2003;
Cejka et al., 2010). A hallmark phenotype of mus81D mutants therefore is the synthetic lethality
with sgs1D (Kaliraman et al., 2001; Mullen et al., 2001; Fabre et al., 2002; Bastin-
Shanower et al., 2003). A strong synthetic phenotype was observed when we restricted Mus81
expression to S phase, but no such defect was seen when we restricted Mus81 expression to M
phase (Figure 4E, Figure 4—figure supplement 2). Overall, the cell cycle tag methodology there-
fore makes a strong case for Mus81-Mms4 having its dominant function in response to replication
perturbation by acting post-replicatively in M phase, likely as a resolvase processing HR or replica-
tion intermediates. Such an M function is consistent with M phase specific phosphorylation and stim-
ulation (Matos et al., 2011; Gallo-Fernández et al., 2012; Matos et al., 2013; Saugar et al., 2013;
Szakal and Branzei, 2013; Gritenaite et al., 2014; Princz et al., 2017), but does not exclude an S
phase function outside of the tested phenotypes.
Premature activation of Yen1 from S to early M phase interferes with
the response to replication stalling lesions
Why are resolvases cell cycle regulated? We and others have reasoned that high levels of resolvase
activity during S phase may interfere with replication and the response to replication stalling
(Szakal and Branzei, 2013; Blanco et al., 2014; Duda et al., 2016; Pfander and Matos, 2017). We
realized that cell cycle tags could also be used to reinstall cell cycle regulation to deregulated ver-
sions of proteins, in this case resolvases. To this end we turned to a second resolvase – Yen1, which
Figure 4 continued
source data 1 for underlying values and exact p-values). (B/C) Resolution of replication/repair intermediates arising in response to replication stalling in
S phase requires mitotic Mus81-Mms4 function. PFGE analysis of cells recovering (1–4 hr in Nocodazole) from a pulse of MMS (0.033%, 1 hr) in S phase
(see upper panel for experimental setup). PFGE gels were stained with EtBr or subjected to southern blot hybridization with a probe against the ADE2
locus located on chromosome XV. The relative number of resolved chromosomes XV from the southern blots was quantified using ImageJ and is
depicted below. (B) PFGE/southern analysis of Mlow-Mus81-Mms4/Slow-Mus81-Mms4 cells. (C) PFGE/southern analysis of Mhigh-Mus81-Mms4/Shigh-
Mus81-Mms4 cells. (D) HR repair resulting in crossovers depends on the mitotic function of Mus81. I-SceI induced recombination assay between
heterologous ade2 alleles in diploid cells as described in Ho et al., 2010. Upper panel: arrangement of marker genes on chromosomes IV used for
classifying the genetic outcomes of DSB repair. The arrow indicates the I-SceI site. Bottom panel: genetic outcome of repair, with overall crossover
events (grey) and crossovers among individual classes (red, red/white, white) that differ in conversion tract length. Depicted are mean values from two
independent experiments each scoring 400–600 cells with the standard deviation as error bars. Significance: n.s. p>0.05, *p<0.05, **p<0.005 compared
to WT cells by unpaired Student´s T-test (see Figure 4—source data 2 for underlying values and exact p-values). (E) The essential requirement of
Mus81 in the absence of SGS1-dependent dissolution occurs during M phase. Tetrad analysis of yeast diploid cells with indicated genotypes reveals
synthetic lethality between sgs1D and Slow-/Shigh-Mus81-Mms4 while Mlow-/Mhigh-Mus81-Mms4 shows no discernible effect on cell growth in the
background of sgs1D (see Figure 4—figure supplement 2 for a growth analysis of the individual spores of the tetrad analysis with Shigh-/Mhigh-Mus81-
Mms4).
The online version of this article includes the following source data and figure supplement(s) for figure 4:
Source data 1. Average, stdv and p-values of normalized colony numbers from replicates 1–3 depicted in Figure 4A.
Source data 2. Average, stdv and p-values of CO rates from two independent experiments depicted in Figure 4D.
Figure supplement 1. Cell cycle tags restrict efficiently to S or M phase also after DNA damage treatment.
Figure supplement 2. Mus81 function during M phase is required in the absence of Sgs1 function.
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is cell cycle-controlled and restricted to late M phase by inhibitory cyclin-CDK phosphorylation
(Kosugi et al., 2009; Matos et al., 2011; Blanco et al., 2014; Eissler et al., 2014; Garcı́a-
Luis et al., 2014). A mutant version of Yen1 called YEN1-ON is deficient in inhibitory CDK phosphor-
ylation sites, constitutively active throughout the cell cycle and detrimental to cellular survival after
genotoxic insults as well as during meiosis (Blanco et al., 2014; Eissler et al., 2014; Arter et al.,
2018).
To restrict Yen1-ON to specific cell cycle phases and reveal at which cell cycle phase the detri-
mental effects of YEN1-ON manifest, we combined this allele with cell cycle tags. Specifically, we
used our proposed cell cycle tag workflow (Figure 1D) and generated two sets of G1-S-M triples
expressed at low and high levels, with similar peak expression levels within each set. Tagging of
Yen1 at the N-terminus interfered with protein function and we therefore constructed C-terminal cell
cycle-tagged versions of Yen1-ON (Figure 5A, Figure 5—figure supplement 1). When we screened
different cell cycle tag constructs, we found that Clb6pClb6 -80bp-tagged, Clb2pClb2 -60bp-tagged and
Sic1pSic1 u(ATA)AUG-tagged versions of Yen1-ON showed peak expression levels in S, M and G1 phase
that were between 1.3 to 1.5-fold of Yen1-ON expressed from endogenous promoter (Figure 5A,
Figure 5—figure supplement 2A,C) and will therefore be referred to as Mlow-Yen1-ON, Slow-Yen1-
ON and G1low-Yen1-ON, respectively. Furthermore, Clb2pClb1-tagged, Clb6pClb6-tagged and Sic1p-
Sic1 -20bp-tagged versions of Yen1-ON showed 2.5 to 3-fold peak expression levels compared to
endogenous Yen1-ON expressed from its endogenous promoter, but similar among the different
constructs (Figure 5A, Figure 5—figure supplement 2B,C), and will be referred to as Mhigh-Yen1-
ON, Shigh-Yen1-ON and G1high-Yen1-ON, respectively. Slow-Yen1-ON and Shigh-Yen1-ON expression
peaked in S phase (20–50 min and 20–60 min after G1 release, respectively), Mlow-Yen1-ON and
Mhigh-Yen1-ON expression in M phase (50–70 min) and G1low-Yen1-ON and G1high-Yen1-ON started
to express in late M phase (70 min, Figure 5A), thereby confirming cell cycle restriction of Yen1-ON
expression to the expected cell cycle phases.
With cell cycle-restricted versions of Yen1-ON at hand we tested known Yen1-ON phenotypes.
Deregulated Yen1-ON is able to complement phenotypes of the MUS81 deletion mutant such as
MMS hypersensitivity, suggesting that both resolvases display a degree of functional redundancy
(Blanco et al., 2014). Notably, only the M phase-restricted version of Yen1-ON and the constitu-
tively expressed Yen1-ON were able to rescue the MMS sensitivity of cells lacking MUS81, while the
S phase-restricted and the G1 phase-restricted versions of Yen1-ON were unable to do so
(Figure 5B). These data further indicate that early M phase is a window of opportunity, during which
a Mus81-like resolvase must act and that Yen1-ON can take this function, if specifically activated dur-
ing this time.
Conversely, YEN1-ON itself induces hypersensitivity towards MMS compared to WT cells
(Blanco et al., 2014; Figure 5C–D). We therefore tested the cell cycle-restricted versions of Yen1-
ON for MMS hypersensitivity and found that restriction of Yen1-ON expression to late M and G1
using the G1high-Yen1-ON or G1low-Yen1-ON construct did not yield hypersensitivity, no matter
whether cells were chronically exposed to MMS (Figure 5C) or treated with a pulse of MMS during S
phase (Figure 5D). This suggests that restricting Yen1-ON expression to those cell cycle phases
where the protein would normally be in its dephosphorylated form is sufficient to suppress the MMS
hypersensitivity phenotype. In contrast, Yen1-ON expression in S or M phase caused MMS hypersen-
sitivity that was similar to what was observed with unrestricted expression of Yen1-ON (Figure 5C–
D). Notably, Yen1-ON phenotypes depend strongly and in a dose-dependent manner on its expres-
sion levels (Blanco et al., 2014; MG Blanco, personal communication). Consistently, we saw slightly
increased MMS hypersensitivity in Shigh-Yen1-ON and Mhigh-Yen1-ON compared to Slow-Yen1-ON
and Mlow-Yen1-ON (Figure 5C–D).
Therefore, we conclude that (i) the presence of deregulated Yen1 in S phase is detrimental to the
cellular response to replication stalling and that (ii) deregulated Yen1 in M phase is detrimental as
well but can at the same time partially compensate for the absence of Mus81-Mms4. Overall, the
cell cycle tag approach therefore demonstrated that the dominant functions of Mus81-Mms4 and
Yen1 manifest in those cell cycle phases – M phase and late M/G1 phase, respectively – where the
proteins also become stimulated by PTM modification/demodification.
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Figure 5. Premature activation of Yen1 in S or early M phase interferes with the response to replication stalling lesions. (A) Cell cycle-tagged Yen1-ON-
9MYC constructs restrict expression of constitutively active Yen1-ON to S, M or G1 phase. (Left) Western blot analysis of strains expressing WT, S (Slow
(Clb6pClb6 -80bp)-Yen1-ON9MYC/Shigh (Clb6pClb6)-Yen1-ON9MYC), M (Mlow (Clb2pClb2 -60bp)-Yen1-ON9MYC/Mhigh (Clb2pClb1)-Yen1-ON9MYC) and G1 (G1low
(Sic1pSic1 u(ATA)ATG)-Yen1-ON9MYC/G1high (Sic1pSic1 -20bp)-Yen1-ON9MYC) phase-restricted Yen1-ON during synchronous cell cycle progression as in
Figure 5 continued on next page
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Discussion
An advanced toolbox of cell cycle tags
Cell cycle tags are a straightforward method to restrict protein expression to specific cell cycle
phases. The toolbox of constructs presented here allows straightforward introduction of cell cycle
tags at the locus of interest within the budding yeast genome using standard recombination-based
techniques (Knop et al., 1999; Janke et al., 2004). Importantly, with constructs that vary in peak
expression, our cell cycle tag toolbox allows for the first time to restrict protein expression to differ-
ent cell cycle phases and at similar peak expression levels. Similar peak expression levels are neces-
sary, if one wants to compare phenotypes arising from restricting protein expression to different cell
cycle phases or tries to unravel at which cell cycle phase a protein exhibits its essential function. To
allow titration of expression levels, our cell cycle tag toolbox currently contains a total of 46 cell cycle
tag constructs, with the upper expression limit being determined by cyclin promoters (Figure 1). So
far, we have used these constructs to restrict expression of 13 proteins (Figures 2–4; JB and BP
unpublished data). Based on this experience, we suggest the following experimental workflow: (i)
Compare peak expression levels of cell cycle-restricted constructs to endogenously expressed pro-
tein. Here, a western blot against 3FLAG-tagged protein might be used (see Pfander and Diffley,
2011 for pYM-3FLAG tagging constructs). (ii) Due to the dynamic expression regime, a given cell
cycle-tagged construct is unlikely to give endogenous expression levels throughout the cell cycle
phase of interest. This problem is further aggravated if experimental conditions are varied (for exam-
ple: growth on liquid vs solid media, cell cycle arrest, or drug treatment activating cell cycle check-
points). Therefore, we suggest finding triples of S-, M- and G1-tag constructs (or sometimes pairs)
with similar peak expression levels. Furthermore, we advise to select two sets of triples/pairs (called
‘low’ and ‘high’ throughout the manuscript), which vary in peak expression levels and thereby allow
to separate phenotypes arising from under- or overexpression from those arising from cell cycle
restriction. Although expression may vary for individual proteins, combinations of constructs that
regularly gave us similar peak expression levels are Clb6pClb6 (or Clb6pClb5), Clb2pClb1, Sic1pSic1 -20bp
for the high expressing set and Clb6pClb6 -80bp, Clb2pClb2-60bp (or Clb2pClb1 -150bp), Sic1pSic1 u(ATA)ATG
for the low set. (iii) Genetics will often indicate whether N-terminal tagging is compatible with pro-
tein function as such, but an additional control for the functionality of the tagged constructs is desir-
able. For Mus81-Mms4 we used cleavage of DNA junctions in vitro (Figure 2D). Collectively these
considerations are expected to allow interpretation of the cell cycle restriction experiment and
reveal cell cycle stage-specific functionality of the protein of interest.
The essential function of the structure-selective nuclease Mus81-Mms4
manifests in M phase
Phenotypic analysis suggests that Mus81-Mms4 plays a major role in the response to replication
stalling (Xiao et al., 1998; Interthal and Heyer, 2000; Boddy et al., 2001; Mullen et al., 2001;
Doe et al., 2002; Bastin-Shanower et al., 2003; Kai et al., 2005; Saugar et al., 2013). As such, it is
seemingly contradictory that Mus81-Mms4 becomes post-translationally modified and stimulated in
its activity only after S phase, when cells enter M phase (Matos et al., 2011; Matos et al., 2013;
Gallo-Fernández et al., 2012; Saugar et al., 2013; Szakal and Branzei, 2013; Princz et al., 2017).
Figure 5 continued
Figure 2A. (see Figure 5—figure supplement 2 for quantification of peak expression levels for individual constructs). (Right) schematic representation
of endogenously expressed and cell cycle-tagged Yen1-ON constructs. Blue, green and orange bars indicate location of cell cycle regulatory elements
in the promoter and N-terminal degron sequence. (B), The M phase function of Yen1-ON is able to bypass Mus81 requirement after MMS induced
replication fork stalling. Strains with indicated genotypes were chronically exposed to MMS as in Figure 3A (note the mus81D background). (C–D),
Viability after MMS induced replication fork stalling decreases when Yen1-ON is restricted to S or early M phase. (C) Survival of indicated strains after
chronic MMS exposure as in (B). (D) Viability assay after a single pulse of MMS in S phase was measured for indicated strains as in Figure 4A (see
Figure 5—source data 1 for underlying values and exact p-values).
The online version of this article includes the following source data and figure supplement(s) for figure 5:
Source data 1. average, stdv and p-values of normalized colony numbers from replicates 1–3 depicted in Figure 5D.
Figure supplement 1. Strategy for C-terminal cell cycle tagging of Yen1-ON.
Figure supplement 2. Analysis of ‘low’ and ‘high’ S-, M- and G1-tagged Yen1-ON peak expression levels.
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Mutations abolishing Mus81-Mms4 phosphorylation showed pronounced phenotypes and M phase-
specific stimulation of Mus81-Mms4 shows hallmark signs of switch-like activation (Matos et al.,
2011; Gallo-Fernández et al., 2012; Matos et al., 2013; Szakal and Branzei, 2013; Princz et al.,
2017). Nonetheless, a possible S phase function as well as the relative contribution of S and M phase
phenotypes have been widely discussed (Xiao et al., 1998; Boddy et al., 2000; Interthal and
Heyer, 2000; Haber and Heyer, 2001; Kaliraman et al., 2001; Mullen et al., 2001; Doe et al.,
2002; Fabre et al., 2002; Bastin-Shanower et al., 2003; Kai et al., 2005; Hanada et al., 2007;
Shimura et al., 2008; Regairaz et al., 2011; Fu et al., 2015; Xing et al., 2015; Lemaçon et al.,
2017). In this study, we have applied the cell cycle tag approach to tackle this question and
observed that restriction of Mus81-Mms4 expression to S phase induces strong phenotypes similar
to those of the MUS81 deletion, while restriction of Mus81-Mms4 to M phase allows full functional-
ity. The essential function(s) of Mus81-Mms4 therefore appear to be specific to M phase, correlating
with its M phase-specific stimulation.
Consequently, this raises the question about the mechanism underlying the Mus81-Mms4 M
phase function. We think that our data are generally consistent with a model whereby Mus81-Mms4
acts as a resolvase that processes an HR intermediate (for example a HJ or a D loop (Boddy et al.,
2001; Kaliraman et al., 2001; Chen et al., 2001; Constantinou et al., 2002; Doe et al., 2002; Bas-
tin-Shanower et al., 2003; Ciccia et al., 2003; Gaillard et al., 2003; Osman et al., 2003;
Whitby et al., 2003; Fricke et al., 2005; Ehmsen and Heyer, 2008; Taylor and McGowan, 2008;
Schwartz et al., 2012; Pepe and West, 2014b)). This HR intermediate could originate from the
usage of HR (or template switch replication) to bypass replication stalling lesions or DNA breaks aris-
ing in S phase (Liberi et al., 2005; Branzei et al., 2008; Giannattasio et al., 2014; Branzei and Sza-
kal, 2016). As such, the prime function of Mus81-Mms4 would be to aid resolution of sister
chromatids (Roseaulin et al., 2008; Wechsler et al., 2011; Wyatt et al., 2013; Mankouri et al.,
2013; Matos et al., 2013; Szakal and Branzei, 2013; Gritenaite et al., 2014; Princz et al., 2017)
and share functional overlap with STR-dependent dissolution (Gangloff et al., 1994; Fabre et al.,
2002; Wu and Hickson, 2003; Ira et al., 2003).
Mus81-Mms4 might also have more than one M phase function. For example, it is possible that
Mus81-Mms4 might act on replication forks that persist until M phase, similar to what has been
shown for MUS81 in human cells, which acts in the MIDAS pathway to process replication forks at
sites of under-replicated DNA and to thereby initiate repair by BIR (Minocherhomji et al., 2015;
Duda et al., 2016). Furthermore, Mus81-Mms4 may also act at a later step in BIR to switch from an
extending D-loop mechanism of DNA synthesis to a type of DNA synthesis that is more similar to
canonical DNA replication, a model that has been suggested by a study in budding yeast
(Mayle et al., 2015). Interestingly, we observed using the same experimental set-up as Mayle et al.
that M phase-restricted Mus81-Mms4 is entirely sufficient for survival after induction of the Flp-nick-
ase (Figure 3E,F), suggesting that a possible function of Mus81-Mms4 in BIR takes place in M phase
thus bearing a similar cell cycle profile as MIDAS (Minocherhomji et al., 2015). In line with our con-
clusions, and while this manuscript was in preparation, the Pasero and Aguilera labs published a pre-
print showing by several approaches a post-replicative function of Mus81-Mms4 in response to
replication blockage (Pardo et al., 2019).
We emphasize that our study can by no means rule out that Mus81-Mms4 also functions in S
phase. However, at least in budding yeast we are not aware of any data in the current literature that
would necessitate to evoke such an S phase function for Mus81-Mms4. This raises the question of
whether budding yeast Mus81-Mms4 can serve as a paradigm for other species. The fact that human
MUS81 complexes are cell cycle regulated (Wyatt et al., 2013; Duda et al., 2016) suggests that
Mus81-Mms4 with its essential M phase function may indeed be a good model for the Mus81 biol-
ogy in other organisms. However, we caution that additional regulatory mechanisms exist in other
systems. Fission yeast Mus81-Eme1 harbours for example an additional layer of control by the DNA
damage checkpoint (Boddy et al., 2000; Kai et al., 2005; Froget et al., 2008; Dehé et al., 2013).
Human MUS81 has two accessory subunits (EME1 and EME2; Ciccia et al., 2003), which are likely
differentially regulated (Matos et al., 2011; Duda et al., 2016). Indeed, there is overwhelming
genetic data showing that in human cells MUS81 is required for the cellular response to replication
perturbation (Hanada et al., 2007; Shimura et al., 2008; Regairaz et al., 2011; Fugger et al.,
2013; Naim et al., 2013; Ying et al., 2013; Pepe and West, 2014a; Xing et al., 2015; Fu et al.,
2015; Minocherhomji et al., 2015; Lemaçon et al., 2017). While some of these data could be
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explained by a role for MUS81 as a post-replicative resolvase – similar to what is shown here for the
budding yeast protein – an earlier role at stalled replication forks in S phase cannot be excluded.
Perhaps the strongest case for an S phase function of human MUS81 is made by several genetic
studies showing that cells depleted for MUS81 display perturbed DNA replication, a constitutive
DNA damage response and defects in the response to replication perturbation (Hanada et al.,
2007; Shimura et al., 2008; Regairaz et al., 2011; Buisson et al., 2015; Fu et al., 2015;
Xing et al., 2015). These phenotypes could arise from a direct function at replication forks in S
phase (perhaps in processing/cleavage of stalled replication forks), which would then be absent from
the budding yeast system (or so far elusive). Since at this stage a possible indirect effect upon
MUS81 deletion or depletion can also not be excluded, we suggest that methodologies analogous
to the cell cycle tag system described here might be useful to ascertain the relative contribution of
M and S phase functions in human cells.
Premature resolvase activation is detrimental to the response to
replication stalling
A second and so far under-utilized application of cell cycle tags is to install de novo cell cycle regula-
tion on a deregulated mutant protein. We demonstrated this strategy using the deregulated YEN1-
ON allele of the Yen1 resolvase (Blanco et al., 2014). Specifically, we showed that the previously
described MMS hypersensitivity phenotype of YEN1-ON cells is generated by premature activation
of Yen1 in S and early M phase. These data corroborate the importance of restricting post-transla-
tional activation of Yen1 specifically to late M and G1 phase. They also argue against Yen1 having a
function in S phase and raise the question about what detrimental effects premature resolvase acti-
vation might be causing.
Interestingly, these data suggest that differences between the Mus81-Mms4- and Yen1-depen-
dent mechanisms exist and fit to both enzymes having distinct temporal activation profiles. Differen-
tial activation of Mus81-Mms4 and Yen1 could perhaps simply serve the purpose to equip cells with
at least one highly active SSE at different cell cycle stages from early M to the G1/S transition
(Wild and Matos, 2016). Furthermore, temporal activation establishes hierarchy in the correspond-
ing resolution/dissolution mechanisms. In particular, we favour a three-tiered hierarchy for enzymes
that process recombination intermediates: first, STR-dependent dissolution is fully active in S phase
(Ashton et al., 2011; Versini et al., 2003; Bizard and Hickson, 2014; Grigaitis et al., 2020), sec-
ond, Mus81-Mms4 gets stimulated in early M and third, Yen1 would become activated only in late M
and as a measure of last resort. Such a hierarchy could be a means to counteract cross-overs and
loss-of-heterozygosity in mitotically dividing cells (Ho et al., 2010; Matos et al., 2013; Szakal and
Branzei, 2013; Blanco et al., 2014), but it may simply reflect differential efficiency of competing
molecular mechanisms. Furthermore, it is possible that the three mechanisms are directed towards
distinct substrates. In order to identify the exact nature of these substrates, molecular genetic assays
will be necessary and we suggest they be carried out with very precise genetic perturbation pro-
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All yeast strains are based on W303 (Rothstein, 1983) and constructed by genetic crossing and
transformation techniques. ORF deletion as well as N-terminal cell cycle tagging was done using
standard techniques (Knop et al., 1999; Janke et al., 2004) and is described in more detail in the
paragraph construction of cell cycle-tagged strains. A list of all yeast strains used in this study can be
found in Supplementary file 1 – Table 1.
Construction of cell cycle-tagged strains
Tagging constructs for N-terminal cell cycle tagging of genes are based on the pYM-N plasmid
(Janke et al., 2004) and harbour the regulatory sequences of the corresponding cyclin (promoter +
N-terminus) together with a 3FLAG-tag and the NAT marker sequence flanked by S1 and S4 primer
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sequences (Figure 1—figure supplement 1). Plasmid constructs were generated using standard
molecular biology techniques and truncation of the 5´UTR or insertion of upstream out of frame
ATGs was achieved by site-directed mutagenesis techniques. A list of tagging constructs for N-ter-
minal cell cycle tagging of genes can be found in Supplementary file 1 - Table 2.
Amplification of the N-terminal tagging cassettes was achieved by PCR using S1 and S4 primer
sequences (see Key Resources table for sequences) fused to a 55 bp sequence homologous to the
promoter-gene junction of the corresponding gene (Figure 1—figure supplement 1) (see Key
Resources table for sequences of S1, S4 primers coupled to the GFP, Mus81 and Mms4 promoter-
gene junction sequences). The PCR product was transformed into competent yeast cells and correct
integration of the tagging constructs was verified by genotyping PCR using two primer pairs,
whereby the first tested integration of the tagging construct and the second verified deletion of the
endogenous promoter sequence. Expression of the gene fusion product was then verified by west-
ern blotting (see Figure 1—figure supplement 1 for a protocol of the experimental workflow).
For C-terminal cell cycle tagging of Yen1-ON, constructs were assembled together with the gene
of interest within the integrative pRS303 vector backbone, linearized by restriction enzyme cutting
and integrated into the HIS3 locus. Correct integration of the plasmids was checked by genotyping
PCR using two primer pairs verifying integration of a single copy of the plasmid and expression of
the tagged protein was verified by western blotting (see Figure 5—figure supplement 1 for a pro-
tocol of the workflow).
Antibodies
Detection of proteins was achieved by using antibodies listed in the Key Resources table.
DNA content measurement
Cell cycle progression was analysed by DNA content measurements by flow cytometry. 1 ! 107 – 2
! 107 cells were harvested and resuspended in 1 ml of fixation buffer (70% ethanol + 50 mM Tris pH
8). Cells were washed 1x with 1 ml of 50 mM Tris pH 8 and incubated in 520 ml of RNase solution
(500 ml 50 mM Tris pH 8 + 20 ml RNase A (10 mg/ml in 10 mM Tris pH 7.5, 10 mM MgCl2) over night
at 37˚C. Next, cells were treated with 220 ml proteinase K solution (200 ml 50 mM Tris pH 8 + 20 ml
proteinase K (10 mg/ml in 50˚C glycerol, 10 mM Tris pH 7.5, 25 mM CaCl2) for 30 min at 50˚C. After-
wards, cells were resuspended in 500 ml 50 mM Tris pH 8, sonicated (5’’, 50% Cycle, minimum
power) and stained in SYTOX solution (1:1000 in Tris pH 8). Fluorescence intensity was measured at
520 nm using MACSquant Analyzer 10 (Milteny Biotech) and the data was analysed using FlowJo
(FlowJo, LLC).
Acrylamide gel electrophoresis and western blotting
Separation of proteins was achieved using standard SDS-polyacrylamid gel electrophoresis in 4–12%
Novex NuPage BisTris precast gels (ThermoFisher) with MOPS buffer (50 mM MOPS, 50 mM Tris-
base, 0.1% SDS, 1.025 mM EDTA, adjusted to pH 7.7). Afterwards, proteins were transferred to
nitrocellulose membrane (Amersham Protran Premium 0.45 mm NC) by wet blotting in western trans-
fer buffer (48 mM Tris-base, 39 mM glycine, 0.0375% SDS, 20% methanol). Membranes were incu-
bated with the primary antibodies (diluted at concentrations indicated in the Key resources table in
milk buffer: 2.5% milk powder, 0.5% BSA, 0.5 % NP-40, 0.1% Tween-20, 50 mM Tris pH 7.5, 137 mM
NaCl, 3 mM KaCl) over night at 4˚C or at room temperature for 2 hr when using mouse-anti-FLAG
directly coupled to HRP. Appropriate secondary antibodies coupled to HRP were applied at room
temperature for 2 hr. Washing of the membranes was performed three times for 5 min with western
wash buffer (50 mM Tris pH 7.5, 137 mM NaCl, 3 mM KaCl, 0.2% NP-40) and incubated with Pierce
ECL western blotting substrate (ThermoFisher) according to the manufacturer’s instruction. Chemilu-
minescence was detected using a tabletop film processor (OPTMAX, Protec) or with an iBright
FL1000 imaging system (ThermoFisher).
Preparation of whole cell extracts (alkaline lysis/TCA)
2 ! 107 cells were resuspended in 1 ml of pre-cooled water and mixed with 150 ml of freshly pre-
pared lysis solution (1.85 M NaOH, 7.5% beta-mercaptoethanol). Lysis was performed at 4˚C for 15
min and protein precipitation was achieved by adding 150 ml of 55% pre-cooled TCA solution and
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incubation for 10 min. After centrifugation and aspiration of the supernatant, protein pellets were
resuspended in 50 ml HU-buffer (8 M Urea, 5% SDS, 200 mM Tris pH 6.8, 1.5% dithiothreitol, traces
of bromophenol blue) and incubated at 65˚C for 10 min.
Synchronization of cells, cell cycle release, viability
Generally, cell cycle arrests and releases were performed as described in Reusswig et al., 2016.
Cells were grown to log-phase (OD6000.4–0.6) in YP + 2% glucose (YPD) prior to arrest. To arrest
cells in G1, S and M phase, the cultures were supplemented with a-factor (5 mg/ml, MPIB), nocoda-
zole (5 mg/ml, Sigma-Aldrich) and hydroxyurea (HU) (200 mM, Sigma-Aldrich) for 2 hr, respectively.
Release from G1 was performed by washing cells twice with prewarmed YP followed by resus-
pending cells in the same volume of prewarmed YPD. To ensure that cells run through the cell cycle
only once, a-factor (5 mg/ml) was added back to the cultures 40 min after release from G1. For DNA
damage treatment in S phase and analysis of fully replicated chromosomes by PFGE cells were
released from G1 into prewarmed YPD containing 0.033% MMS for 1 hr. Afterwards, cells were
washed twice again with prewarmed YP and resuspended in prewarmed YPD containing nocodazole
(5 mg/ml).
To determine survival of MMS treatment cells were kept in MMS containing medium (0.033%)
and plated in triplicates onto YPD plates at time points indicated in the figures. Colony-forming units
were counted after incubation at 30˚C for 3 days. Viability experiments were performed in three
independent biological replicates and the standard deviations of those experiments are represented
as error bars in the corresponding bar charts. Statistical significance for the viability of individual
strains compared to the wild-type was calculated using an unpaired Student´s T-test. These calcula-
tions were done using the GraphPad web-tool ‘T-test calculator’ (http://www.graphpad.com/quick-
calcs/ttest2).
For subsequent analysis of DNA or protein content, aliquots (1 OD600, approx. 1 ! 10
7 cells)
were withdrawn from the culture at indicated time points. For flow cytometric analysis, cells were
resuspended in fixation buffer (70% ethanol + 50 mM Tris pH 8) and incubated at 4˚C for at least 30
min prior to further processing (see section DNA content measurement). For western analysis, cells
were snap-frozen in liquid nitrogen and stored at "80˚C prior to further processing (see section alka-
line lysis/TCA).
Chronic treatment with genotoxic agents
To assess viability of yeast strains on MMS, CPT and HU containing solid medium (prepared 1 day
prior), cells from stationary grown over-night cultures were spotted with a starting concentration of
OD600 0.5 in serial dilution (1:5) and incubated at 30˚C for 2 days. All spottings were done in 2–3 bio-
logical replicates, each containing two technical replicates.
Pulsed-field gel electrophoresis (PFGE) and southern blotting
Cells were fixed and embedded in agarose plugs as described in Finn and Li, 2013. Plugs were
loaded on a 1% (w/v) agarose (Pulsed-field certified, BioRad) gel in 0.5 x TBE (45 mM Tris, 45 mM
borate, 0.5 mM EDTA). Electrophoresis was carried out in 14˚C cold 0.5 x TBE in a CHEF DR-III sys-
tem (initial switch time 60 s, final switch time 120 s, 6 V/cm, angle 120˚C, 24 hr). Afterwards, the gel
was stained with 1 mg/ml ethidium-bromide in 0.5 x TBE for 1 hr and destained with deionized water.
Images were taken using a VWR GenoSmart gel documentation system.
For southern blotting the DNA was nicked in 0.125 M HCl for 10 min, denatured in 1.5 M NaCl,
0.5M NaOH for 30 min and neutralized by 0.5 M Tris, 1.5 M NaCl (pH 7.5) for 30 min. The DNA was
transferred onto a Hybond-N+ membrane (GE healthcare) and cross-linked with UV-light (Stratagen,
auto-crosslink function). The membrane was probed with a radioactive (a"32P dCTP) labelled ADE2
fragment and imaged using a Typhoon FLA 9000 imaging system.
DSB-induced recombination assay
The DSB-induced recombination assay was performed as described previously (Ho et al., 2010). In
brief, diploid cells were grown to log-phase (OD6000.4–0.6) in liquid YPAR (YP + 40 mg/l adenine +
2% raffinose). DSB formation (I-SceI expression) was induced by adding galactose (final concentra-
tion 2%) to the cultures for 1.5 hr. Afterwards cells were plated onto YPAD (YPD + 10 mg/l adenine),
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incubated for 3–4 days and replica plated onto YPAD +Hyg +Nat, YPAD + Hyg, YPAD + Nat, SC -
Ura, SC -Met and SCR -ADE +Gal to classify recombination events. The different classes evaluated
arise from repair of DSBs by either short tract or long tract gene conversion which produces ade2-n
or ADE+ recombinants, respectively (white class: two short tract conversions; red class: two long
tract conversions; red/white class: on long tract, on short tract conversion). CO events in the differ-
ent classes were measured by the number of colonies that have rendered both daughter cells homo-
zygous for the HPH and NAT marker. In each experiment 400–600 cells per strain were evaluated for
the individual class of repair and the experiment was independently repeated twice. Standard devia-
tions were calculated and included as error bars. Statistical significance for the CO rates of individual
strains and classes compared to the wild-type was calculated using an unpaired Student´s T-test.
These calculations were done using the GraphPad web-tool ‘T-test calculator’ (http://www.graph-
pad.com/quickcalcs/ttest2).
Mus81-Mms4 nHJ cleavage assay
Asynchronous mitotic cultures were generated by inoculating 1 l of YP-Raffinose (20 g/l bactopep-
tone, 10 g/l yeast extract, 20 g/l D-(+)-Raffinose) with overnight cultures, to an OD600 of ~0.2. After
cells have grown to an exponential stage (OD600 ~0.5) Mus81-Mms4 expression was induced by add-
ing 20 g/l D-(+)-Galactose to the culture. The cells were then grown for 2 hr and harvested by
centrifugation.
For Myc-affinity purifications yeast pellets were resuspended in 200 ml of lysis buffer (40 mM Tris-
HCl (pH 7.5 at 25˚C), 150 mM NaCl, 20 mM b-glycerolphosphate, 1 mM NaF, 0.5 mM EGTA, 0.1
mM EDTA, 15% (V/V) glycerol, 0.1% (V/V) NP-40, 1 mM DTT, 2 mM PMSF, 1x Complete Protease
inhibitor cocktail (Roche)) and lysed with glass beads. Obtained lysates were cleared by centrifuga-
tion and normalized. Myc-tagged Mus81-Mms4 was then immunoprecipitated using mouse mono-
clonal antibodies to Myc (9E10) coupled to agarose beads (AminoLink Plus), pre-blocked with 1 mg/
ml BSA in lysis buffer. Immunoprecipitations were done on a rotating wheel for 1 hr at 4˚C. Prior
western blotting or DNA cleavage assays the beads were extensively washed with the wash buffer
(40 mM Tris-HCl (pH 7.5 at 25˚C), 150 mM NaCl, 15% (V/V) glycerol, 0.1% (V/V) NP-40) and dephos-
phorylated by treating the beads with bacteriophage l protein phosphatase (New England Biolabs)
in 1x protein metallophosphatases (PMP) buffer supplemented with 1 mM MnCl2. Reactions were
assembled on ice and incubated at 30˚C for 15 min. The dephosphorylated Mus81-Mms4 complexes
were then subjected to SDS-PAGE gel and used for DNA cleavage assays.
DNA cleavage assays on beads were adapted from previously described protocols
(Grigaitis et al., 2018; Matos and West, 2017). In short, 20 ml of reaction mixture (20 mM Tris-Ac,
pH 7.5 (25˚C), 3 mM MgAc2, 1 mM DTT, 100 mg/ml BSA) containing 5 nM fluorescently labeled
nicked Holliday junction, prepared as previously described (Grigaitis et al., 2018) were added to
dry aspirated anti-Myc beads, corresponding to ~20 ml of volume. Reactions were assembled on ice
and initiated by transferring them to 30˚C. Reactions were performed for 2 hr at 30˚C, shaking 800
rpm, stopped by the addition of 5x STOP solution (100 mM Tris-Ac, (pH 7.5 at 25˚C), 50 mM EDTA,
2.5% (m/w) SDS, 10 mg/ml Proteinase K) and incubated for 1 hr at 37˚C, shaking 800 rpm. Subse-
quently 5 ml of 6x DNA loading dye (13 mM Tris-HCl (pH 8.0 at 25˚C), 40 mM EDTA, 0.32% (V/V)
SDS, 250 mM Ficoll 400, 0.4 mM OrangeG) were added. Reaction mixtures were analysed on a native
10% polyacrylamide gel in 1x TBE (89 mM Tris-borate (pH 8.4 at 25˚C), 2 mM EDTA) by running the
electrophoresis for 1 hr 15 min at 7.5 V/cm. The gel was then imaged with a Typhoon scanner (GE
Healtcare).
Nuclear fractionation
The protocol for preparation of nuclear fractions was adapted from Pasero et al., 1999. In brief, 30
ml of the synchronized cultures (at different time points after G1 release) were fixed with sodium
azide (total concentration 0.1%) and harvested by centrifugation (2 min, 3500 rpm, RT). Cells were
resuspended in 5 ml of 100 mM EDTA-KOH, pH 8, 10 mM DTT and incubated with constant shaking
at 30˚C for 10 min. Afterwards, cells were resuspended in 2 ml of YPD/1.1 M sorbitol and 0.5 mg/ml
Z100T was added (incubation for 20 min, constant shaking, 30˚C) and subsequently recovered in 2
ml YPD/1.1 M sorbitol + 0.5 mM PMSF (incubation for 10 min, constant shaking, 30˚C). Zymolyase
digested cells were resuspended in 2 ml of ice cold breakage buffer (10 mM Tris-HCl, pH 7.4, 40
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mM KCl, 4 mM EDTA-KOH, 0.25 mM Spermidine, 0.1 mM Spermine, 18% Ficoll, 1% beta-mercap-
toethanol, 1% aprotinin, 0.5 mM PMSF, 300 mg/ml benzamidine, 1 mg/ml pepstatin A, 0.5 mg/ml leu-
peptin) and dounced on ice using a tight pestle (about 30 strokes) to lyse cells efficiently (Total
extract sample). Lysis was verified microscopically and extracts were centrifuged to remove unbro-
ken cells (2 x, 12 min, 5000 g, 4˚C). Finally, cleared extracts were centrifuged at high speed to sepa-
rate the nuclei from the cytoplasm (15 min, 21000 g, 4˚C). The supernatant (Cytoplasmic sample)
was removed, nuclei washed once by rinsing the pellet with 1 ml of cold breakage buffer and the
nuclear pellet was resuspended in 100 ml 0.25 x buffer A (10 mM Tris-HCl, pH 7.4, 40 mM KCl, 4 mM
EDTA-KOH, 0.25 mM Spermidine, 0.1 mM Spermine) + 0.5 mM PMSF (Nuclear sample).
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Dehé PM, Gaillard PHL. 2017. Control of structure-specific endonucleases to maintain genome stability. Nature
Reviews Molecular Cell Biology 18:315–330. DOI: https://doi.org/10.1038/nrm.2016.177, PMID: 28327556
Doe CL, Ahn JS, Dixon J, Whitby MC. 2002. Mus81-Eme1 and Rqh1 involvement in processing stalled and
collapsed replication forks. Journal of Biological Chemistry 277:32753–32759. DOI: https://doi.org/10.1074/
jbc.M202120200, PMID: 12084712
Duda H, Arter M, Gloggnitzer J, Teloni F, Wild P, Blanco MG, Altmeyer M, Matos J. 2016. A mechanism for
controlled breakage of Under-replicated chromosomes during mitosis. Developmental Cell 39:740–755.
DOI: https://doi.org/10.1016/j.devcel.2016.11.017, PMID: 27997828
Dvir S, Velten L, Sharon E, Zeevi D, Carey LB, Weinberger A, Segal E. 2013. Deciphering the rules by which 5’-
UTR sequences affect protein expression in yeast. PNAS 110:E2792–E2801. DOI: https://doi.org/10.1073/pnas.
1222534110, PMID: 23832786
Ehmsen KT, Heyer WD. 2008. Saccharomyces cerevisiae Mus81-Mms4 is a catalytic, DNA structure-selective
endonuclease. Nucleic Acids Research 36:2182–2195. DOI: https://doi.org/10.1093/nar/gkm1152, PMID: 182
81703
Eissler CL, Mazón G, Powers BL, Savinov SN, Symington LS, Hall MC. 2014. The cdk/cDc14 module controls
activation of the Yen1 holliday junction resolvase to promote genome stability. Molecular Cell 54:80–93.
DOI: https://doi.org/10.1016/j.molcel.2014.02.012, PMID: 24631283
Fabre F, Chan A, Heyer WD, Gangloff S. 2002. Alternate pathways involving Sgs1/Top3, Mus81/ Mms4, and Srs2
prevent formation of toxic recombination intermediates from single-stranded gaps created by DNA replication.
PNAS 99:16887–16892. DOI: https://doi.org/10.1073/pnas.252652399, PMID: 12475932
Finn KJ, Li JJ. 2013. Single-stranded annealing induced by re-initiation of replication origins provides a novel and
efficient mechanism for generating copy number expansion via non-allelic homologous recombination. PLOS
Genetics 9:e1003192. DOI: https://doi.org/10.1371/journal.pgen.1003192, PMID: 23300490
Fricke WM, Bastin-Shanower SA, Brill SJ. 2005. Substrate specificity of the Saccharomyces cerevisiae Mus81-
Mms4 endonuclease. DNA Repair 4:243–251. DOI: https://doi.org/10.1016/j.dnarep.2004.10.001, PMID: 155
90332
Fricke WM, Brill SJ. 2003. Slx1-Slx4 is a second structure-specific endonuclease functionally redundant with Sgs1-
Top3. Genes & Development 17:1768–1778. DOI: https://doi.org/10.1101/gad.1105203, PMID: 12832395
Froget B, Blaisonneau J, Lambert S, Baldacci G. 2008. Cleavage of stalled forks by fission yeast Mus81/Eme1 in
absence of DNA replication checkpoint. Molecular Biology of the Cell 19:445–456. DOI: https://doi.org/10.
1091/mbc.e07-07-0728, PMID: 18032583
Fu H, Martin MM, Regairaz M, Huang L, You Y, Lin CM, Ryan M, Kim R, Shimura T, Pommier Y, Aladjem MI.
2015. The DNA repair endonuclease Mus81 facilitates fast DNA replication in the absence of exogenous
damage. Nature Communications 6:6746. DOI: https://doi.org/10.1038/ncomms7746, PMID: 25879486
Fugger K, Chu WK, Haahr P, Kousholt AN, Beck H, Payne MJ, Hanada K, Hickson ID, Sørensen CS. 2013. FBH1
co-operates with MUS81 in inducing DNA double-strand breaks and cell death following replication stress.
Nature Communications 4:1423. DOI: https://doi.org/10.1038/ncomms2395, PMID: 23361013
Gaillard PHL, Noguchi E, Shanahan P, Russell P. 2003. The endogenous Mus81-Eme1 complex resolves holliday
junctions by a nick and counternick mechanism. Molecular Cell 12:747–759. DOI: https://doi.org/10.1016/
S1097-2765(03)00342-3, PMID: 14527419
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Model of “High”/”Low” strategy
Figure 1. An advanced toolbox of cell cycle tag constructs. (A) Schematic representation of the applied strategies for improved cell cycle tag
methodology. Upper panel: conventional cell cycle tag methodology was limited by only one construct for each cell cycle phase. Lower panel: the
Figure 1 continued on next page
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Figure 1 continued
advanced cell cycle tag toolbox was expanded to 46 constructs. Therefore, we used new promoters and degrons from Clb5 and Clb1, chimeric
promoter-degron combinations and protein expression was crippled using 5´UTR truncations and upstream out of frame ATGs. Vertical bars indicate
location of cell cycle regulatory elements in the promoter and N-terminal degron sequence (see Figure 1—figure supplement 1 for detailed
description of the tagging procedure). (B) New cell cycle tag constructs allow cell cycle-restricted expression of GFP at varied peak expression levels.
Anti-FLAG westerns of cells expressing Clb5pClb5-, Clb6pClb5-, Clb6pClb6-, Clb1pClb1-, Clb2pClb1-, Clb2pClb2-3FLAG-tagged versions of GFP after G1 arrest
with a-factor and synchronous release through the cell cycle up to the next G1 phase. Pgk1 western was used as control and DNA content
measurements indicate cell cycle progression at the individual time points below (see Figure 1—figure supplement 2 for G1 release experiments of
the corresponding 5´UTR truncations and for constructs containing upstream out of frame ATGs). (C) New promoters and degrons, chimeric promoter-
degron combinations, 5’UTR truncations and upstream out of frame ATGs allow a broad spectrum of peak expression levels of cell cycle-restricted GFP.
Western blot analysis of peak expression levels of cell cycle-tagged 3FLAG-GFP variants at indicated time points after G1 release (20 min = S phase, 50
min = M phase, 100 min = G1 phase). DNA content measurements below indicate cell cycle progression. Graph: peak expression levels were quantified
using Image-J and signals of the individual constructs were divided by the corresponding Pgk1 sample to normalize to overall protein levels (see
Figure 1—figure supplement 3 for an overview of all cell cycle-tagged GFP versions in cells arrested in the corresponding cell cycle phase). (D)
Schematic representation of the suggested cell cycle tag strategy using two sets of constructs with matching ‘low’ and ‘high’ peak expression levels.
‘Low’ expressing constructs (light colours) are chosen by matching peak expression levels similar to the endogenous protein but will show
underexpression at cell cycle phase transitions. ‘High’ expressing tags generally show higher expression compared to the wildtype protein with the
advantage of broader timeframes of action (timeframes in which protein levels are similar or higher than endogenous protein levels).
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Figure 1—figure supplement 1. Schematic representation of the cell cycle tagging procedure. A construct from the pYM-N-based (Janke et al.,
2004) collection of cell cycle tags is used as a template for PCR amplification and homologous recombination-based tagging of a gene of interest. A
detailed description of the workflow can be found in Materials and methods (construction of cell cycle-tagged strains).
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Clb5pClb5-tags Clb6pClb6-tags Sic1pSic1-tags Clb1pClb1-tags Clb2pClb2-tags
Figure 1—figure supplement 2. 5’UTR truncations and upstream out of frame ATGs do not interfere with cell cycle restriction. Western blot analysis of
Clb5pClb5-, Clb6pClb6-, Clb1pClb1-, Clb2pClb2- and Sic1pSic1-tagged GFP expressed from 33 constructs with truncated 5’UTR or upstream out of frame
ATGs during a single cell cycle. Cells were arrested in G1 and synchronously released to the cell cycle up to the next G1 as in Figure 1B. Anti-FLAG
western shows cell cycle-tagged constructs, anti-Pgk1 western is used as control. Bottom: DNA content measurement by flow cytometry.
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Figure 1—figure supplement 3. 5’UTR truncations and upstream out of frame ATGs cripple peak expression levels of cell cycle tag constructs.
Western blot analysis of Clb5pClb5-, Clb6pClb6, Clb1pClb1-, Clb2pClb2- and Sic1pSic1-tagged GFP expressed from constructs with truncated 5’UTR and
upstream out of frame ATGs in HU (S), NOC (M) and a-factor (G1) arrested cells. Middle: DNA content measurements of corresponding samples by
flow cytometry. Bottom: Expression levels were quantified using Image-J.
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0.7x 0.8x 0.7x0.6x 0.5x0.4x 1.2x2.4x
anti-Pgk1
Xrs29MYC Rad523FLAG Fun303FLAG Sgs13FLAG
Figure 1—figure supplement 4. Clb6pClb6- and Clb2pClb1-tag induce similar peak expression levels for several cell
cycle-tagged proteins. Clb6pClb6 (S)- and Clb2pClb1 (M)-tagged Xrs2, Rad52, Fun30 and Sgs1 show similar peak
expression levels. Western blot analysis of peak expression levels at indicated time points after G1 release.
Expression levels were quantified using Image-J and signals of the individual constructs were divided by the
corresponding Pgk1 sample to normalize to overall protein levels. Normalized protein levels of Clb6pClb6 and
Clb2pClb1-tagged Xrs2, Rad52, Fun30 and Sgs1 were compared to WT expression at the corresponding time point
(fold difference) and the two analysed time points (20 and 30 min time points for S phase and the 50 and 60 min
time points for M phase) for each construct were averaged to result in a mean fold difference that is indicated
above the western blots. Bottom: DNA content analysis by flow cytometry.
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Figure 2. Cell cycle-restricted expression of Mus81-Mms4. (A) Restriction of Mus81-Mms4 expression to S or M phase of matched pairs of ‘low’ and
‘high’ expressing cell cycle tag constructs. (Left) Western blot and DNA content analysis of strains expressing WT, S phase-restricted (Slow (Clb6pClb6 -
Figure 2 continued on next page
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Figure 2 continued
80bp)-/Shigh (Clb6pClb5)-Mus81-Mms4) and M phase-restricted (Mlow (Clb2pClb1 -150bp)-/Mhigh (Clb2pClb1)-Mus81-Mms4) alleles of Mus81 (9MYC-tagged)-
Mms4 (3FLAG-tagged) during a single cell cycle as in Figure 1D (see Figure 2—figure supplement 1 for quantification of peak expression levels of
the Slow-/Mlow -Mus81-Mms4 and Shigh-/Mhigh-Mus81-Mms4 constructs). (Right) Schematic representation of WT, S (Slow-/Shigh-Mus81-Mms4) and M
phase (Mlow-/Mhigh-Mus81-Mms4) restricted Mus81-Mms4 constructs. Blue and green bars indicate location of cell cycle regulatory elements in the
promoter and N-terminal degron sequence. (B) Different constructs (‘high’ and ‘low’ peak expression levels) of Mus81-Mms4 lead to underexpression of
the Mlow-Mus81-Mms4 construct or to overexpression of the Mhigh-Mus81-Mms4 construct in early M phase and similar trends are seen in the nuclear
fraction. Western blot analysis of protein levels in whole cell extracts (left panel) and after nuclei separation (right panel) at indicated time points after a
G1-release (early M phase; see DNA content profile depicted at the bottom). While immediately with entry into M phase the Mhigh-Mus81-Mms4
construct reaches similar or higher protein levels than endogenous Mus81-Mms4, the Mlow-Mus81-Mms4 construct shows a 10–15 min delay in reaching
comparable expression levels and this holds true for both, whole cell extracts and the nuclear fraction. Expression levels were quantified using Image-J
and signals of the individual time points were divided by the corresponding Pgk1 (whole cell extracts) or Nsp1 (nuclear fraction) signal to normalize to
overall protein levels (graphs below contain normalized values for every construct). (see Figure 2—figure supplement 2 for control western blots of the
nuclear fractionation) (C) Different constructs (‘high’ and ‘low’ peak expression levels) of Mus81-Mms4 lead to different windows of Mus81-Mms4
phosphorylation in Mlow-Mus81-Mms4 and Mhigh-Mus81-Mms4. Western blot analysis of the phosphorylation states of Mms4 at indicated time points
after a G1-release (M phase; see DNA content profile depicted below the western blots). While Mhigh-Mus81-Mms4 shows a similar timeframe of Mms4
phosphorylation to endogenous Mus81-Mms4, Mlow-Mus81-Mms4 is phosphorylated and stimulated during a shortened window of time only (compare
red lines above the Mms4-3FLAG western blots: 15–20 min of phosphorylation in Mlow-Mus81-Mms4 compared to 30 min in Mhigh-Mus81-Mms4 and
30–35 min in Mus81-Mms4). (D) N-terminal tagging does not alter Mus81-Mms4 activity. Resolution assay using a nicked HJ (nHJ) substrate and
immunopurified Mus81-Mms4, S-Mus81-Mms4 and M-Mus81-Mms4 (note that WT and cell cycle-tagged proteins were expressed from pGal1-10
promoter). Myc-tagged Mus81-Mms4 was purified from cycling cells, dephosphorylated using l-Phosphatase and incubated with the nHJ substrate for
2 hr. Upper panel: nHJ cleavage assay with heat DNA substrate (HD) as control. Lower panel: western blot analysis of Mus81-9MYC IP after nHJ
cleavage assay (see Figure 2—figure supplement 3 for a western blot analysis of Mms4 dephosphorylation by l-Phosphatase).
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Figure 2—figure supplement 1. Analysis of ‘low’ and ‘high’ S- and M-tagged Mus81-Mms4 peak expression levels. (A/B) Sets of Slow-Mus81-Mms4
(Clb6pClb6 -80bp)/Mlow-Mus81-Mms4 (Clb2pClb1 -150bp) (A) and Shigh-Mus81-Mms4 (Clb6pClb5)/Mhigh-Mus81-Mms4 (Clb2pClb1) (B) display similar peak
expression levels. Western blot analysis of peak expression levels at individual time points after G1 release. Expression levels were quantified using
Image-J and signals at the individual time points were divided by the corresponding Pgk1 sample to normalize to overall protein levels. Normalized
protein levels of Slow-/Mlow-Mus81-Mms4 and Shigh-/Mhigh-Mus81-Mms4 were compared to wt expression at the corresponding time point (fold
difference) and the two analysed time points (20 and 30 min time points for S phase and 50 and 60 min time points for M phase) for each construct
were averaged to result in a mean fold difference that is indicated above the western blots. Bottom: DNA content measurement by flow cytometry. (C)
Summary of peak expression levels of various cell cycle-tagged Mus81/Mms4 constructs. Depicted are relations of peak expression values in
comparison to WT, which lead to selection of ‘high’ and ‘low’ expressing constructs.
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Figure 2—figure supplement 2. Nuclear/cytoplasmic
fractionation. Western blot analysis of different
fractions obtained after nuclei separation of a
representable sample from the experiment in
Figure 2B shows efficient separation into cytoplasmic
and nuclear fractions. Pgk1 and chaperone Hsp70 serve
as cytosolic markers, histone H4 and the nuclear pore
complex protein NSP1 serve as nuclear markers.
T = total lysate, C = cytoplasmic fraction, N = nuclear
fraction.
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Figure 2—figure supplement 3. l-Phosphatase
treatment leads to efficient Mms4 dephosphorylation
of WT, S- and M-Mus81-Mms4 used for activity assays.
Western blot analysis of Mms4 shows efficient
dephosphorylation of Mms4 after l-Phosphatase
treatment of WT, S- and M-Mus81-Mms4 preparations
used in activity assays (see Figure 2D for activity assay
done with S-, M- and WT Mus81-Mms4).
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Figure 3. Mus81-Mms4 restricted to M phase, but not S phase is sufficient for the response to genotoxic insults. (A/B) M phase-restricted Mus81-Mms4
is sufficient to confer viability to replication fork stalling drugs. Viability of cells with Mlow (Clb2pClb1 -150bp)-Mus81-Mms4/Slow (Clb6pClb6 -80bp)-Mus81-
Mms4 constructs at low peak expression levels (A) or Mhigh (Clb2pClb1)-Mus81-Mms4/Shigh (Clb6pClb5)-Mus81-Mms4 constructs at high peak expression
levels (B) is compared to that of WT and mus81D cells. Strains were plated in 5-fold serial dilutions on YPD plates containing the indicated amounts of
MMS, CPT or HU and incubated at 30˚C for 2 days. (C/D) Mitotic function of Mus81-Mms4 is sufficient to confer viability upon induction of RNA-DNA-
hybrids in the absence of RNAse H enzymes and mild replication stress (HU). Cell cycle-tagged versions of Mus81-Mms4 were integrated in the rnh1D
rnh201D background. Strains were spotted in 5-fold serial dilutions on YPD containing indicated concentrations of HU and incubated at 30˚C for 2 days.
(C) Spotting containing Mlow-Mus81-Mms4/Slow-Mus81-Mms4 cells. (D) Spotting of Mhigh-Mus81-Mms4/Shigh-Mus81-Mms4 cells. (E/F) Repair of Flp-
nickase induced DNA lesions requires the M phase function of Mus81-Mms4. Galactose-induced DNA nicking is presumed to be followed by
replication run-off in S phase to form single-ended DSBs and repair by BIR (Nielsen et al., 2009; Mayle et al., 2015). Location of the corresponding
FRT sites on chromosome IV and VI are indicated relative to replication origins. Cells were spotted in 5-fold serial dilutions in presence of glucose or
Figure 3 continued on next page
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Figure 3 continued
galactose (FLP-induction) and incubated at 30˚C for 2 days. (E) Spottings of Mlow-Mus81-Mms4/Slow-Mus81-Mms4 cells. (F) Spottings of Mhigh-Mus81-
Mms4/Shigh-Mus81-Mms4 cells.
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Figure 3—figure supplement 1. Residual Shigh-Mus81-Mms4 function in response to genotoxic agents is explained by insufficient restriction to S
phase; slight Mlow-Mus81-Mms4 defect in response to genotoxic agents is due to underexpression during M phase, respectively. (A) Slow-Mus81-Mms4
Figure 3—figure supplement 1 continued on next page
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Figure 3—figure supplement 1 continued
cells show comparable DNA damage sensitivity to mus81D even at low CPT and MMS concentrations. Indicated strains were chronically exposed to
CPT and MMS as in Figure 3A/B. (B/C) Residual Mms4 phosphorylation is responsible for the observed difference between mus81D and Shigh-Mus81-
Mms4. While Shigh-Mus81-Mms4 cells show better survival after MMS and CPT treatment compared to mus81D cells, additional removal of
phosphorylation sites targeted during M phase (mms4 14A) from the Shigh-Mus81-Mms4 construct (Shigh-Mus81-mms4 14A) lead to a phenotype
comparable to mus81D indicating this residual functionality comes from leakage of the Shigh tagged protein in M phase (Shigh-Mus81-mms4 14A). (B)
Spotting of indicated strains as in Figure 3A/B. (C) Western blot analysis of the Shigh-Mus81-mms4 14A construct at indicated time points after G1
release as in Figure 1D. (D/E) The observed survival defect of Mlow-Mus81-Mms4 cells upon exposure with high MMS and CPT concentrations is not
derived from a missing S phase function, but rather from underexpression of the Mlow-Mus81-Mms4 construct. Additional expression of Slow-Mus81-
Mms4 as a second copy together with Mlow-Mus81-Mms4 (Slow+Mlow-Mus81-Mms4) does not rescue the defect of Mlow-Mus81-Mms4 cells at high MMS
and CPT concentrations and thereby rules out a contribution of S phase Mus81-Mms4. (D) Spotting of indicated strains as in Figure 3A/B. (E) Western
blot analysis of cells expressing both Slow-Mus81-Mms4 and Mlow-Mus81-Mms4 (Slow+Mlow-Mus81-Mms4) constructs at indicated time points after G1
release as in Figure 1D.
Bittmann et al. eLife 2020;9:e52459. DOI: https://doi.org/10.7554/eLife.52459 17 of 26
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Figure 4. Mus81-Mms4 act as a post-replicative resolvase. (A) Viability after a pulse of MMS in S phase and subsequent replication fork stalling
depends on the M phase function of Mus81-Mms4. Viability assay scoring survivors after pulses of MMS in S phase for one to three hours (upper). Cell
Figure 4 continued on next page
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Figure 4 continued
viability (%) was determined by colony forming units normalized to untreated cells (0 hr) and is depicted as mean of biological replicates (n = 3) with
error bars indicating standard deviation. Significance: n.s. p>0.05, *p<0.05, **p<0.005 as calculated by an unpaired Student´s T-test (see Figure 4—
source data 1 for underlying values and exact p-values). (B/C) Resolution of replication/repair intermediates arising in response to replication stalling in
S phase requires mitotic Mus81-Mms4 function. PFGE analysis of cells recovering (1–4 hr in Nocodazole) from a pulse of MMS (0.033%, 1 hr) in S phase
(see upper panel for experimental setup). PFGE gels were stained with EtBr or subjected to southern blot hybridization with a probe against the ADE2
locus located on chromosome XV. The relative number of resolved chromosomes XV from the southern blots was quantified using ImageJ and is
depicted below. (B) PFGE/southern analysis of Mlow-Mus81-Mms4/Slow-Mus81-Mms4 cells. (C) PFGE/southern analysis of Mhigh-Mus81-Mms4/Shigh-
Mus81-Mms4 cells. (D) HR repair resulting in crossovers depends on the mitotic function of Mus81. I-SceI induced recombination assay between
heterologous ade2 alleles in diploid cells as described in Ho et al., 2010. Upper panel: arrangement of marker genes on chromosomes IV used for
classifying the genetic outcomes of DSB repair. The arrow indicates the I-SceI site. Bottom panel: genetic outcome of repair, with overall crossover
events (grey) and crossovers among individual classes (red, red/white, white) that differ in conversion tract length. Depicted are mean values from two
independent experiments each scoring 400–600 cells with the standard deviation as error bars. Significance: n.s. p>0.05, *p<0.05, **p<0.005 compared
to WT cells by unpaired Student´s T-test (see Figure 4—source data 2 for underlying values and exact p-values). (E) The essential requirement of
Mus81 in the absence of SGS1-dependent dissolution occurs during M phase. Tetrad analysis of yeast diploid cells with indicated genotypes reveals
synthetic lethality between sgs1D and Slow-/Shigh-Mus81-Mms4 while Mlow-/Mhigh-Mus81-Mms4 shows no discernible effect on cell growth in the
background of sgs1D (see Figure 4—figure supplement 2 for a growth analysis of the individual spores of the tetrad analysis with Shigh-/Mhigh-Mus81-
Mms4).
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Figure 4—figure supplement 1. Cell cycle tags restrict efficiently to S or M phase also after DNA damage
treatment. Western blot analysis of WT cells (left), of cells expressing Slow-Mus81-Mms4 or Mlow-Mus81-Mms4
(middle) and of cells expressing Shigh-Mus81-Mms4 or Mhigh-Mus81-Mms4 (right) S- and M-tagged Mus81-Mms4
recovering from a pulse of MMS (0.033%, 1 hr) as in Figure 4B/C. Rise in Clb2 levels are coincidental with entry
into M phase. Pgk1 serves as control.
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Figure 4—figure supplement 2. Mus81 function
during M phase is required in the absence of Sgs1
function. Growth assay of yeast haploid cells with the
indicated genotypes derived from the tetrad analysis of
Shigh-/Mhigh-Mus81-Mms4 in Figure 4E including very
slow growing Shigh-/Mhigh-Mus81-Mms4 sgs1D
haploids. Four strains of indicated genotypes were
spotted in 5-fold serial dilutions and growth was
analysed after incubation of 1.5 days at 30˚C on YPD
plates.
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Figure 5. Premature activation of Yen1 in S or early M phase interferes with the response to replication stalling lesions. (A) Cell cycle-tagged Yen1-ON-
9MYC constructs restrict expression of constitutively active Yen1-ON to S, M or G1 phase. (Left) Western blot analysis of strains expressing WT, S (Slow
Figure 5 continued on next page
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Figure 5 continued
(Clb6pClb6 -80bp)-Yen1-ON9MYC/Shigh (Clb6pClb6)-Yen1-ON9MYC), M (Mlow (Clb2pClb2 -60bp)-Yen1-ON9MYC/Mhigh (Clb2pClb1)-Yen1-ON9MYC) and G1 (G1low
(Sic1pSic1 u(ATA)ATG)-Yen1-ON9MYC/G1high (Sic1pSic1 -20bp)-Yen1-ON9MYC) phase-restricted Yen1-ON during synchronous cell cycle progression as in
Figure 2A. (see Figure 5—figure supplement 2 for quantification of peak expression levels for individual constructs). (Right) schematic representation
of endogenously expressed and cell cycle-tagged Yen1-ON constructs. Blue, green and orange bars indicate location of cell cycle regulatory elements
in the promoter and N-terminal degron sequence. (B), The M phase function of Yen1-ON is able to bypass Mus81 requirement after MMS induced
replication fork stalling. Strains with indicated genotypes were chronically exposed to MMS as in Figure 3A (note the mus81D background). (C–D),
Viability after MMS induced replication fork stalling decreases when Yen1-ON is restricted to S or early M phase. (C) Survival of indicated strains after
chronic MMS exposure as in (B). (D) Viability assay after a single pulse of MMS in S phase was measured for indicated strains as in Figure 4A (see
Figure 5—source data 1 for underlying values and exact p-values).
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Figure 5—figure supplement 1. Strategy for C-terminal cell cycle tagging of Yen1-ON. In order to generate Yen1-ON alleles expressed under cell
cycle-regulated promoters and with C-terminal degrons, Yen1-ON constructs were generated in pRS303 integrative vectors. Cell cycle-tagged Yen1-ON
Figure 5—figure supplement 1 continued on next page
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Figure 5—figure supplement 1 continued
constructs were linearized and integrated at the his3-11,15 locus via homologous recombination. A detailed description of the workflow can be found in
Materials and methods (construction of cell cycle-tagged strains).
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Figure 5—figure supplement 2. Analysis of ‘low’ and ‘high’ S-, M- and G1-tagged Yen1-ON peak expression levels. (A/B) Sets of Slow (Clb6pClb6 -80bp)-
, Mlow (Clb2pClb2 -60bp)- and G1low (Sic1pSic1 u(ATA)ATG)-Yen1-ON (A) and Shigh (Clb6pClb6)-, Mhigh (Clb2pClb1)- and G1high (Sic1pSic1 -20bp)-Yen1-ON (B)
display similar peak expression levels in S, M and G1 phase, respectively. Western blot analysis of peak expression levels of cell cycle-tagged Yen1-ON-
9MYC variants at individual time points after G1 release (20,30 min = S; 50,60 min = M; 100,110 = G1) as controlled by DNA content measurement by
flow cytometry (lower). Peak expression levels were quantified using Image-J and signals of the individual constructs were divided by the corresponding
Pgk1 sample to normalize to overall protein levels. Normalized peak expression levels were compared to WT expression at the corresponding time
point (fold difference) and the two analysed time points were averaged for each construct to result in a mean fold difference that is indicated above the
western blots. (C) Summary of peak expression levels of various tested cell cycle-tagged Yen1-ON constructs. Depicted are relations of peak expression
values in comparison to WT, which lead to selection of ‘high’ and ‘low’ expressing constructs.
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Dbf4-dependent kinase and the Rtt107 scaffold
promote Mus81-Mms4 resolvase activation
during mitosis
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Abstract
DNA repair by homologous recombination is under stringent cell
cycle control. This includes the last step of the reaction, disentan-
glement of DNA joint molecules (JMs). Previous work has estab-
lished that JM resolving nucleases are activated specifically at the
onset of mitosis. In case of budding yeast Mus81-Mms4, this cell
cycle stage-specific activation is known to depend on phosphoryla-
tion by CDK and Cdc5 kinases. Here, we show that a third cell cycle
kinase, Cdc7-Dbf4 (DDK), targets Mus81-Mms4 in conjunction with
Cdc5—both kinases bind to as well as phosphorylate Mus81-Mms4
in an interdependent manner. Moreover, DDK-mediated phospho-
rylation of Mms4 is strictly required for Mus81 activation in mito-
sis, establishing DDK as a novel regulator of homologous
recombination. The scaffold protein Rtt107, which binds the
Mus81-Mms4 complex, interacts with Cdc7 and thereby targets
DDK and Cdc5 to the complex enabling full Mus81 activation.
Therefore, Mus81 activation in mitosis involves at least three cell
cycle kinases, CDK, Cdc5 and DDK. Furthermore, tethering of the
kinases in a stable complex with Mus81 is critical for efficient JM
resolution.
Keywords cell cycle; genome stability; homologous recombination; joint
molecule resolution; post-translational modification
Subject Categories Cell Cycle; DNA Replication, Repair & Recombination
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Introduction
Many DNA transactions are under cell cycle control to adjust them
to cell cycle phase-specific features of chromosomes (Branzei &
Foiani, 2008). Homologous recombination (HR) is cell cycle-
regulated at several steps including the first, DNA end resection, and the
last, JM removal (Heyer et al, 2010; Ferretti et al, 2013; Mathiasen
& Lisby, 2014; Matos & West, 2014). Given that JMs provide stable
linkages between sister chromatids, they will interfere with chromo-
some segregation and therefore need to be disentangled before sister
chromatid separation during mitosis. Accordingly, JM resolvases,
such as budding yeast Mus81-Mms4 (Interthal & Heyer, 2000;
Schwartz et al, 2012) or Yen1 (Ip et al, 2008), become activated
during mitosis (Matos et al, 2011, 2013; Gallo-Fernández et al,
2012; Szakal & Branzei, 2013; Blanco et al, 2014; Eissler et al,
2014). In contrast, the alternative JM removal pathway, JM dissolu-
tion by the Sgs1-Top3-Rmi1 complex, is thought to be constantly
active throughout the cell cycle (Mankouri et al, 2013; Bizard &
Hickson, 2014). The activation of JM resolvases in mitosis therefore
leads to a shift in the balance between JM removal pathways, with
dissolution being preferred outside of mitosis, but JM resolution
becoming increasingly important in mitosis (Matos et al, 2011,
2013; Gallo-Fernández et al, 2012; Dehé et al, 2013; Saugar et al,
2013; Szakal & Branzei, 2013; Wyatt et al, 2013). It has been
hypothesized that JM resolvases are downregulated at cell cycle
stages other than mitosis in order to counteract crossover-induced
loss of heterozygosity or to prevent over-active resolvases from
interfering with S phase by, for example, cleaving stalled replication
forks (Gallo-Fernández et al, 2012; Szakal & Branzei, 2013; Blanco
et al, 2014).
Budding yeast Mus81-Mms4 has previously been shown to be
targeted by two cell cycle kinases, cyclin-dependent kinase Cdc28
(CDK) and the yeast polo-kinase Cdc5 (Matos et al, 2011, 2013;
Gallo-Fernández et al, 2012; Szakal & Branzei, 2013). The corre-
sponding Mms4 phosphorylation events were shown to correlate
with and to be required for activation of Mus81-Mms4 in mitosis. In
2014, we showed that in mitosis Mus81-Mms4 also forms a complex
with Slx4-Slx1 and the scaffold proteins Dpb11 and Rtt107
(Gritenaite et al, 2014). Interestingly, mass spectrometric analysis of
this complex (Gritenaite et al, 2014) revealed that Cdc5 and a third
cell cycle kinase Dbf4-Cdc7 (Dbf4-dependent kinase, DDK) are also
a stable part of this protein assembly (see Appendix Fig S1A). Here,
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we investigate the role of DDK in Mus81-Mms4 regulation and find
that DDK can phosphorylate Mms4 and that DDK and Cdc5 target
Mus81-Mms4 in an interdependent manner. Moreover, we show
that Rtt107 promotes the association of both kinases with the
Mus81-Mms4 complex. The DDK-dependent regulation of Mus81-
Mms4 is critical for Mus81 activity thus revealing DDK as a novel
regulator of homologous recombination.
Results
Mus81-Mms4 is a DDK phosphorylation target
The cell cycle regulation of JM resolution by Mus81-Mms4 is intri-
cate and involves phosphorylation by the cell cycle kinases CDK
and Cdc5 (Matos et al, 2011, 2013; Gallo-Fernández et al, 2012;
Szakal & Branzei, 2013) as well as complex formation with the scaf-
fold proteins Dpb11, Slx4 and Rtt107 (Gritenaite et al, 2014). To
study this protein complex, we performed an analysis of Mms43FLAG
interactors in mitosis by SILAC-based quantitative mass spectrome-
try (Gritenaite et al, 2014) and found in addition to Dpb11, Slx4,
Rtt107 and Cdc5, also Cdc7 and Dbf4 as specific interactors of
Mms4 (Appendix Fig S1A). We verified that Cdc7 binds to Mus81-
Mms4 in an Mms43FLAG pull down from mitotic cells analysed
by Western blots (Fig 1A). The fact that Mus81-Mms4 binds to
DDK suggested that it might be involved in the phosphorylation
cascade that occurs on Mms4 and controls Mus81 activity in
mitosis. Accordingly, we found that purified DDK was able to phos-
phorylate both subunits of purified Mus81-Mms4 in vitro (Fig 1B,
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Figure 1. Dbf4-dependent kinase (DDK) binds to the Mus81-Mms4 complex in mitosis and can phosphorylate Mms4 at (S/T)(S/T) motifs.
A Cdc7 and Cdc5 are specifically enriched in Mms43FLAG co-IPs from cells arrested in mitosis (with nocodazole). Under the same conditions, Mus81-Mms4 associates
with scaffold proteins such as Dpb11 and Slx4 (Appendix Fig S1A and Gritenaite et al, 2014).
B DDK can phosphorylate Mus81-Mms4 in vitro. Purified, immobilized Mus81-Mms4 is incubated in an in vitro kinase assay with purified CDK2/cycAN170 (a model CDK),
DDK or Cdc5 (lanes 1–4). Additionally, Mus81-Mms4 is incubated with respective kinases after a non-radioactive priming step with CDK (lanes 5–8).
C DDK phosphorylates Mms4 peptides at (S/T)(S/T) motifs and is enhanced by priming phosphorylation. Mms4 peptides including (S/T)(S/T) motifs (221/222; 133/134)
were synthesized in different phosphorylation states (depicted in left panel) and incubated in an in vitro kinase assay with either CDK or DDK. CDK targets
unphosphorylated Mms4 peptides 1 and (to a weaker extent) 4 consistent with its substrate specificity (Mok et al, 2010), while DDK primarily targets Mms4 peptides
2 and 5, which harbour a priming phosphorylation at the C-terminal (S/T) site (see Appendix Fig S1B for in-gel running behaviour of peptides).
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phosphorylation signal to Mms4 phosphorylation by CDK and Cdc5
(Fig 1B, lanes 2–4), we observed different degrees of phosphoryla-
tion shifts indicating that the three kinases phosphorylate Mms4 at
distinct sites and/or to different degrees. DDK target sites on other
proteins have been studied in detail, and in several cases, DDK was
found to target (S/T)(S/T) motifs, where phosphorylation was stim-
ulated by a priming phosphorylation usually on the second (S/T)
(Masai et al, 2006; Montagnoli et al, 2006; Randell et al, 2010;
Lyons et al, 2013). Intriguingly, Mms4 contains 15 of these motifs
and we therefore tested whether these could be targeted by DDK
and would depend on priming phosphorylation. We therefore
turned to a peptide-based assay where Mms4 phosphorylation states
are precisely defined. To this end, we synthesized peptides corre-
sponding to two (S/T)(S/T) motifs of Mms4. We chose two repre-
sentative motifs: S222, as it harbours a minimal CDK consensus
motif (S/T)P, and S134, as it contains a non-(S/T)P consensus for
CDK [(S/T)X(K/R)(K/R) (Suzuki et al, 2015)]. For each of these
motifs, we generated peptides in three different phosphorylation
states: non-phosphorylated, phosphorylated at the second serine
and doubly phosphorylated (Fig 1C and Appendix Fig S1B). When
using such peptides as substrates in in vitro kinase reactions, we
saw that CDK targeted specifically only the second serine in each
peptide, although much stronger for S222 than for S134, consistent
with these residues matching CDK consensus motifs (Fig 1C). In
contrast, DDK showed only little activity towards the non-
phosphorylated peptides, but was strongly stimulated when the
second residue in the (S/T)(S/T) motif was in a phosphorylated
state (Fig 1C). DDK may thus be stimulated by priming phosphory-
lation in order to efficiently phosphorylate Mms4 on (S/T)(S/T)
sites. However, using the full-length protein as a phosphorylation
substrate, we did not obtain evidence for a stimulatory effect on
DDK by prior CDK phosphorylation (Fig 1B and Appendix Fig S1C),
perhaps because over the whole 15 (S/T)(S/T) motifs CDK phospho-
rylation plays a minor role. We also did not reveal any priming
activity of either CDK or DDK for Mms4 phosphorylation by Cdc5
(Fig 1B and Appendix Fig S1D). Overall, the data in Fig 1 thus iden-
tify Mus81-Mms4 as an interaction partner and potential substrate
of DDK.
Mus81-Mms4 is phosphorylated by a mitotic Cdc5-DDK complex
DDK is present and active throughout S phase and mitosis until
anaphase when the Dbf4 subunit is degraded by APC/CCdc20 (Cheng
et al, 1999; Weinreich & Stillman, 1999; Ferreira et al, 2000). We
therefore tested at which cell cycle stage DDK would associate with
Mus81-Mms4 using cells synchronously progressing through the cell
cycle. Figure 2A shows that DDK did not associate with Mus81-
Mms4 in S phase, but only once cells had reached mitosis. Strik-
ingly, DDK binding therefore coincided with binding of Cdc5, Slx4
and Dpb11 and most notably the appearance of the hyperphospho-
rylated form of Mms43FLAG (Fig 2A).
Given this late timing of the association, we tested in co-
immunoprecipitation (co-IP) experiments whether DDK binding to
Mus81-Mms4 would depend on CDK or Cdc5 activity. Using analog-
sensitive mutant yeast strains for CDK [cdc28-as1 (Bishop et al,
2000)] and for Cdc5 [cdc5-as1 (Snead et al, 2007)], we observed that
inhibition of these kinases in mitotically arrested cells strongly
reduced the hyperphosphorylation shift of Mms4 (see also Matos
et al, 2013) and compromised the association with DDK (Fig 2B and
C, and Appendix Fig S2A–C). Notably, both conditions also inter-
fered with Cdc5 binding (Fig 2B and C, and Appendix Fig S2A),
suggesting that the association of DDK may follow a similar regula-
tion as Cdc5.
Next, we tested whether conversely DDK is involved in Mms4
phosphorylation. To bypass the essential function of DDK in DNA
replication, we used the mcm5bob1-1 allele (Hardy et al, 1997),
which allowed us to test a cdc7D mutant. Using Western blot and
SILAC-based mass spectrometry as a read-out of Mms43FLAG co-IPs
from cells arrested in mitosis, we found that Cdc5 association with
Mus81-Mms4 was strongly reduced in the cdc7D mutant strain
(Fig 2D and E). Moreover, we observed that Mms43FLAG phospho-
rylation as indicated by mobility shift was decreased in the
absence of DDK, although not to the same extent as upon CDK or
Cdc5 inhibition (Fig 2D and Appendix Fig S2C). Additionally, as
an alternative way to deregulate DDK, we used the cdc7-1 tempera-
ture-sensitive mutant. Even with WT cells, we observed that
elevated temperature (38°C) leads to a slight reduction in Cdc5
binding to Mus81-Mms4. However, in cdc7-1 mutant cells, incuba-
tion at 38°C leads to the complete disappearance of Cdc5 binding
to Mus81-Mms4 (Appendix Fig S2D). Therefore, we conclude from
these data that DDK and Cdc5 bind to Mus81-Mms4 in an inter-
dependent fashion.
Interestingly, Cdc5 was previously shown to interact with DDK
via a non-consensus polo-box binding site within Dbf4 (Miller et al,
2009; Chen & Weinreich, 2010). The proposed model based on
genetic experiments suggested that DDK binding antagonizes mitotic
functions of Cdc5. However, the catalytic activity of Cdc5 was not
inhibited in this complex (Miller et al, 2009) and we reason that
DDK may simply target Cdc5 to a specific set of substrates. Since the
Cdc5 binding site was mapped to the N-terminal portion of Dbf4
(Miller et al, 2009), we tested whether N-terminal truncations of
Dbf4 would affect DDK or Cdc5 association with Mus81-Mms4.
While the dbf4-DN66 truncation lacking the first 66 amino acids (in-
cluding a D-box motif) did not influence DDK or Cdc5 binding to
Mms43FLAG, the dbf4-DN109 truncation, which additionally lacks
the Cdc5 binding motif (Miller et al, 2009), showed strongly
decreased DDK and Cdc5 binding to Mus81-Mms4 (Fig 2F). Addi-
tionally, also mitotic hyperphosphorylation of Mms4 was dimin-
ished when DDK and Cdc5 could not interact with each other
(Fig 2F). Overall, these data strongly suggest that Cdc5 and DDK
interact with and target Mus81-Mms4 in an interdependent manner.
Furthermore, it is currently unclear whether collaboration of DDK
and Cdc5 is a widespread phenomenon that may affect other Cdc5
substrates as well, given that mitotic phosphorylation of two
candidate Cdc5 substrates, Ulp2 and Scc1 (Alexandru et al, 2001),
was affected to varying degree by the cdc7D mutation
(Appendix Fig S2E).
Given the known cell cycle regulation of Cdc5 and DDK
(Shirayama et al, 1998; Cheng et al, 1999; Weinreich & Stillman,
1999; Ferreira et al, 2000; Mortensen et al, 2005), the limiting
factor for the temporal regulation of this complex and its
restriction to mitosis is expected to be Cdc5 and not DDK, which
is present already throughout S phase. Consistently, we
observed that forced expression of Cdc5 (using the galactose-
inducible GAL promoter) in cells that were arrested in S phase by
hydroxyurea (HU) led to the premature occurrence of Mms4
The EMBO Journal Vol 36 | No 5 | 2017 ª 2017 The Authors
The EMBO Journal Mus81 regulation during the cell cycle Lissa N Princz et al
666
hyperphosphorylation (Fig EV1A; Matos et al, 2013), suggesting
that S-phase DDK is in principle competent for Cdc5 binding and
joint substrate phosphorylation.
Furthermore, we performed additional experiments that
addressed the regulation of Mus81-Mms4 by the DNA damage
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Cdc5 with Mus81-Mms4 was reduced after induction of DNA
damage with phleomycin (Appendix Fig S2F), but this treatment
was not sufficient to induce a significant reduction in the Mms4
phosphorylation shift. Interestingly, when we forced Cdc5 expres-
sion in S-phase cells and compared normal S-phase cells to cells
treated with hydroxyurea (HU), we observed that the Mms4
phosphorylation shift was less pronounced in the presence of
hydroxyurea (HU) (Fig EV1B). These data are therefore
consistent with the current view that DNA damage, specifically
the DNA damage checkpoint, negatively influences Mus81 resolu-
tion activity (Szakal & Branzei, 2013; Gritenaite et al, 2014).
Since DDK is known to be targeted and inhibited by the DNA
damage checkpoint (Weinreich & Stillman, 1999; Lopez-
Mosqueda et al, 2010; Zegerman & Diffley, 2010), it could
become particularly critical to regulate Mms4 phosphorylation
after DNA damage.
Even though DDK and Cdc5 seem to target Mus81-Mms4 in
unison, we tested whether it was possible to resolve differences on
the level of individual phosphorylation sites. Therefore, we
analysed Mms4 phosphorylation sites in M-phase cells after Cdc5
inhibition (Fig 3A and C) or CDC7 deletion (Fig 3B and D) by
SILAC-based mass spectrometry. We also applied two different
experimental set-ups that used either endogenously expressed
Mus81-Mms4 (Fig 3A and B) or overexpressed Mus81-Mms4
(Fig 3C and D), as the latter set-up allowed much better coverage
of Mms4 phosphopeptides in higher order phosphorylation states
(peptides harbouring > 1 phosphorylated site). Cdc5 inhibition or
lack of DDK led to overlapping, but distinct changes in Mms4
phosphorylation sites, suggesting that each kinase phosphorylates
specific sites on Mms4. After Cdc5 inhibition, phosphorylation of
many sites was reduced and among those were sites that match to
a putative Cdc5 consensus [(D/E/N)X(S/T), blue, Fig 3A and C;
Mok et al, 2010]. Overall, CDC7 affected Mms4 phosphorylation
less than Cdc5 inhibition, but nonetheless, we found widespread
changes in the phosphorylation of (S/T)(S/T) motifs (Fig 3B and
D). (S/T)(S/T) motifs were found less abundantly in the doubly
phosphorylated state (Fig 3D, red), while conversely these motifs
were found more abundantly in the state where only the second
(S/T) was singly phosphorylated (Fig 3B and D, yellow), as
expected for a substrate–product relation. These data are thus
consistent with phosphorylation of the second (S/T) priming for
phosphorylation at the preceding (S/T) (Appendix Table S1 and
Appendix Fig S3).
DDK phosphorylation is required for activation of Mus81-Mms4
during mitosis
Phosphorylation of Mms4 by CDK and Cdc5 has previously been
shown to be required for the upregulation of Mus81-Mms4 activity
during mitosis (Matos et al, 2011, 2013; Gallo-Fernández et al,
2012; Szakal & Branzei, 2013). Based on our finding that hyper-
phosphorylation of Mms4 was impaired in the absence of DDK
(Fig 2D and Appendix Fig S2C), we predicted that also Mus81-
Mms4 activity would be influenced. Therefore, we tested the activ-
ity of endogenous Mus819myc-Mms43FLAG immunopurified from
G2/M arrested cells (approx. 5 fmol) on a nicked Holliday junction
(nHJ) substrate (500 fmol) using an assay related to those in
(Matos et al, 2011, 2013; Gritenaite et al, 2014). Notably, the
activity of the endogenous purified Mus81-Mms4 from G2/M cells
exceeded the activity of recombinant Mus81-Mms4 (subjected to a
dephosphorylation step during the purification), indicating that it
is the mitotically activated form (Appendix Fig S4A). Moreover,
the activity of endogenous purified Mus81-Mms4 was not influ-
enced by 350 mM NaCl salt washes. This indicates that the pres-
ence of accessory, salt-labile factors such as Rtt107 or Cdc5 in the
reaction is unlikely to contribute to Mus81 activity (Appendix Fig
S4B and C).
Importantly, when we used this assay to test immunopurified
Mus819myc-Mms43FLAG from mitotic cells lacking DDK (cdc7D or
dbf4D), we observed a reduced activity compared to Mus819myc-
Mms43FLAG from WT cells (Fig 4A and Appendix Fig S4D; also
observed with an RF substrate, Appendix Fig S4E). In order to
exclude that indirect effects of the CDC7 deletion may cause the
reduction in Mus81 activity, we furthermore created an Mms4
mutant that specifically lacks candidate DDK phosphorylation sites.
We chose to mutate (S/T)(S/T) motifs (SS motifs in particular)
and created an mms4-8A mutant that harboured eight S to A
exchanges at the N-terminal (S/T) of the motifs (see Appendix Fig
S3A). This mutant appeared less phosphorylated in mitosis as
judged by a less pronounced phosphorylation shift (Fig 4B).
Furthermore, we observed a reduction in the association of DDK
and Cdc5 with the Mus81-Mms4-8A complex in pull-down experi-
ments (Fig 4B), suggesting that phosphorylation of Mms4 also
plays a role in tethering these kinases. Notably, Mus819myc-
Mms43FLAG-8A from mitotic cells showed a moderate but repro-
ducible reduction in resolution activity on nHJ substrates
compared to WT Mus819myc-Mms43FLAG (Fig 4C and Appendix Fig
Figure 2. DDK and Cdc5 target Mus81-Mms4 in an interdependent manner.
A DDK stably associates with Mus81-Mms4 in mitosis, but not in S phase or G1. Mms43FLAG pull down experiment (left panel, as in Fig 1A) from cells arrested in G1
(with alpha-factor) or in cells progressing synchronously through S phase until mitosis (arrest with nocodazole) reveals that DDK binds specifically in mitosis
concomitant with the raise in Cdc5 levels and Cdc5 binding to Mus81-Mms4. A nocodazole-arrested untagged strain was used as a control. Right panel shows
measurements of DNA content by FACS from the respective samples.
B CDK activity is required for DDK and Cdc5 association with Mus81-Mms4. Mms43FLAG pull down as in (A), but in mitotic WT or cdc28-as1 mutant cells treated with
5 lM 1NM-PP1 for 1 h. Additional Western blots of this experiment are shown in Appendix Fig S5B, including as a control the identical anti-FLAG Western blot.
C Cdc5 activity is required for DDK association with Mus81-Mms4. Mms43FLAG pull down as in (A), but with mitotically arrested WT or cdc5-as1 mutant cells treated
with 10 lM CMK for 1 h.
D, E DDK is required for Cdc5 binding to Mus81-Mms4 in mitosis and the mitotic Mms4 phospho-shift. (D) Mms43FLAG pull down using mitotically arrested cells as in
(A), but using a bob1-1 background (all samples), where the DDK subunit Cdc7 could be deleted. (E) SILAC-based quantification of Mms43FLAG pull downs in
mitotically arrested bob1-1 vs. bob1-1 cdc7D cells. Plotted are the H/L ratios of two independent experiments including label switch.
F The Cdc5 binding region on Dbf4 is required for interaction of DDK and Cdc5 with Mus81-Mms4 and for efficient Mms4 phosphorylation. Mms43FLAG pull down as
in (A), but using mitotically arrested cells expressing N-terminal truncation mutants of Dbf4 lacking aa2–66 (including a D-box motif) or 2–109 [additionally
including the Cdc5 binding site (Miller et al, 2009)].
◀
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Figure 3. Analysis of Mms4 phosphorylation sites reveals Cdc5 and DDK target sites, as well as the interdependence between the two.
Changes of the abundance of phosphorylated Mms4 peptides after Cdc5 inhibition (as in Fig 2C) (A, C) or in the absence of Cdc7 (B, D) in mitotically arrested cells.
A, B Depicted are SILAC-based intensity ratios of individual MS evidences for peptides of endogenously expressed Mms4. Evidences of non-phosphorylated Mms4
peptides are shown in grey; evidences of phosphorylated peptides are shown in black, yellow, orange or blue. Blue colour indicates putative Cdc5 phosphorylation
as defined by the (D/E/N)X(S/T) consensus (and additionally S268, which was also very strongly deregulated upon Cdc5 inhibition). Yellow or orange colours mark
singly phosphorylated (S/T)(S/T) motifs, with orange marking p(S/T)(S/T) and yellow marking (S/T)p(S/T). Numbers indicate the phosphorylated residue in the
depicted peptide. An asterisk marks peptide evidences that contained measured intensity values exclusively in the heavy or light sample. For doubly
phosphorylated peptides, the two phospho-sites are separated by a comma. For singly phosphorylated (S/T)(S/T) motifs, peptide ion fragmentation was in some
cases unable to unambiguously identify the phosphorylated residue. In these cases, possible phosphorylation sites are indicated as “a/b”. Note that doubly
phosphorylated (S/T)(S/T) sites were not reproducibly identified under conditions of endogenous Mus81-Mms4 expression.
C, D As in panels (A, B) but using Mus81-Mms4 expressed from a high-copy promoter. Depicted are SILAC-based H/L ratios of individual MS evidences for
phosphorylated peptides only. Peptides were sorted into categories according to their phosphorylation status: putative DDK target sites ((S/T)(S/T) motifs) were
differentiated into the categories p(S/T)p(S/T) (red), p(S/T)(S/T) (orange) or (S/T)p(S/T) (yellow). Phosphorylated peptides matching the Cdc5 consensus site are
coloured in blue. All other phosphorylated peptides are marked in grey. Bars depict the mean of the ratios of the respective category. Overall, Mms4 H/L ratio is
shown on top.
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S4F). These data thus indicate that DDK targets Mus81-Mms4 and
that (S/T)(S/T) phosphorylation events are essential for full
activation of Mus81 in mitosis.
Additionally, we investigated the relevance of the mms4-8A
mutation in vivo. In comparison with mus81D or mms4D mutants,
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example, it did neither significantly increase the MMS hypersensitiv-
ity of a yen1D mutant, nor did it confer synthetic lethality with
mutants defective in STR function, such as sgs1D, even though the
mms4-8A sgs1D double mutant displayed a slow growth phenotype
(Figs 4D and EV2A). Importantly, however, we did observe a
strongly increased hypersensitivity towards MMS, when we tested
an mms4-8A sgs1D double mutant and compared it to an sgs1D
single mutant (Fig 4D). The mms4-8A mutation thus leads to a
phenotype that is very similar to other activation-deficient MMS4
mutants in budding and fission yeast (Gallo-Fernández et al, 2012;
Dehé et al, 2013; Matos et al, 2013). Remarkably, the MMS hyper-
sensitivity phenotype of the mms4-8A mutant was highly similar to
that of the Cdc5 binding-deficient dbf4-DN109 mutant (Figs 4E and
EV2B), which also showed reduced survival when combined with
sgs1D (Fig 4E). These data are therefore consistent with DDK func-
tioning to stimulate JM resolution via Mms4 hyperphosphorylation.
It is likely that the mms4-8A mutant is only partially deficient in
DDK phosphorylation, since Mms4 contains overall 15 (S/T)(S/T)
sites and DDK may phosphorylate the protein on non-(S/T)(S/T)
sites as well. We therefore note that an mms4-12A mutant, harbour-
ing four additional S to A exchanges on (S/T)(S/T) motifs, showed
further increased MMS sensitivity in the mms4-12A sgs1D mutant,
when compared to the mms4-8A sgs1D mutant, even though there
were only minor additional effects on either the Mms4 mitotic phos-
phorylation shift or JM resolution activity (Fig EV2C–E).
In order to directly assess whether DDK phosphorylation was
required for Mus81 function during JM resolution, we tested the
influence of the mms4-8A mutant in a genetic crossover assay (Ho
et al, 2010). In this system, a site-specific DSB is induced in
diploid cells and repair products can be measured by the arrange-
ment of markers and colony sectoring (Fig 4F, upper panel). In
this assay, mus81D and mms4D mutants show a reduction in CO
products and a proportional increase in NCO products (Fig 4F; Ho
et al, 2010), as would be expected from a defect in JM resolution
and the accompanying shift of repair pathways towards JM disso-
lution. The mms4-8A mutant shows a similar, albeit weaker defect
in the formation of CO products (Fig 4F), suggesting that the
defect in Mus81 activation in mitosis results in an overall defect in
JM resolution. We therefore conclude that DDK—in conjunction
with Cdc5—acts directly on Mms4 and that these phosphorylation
events are required for efficient Mus81-dependent JM resolution in
mitosis.
The Dpb11-Mms4 interaction is not required for DDK-Cdc5-
dependent activation of Mus81-Mms4
It is noteworthy that the association of DDK and Cdc5 with Mus81-
Mms4 coincides with the formation of the Mus81-Mms4 complex
with scaffold proteins such as Slx4, Dpb11 and Rtt107, which come
together in mitosis (Fig 2A). Therefore, we asked whether the scaf-
fold proteins Dpb11, Slx4 or Rtt107 would be required to target DDK
and Cdc5 to Mus81-Mms4. In order to investigate the influence of
Dpb11, we searched for an MMS4 mutant that was deficient in the
interaction with Dpb11. When we used a two-hybrid approach to
map the Dpb11 interaction site on Mms4, we found that Mms4
constructs comprising aa 1–212 or 101–230 interacted with Dpb11,
while constructs comprising aa 1–195 or 176–230 showed no or
reduced interaction (Appendix Fig S5A). This suggested that the
Dpb11 binding site may be located between aa 101–212 of Mms4.
Consistently, we observed that the Mms4-S201A mutation abolished
binding to Dpb11 in yeast two-hybrid and co-IP (Fig 5A and B),
while the Mms4-S184A mutation reduced it (Fig 5A). Serine 201
and 184 are therefore likely candidates for phospho-sites bound and
read by Dpb11. Serine 201 matches the full CDK consensus motif
(S/T)PxK, while serine 184 matches the minimal CDK consensus
motif (S/T)P. Indeed, we find that CDK inhibition reduced the
Dpb11 interaction with Mus81-Mms4 (Appendix Fig S5B) consistent
with a requirement of CDK phosphorylation for a robust interaction
between Dpb11 and Mms4.
When we investigated the phenotype of the mms4-SS184,201AA
mutant, we found that it showed enhanced hypersensitivity to MMS
specifically in the sgs1D mutant background, consistent with a role
of Dpb11 in JM resolution after MMS damage (Fig 5C). We also
noted that the phenotype of this MMS4 variant differed from that
induced by Dpb11 binding-deficient version of Slx4 [slx4-S486A
(Gritenaite et al, 2014; Ohouo et al, 2012)]. This could suggest that
these mutants are able to separate different Dpb11 functions such as
a mitotic function in conjunction with Mus81-Mms4 and an S-phase
function, which Slx4 and Dpb11 might have independently of
Mus81-Mms4 (Ohouo et al, 2012; Gritenaite et al, 2014; Cussiol
et al, 2015; Princz et al, 2015). However, it also needs to be consid-
ered that Slx4 and Mus81-Mms4 may be connected by more than
one scaffold protein (see below).
Importantly, however, we did not observe a defect in the
association of DDK or Cdc5 with Mus81-Mms4, when we performed
Figure 4. DDK phosphorylation controls activation of Mus81-Mms4 resolvase activity in mitosis.
A DDK is required for mitotic activation of Mus81-Mms4. Resolution assay using a nicked Holliday junction (nHJ) substrate and Mus819myc-Mms43FLAG purified from
mitotically arrested bob1-1 (DDK-WT+), bob1-1 dbf4D and bob1-1 cdc7D strains or untagged control cells. Right panel: quantification of cleavage products. See
Appendix Fig S4D for Western blots samples of anti-myc IPs. Left panel: representative gel image.
B A defect in the phosphorylation of Mms4 (S/T)(S/T) sites causes reduced association of Cdc5 and DDK with Mus81-Mms4 and reduced phosphorylation of Mms4.
Mms43FLAG pull down as in Fig 1A, but using mitotically arrested WT and mms4-8A mutant cells, which harbour 8 serine to alanine exchanges at (S/T)(S/T) motifs
(detailed in Appendix Fig S3).
C Reduced (S/T)(S/T) phosphorylation of Mms4 generates a defect in Mus81-Mms4 activity. Resolution assay as in (A), but comparing mitotic Mus81-Mms4 from
untagged, WT and mms4-8A strains (see Appendix Fig S4F for Western blot samples of anti-myc IPs).
D, E The mms4-8A mutation and lack of the Cdc5-DDK interaction (dbf4-DN109) lead to hypersensitivity towards MMS specifically in the sgs1D background. Shown is
the growth of indicated strains in fivefold serial dilution on plates containing MMS at indicated concentrations after 2 days at 30°C.
F The mms4-8A mutant leads to a reduction in crossover formation. Recombination assay between heterologous ade2 alleles in diploid cells as described in Ho et al
(2010). The top panel indicates markers on both copies of chromosome XV that are used to determine genetic outcomes of DSB repair. Arrow indicates the I-SceI
cut site. Bottom panel indicates rates of crossover events (%) overall (grey) and in the individual classes (red, red/white, white) that differ in gene conversion tract
length. Error bars indicate standard deviation of two independent experiments, each scoring 400–600 colonies per strain.
Data information: (A, C) Depicted are means from three independent experiments, error bars correspond to standard deviation.
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Mms4-S201A3FLAG pull downs and compared them to a WT
Mms43FLAG pull down (Fig 5B). Furthermore, we only observed a
very minor defect in the in vitro resolution of nHJ substrates, when
we purified Mus81-Mms4 from mitotically arrested mms4-S201A
cells (Appendix Fig S5C). We therefore reason that Dpb11 is most
likely not involved in promoting Mms4 phosphorylation or
DDK-Cdc5-dependent activation of Mus81-Mms4.
The Rtt107 scaffold recruits DDK and Cdc5 to Mus81-Mms4
Having excluded a role of Dpb11 in the recruitment of DDK and
Cdc5, we next tested a possible involvement of the Rtt107 scaffold
protein. Indeed, when we used an rtt107D mutant in IP and SILAC-
based IP-MS experiments, we observed that DDK and Cdc5 binding
to Mus81-Mms4 was strongly reduced (Fig 6A and Appendix Fig
S6A). Interestingly, Rtt107 bound to DDK and Cdc5 even under
conditions where Rtt107 binding to Mus81-Mms4 was abolished
(mus81D, Appendix Fig S6B). This suggests that Rtt107 may form a
subcomplex with DDK and Cdc5. Consistently, we found that Rtt107
bound to Cdc7 in a two-hybrid assay (Fig 6B). These data therefore
suggest that Rtt107 mediates binding of DDK and Cdc5 to the
Mus81-Mms4 complex, most likely via a Cdc7 interaction site on
Rtt107.
During our co-IP studies, we furthermore found that the location
of Rtt107 in the mitotic Mus81-Mms4 complex was different than
expected. Given that Slx4 was required to bridge between Rtt107
and Dpb11 (Ohouo et al, 2010) and that Mms4 and Dpb11 seem-
ingly interact directly (Gritenaite et al, 2014 and Fig 5A and B), we
initially expected that Slx4 and Dpb11 would be required to mediate
the interaction between Rtt107 and Mus81-Mms4. Surprisingly, we
found that an slx4D mutant did not influence DDK or Cdc5 binding
to Mus81-Mms4 and thereby differed from rtt107D (Fig 6A). There-
fore, we tested if Rtt107 could bind to Mus81-Mms4 independently
of Slx4 or Dpb11. Indeed, we found that the Mus81-Mms4 interac-
tion to Rtt107 was not influenced by the slx4D mutant (Fig 6C) or
the Dpb11 binding-deficient mms4-S201A allele (Fig 6D), indicating
that Rtt107 binding to the Mus81-Mms4 complex occurs indepen-
dently of the other scaffold proteins. In contrast, our data also show
that its binding is strongly dependent on kinases and Mms4 phos-
phorylation, since Rtt107 binding was strongly reduced in the
absence of DDK (Fig 2E), after Cdc5 inhibition (Appendix Fig S2A)
or in the mms4-8A phosphorylation site mutant (Fig EV3).
Therefore, these data provide novel insight into the role of
Rtt107 in Mus81-Mms4 regulation. First, it shows that Rtt107 medi-
ates the association of DDK and Cdc5 kinases with Mus81-Mms4.
Second, it also suggests that Rtt107 may bind directly to Mus81-
Mms4 and that this binding is dependent on Mms4 phosphorylation
and the cell cycle kinases DDK and Cdc5, although an alternative
model whereby Rtt107 indirectly promotes DDK and Cdc5 to tightly
associate with Mus81-Mms4 cannot be ruled out entirely. The fact
that Rtt107 promotes the interaction of Mus81-Mms4 with the
kinases, yet in turn requires the kinases and Mms4 phosphorylation
for interaction, suggests that Rtt107 may be acting after initial Mms4
phosphorylation has occurred and at this late stage tethers the
kinases, thus promoting phosphorylation of otherwise inefficiently
phosphorylated sites.
Rtt107 stimulates Mms4 hyperphosphorylation in order to
enhance Mus81-Mms4 activity in mitosis
Given Rtt107’s involvement in tethering DDK and Cdc5 to the
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Figure 5. The interaction between Mms4 and Dpb11 is dispensable for binding of Cdc5 and DDK and mitotic Mus81-Mms4 activation.
A, B Serine 201 of Mms4 is required for Dpb11 binding, but not for interaction with DDK and Cdc5. (A) Two-hybrid interaction analysis using Gal4-BD-Dpb11 with Gal4-
AD-Mms4, Gal4-AD-Mms4-S184A and Gal4-AD-Mms4-S201A constructs. (B) Mms43FLAG pull downs from mitotically arrested cells as in Fig 1A, but using WT or
S201A variants of Mms43FLAG. Asterisks mark cross-reactive bands.
C The Dpb11 binding-deficient allele mms4-SS184,201AA leads to a MMS hypersensitivity specifically in the sgs1D background. Spotting assay as in Fig 4D.
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mitotic hyperphosphorylation of Mms4 and concomitant activation
of the Mus81 nuclease. We observed only a minor effect on the
mitotic phospho-shift of Mms4 when using rtt107D mutants (Fig 6A
and Appendix Fig S2C). However, as it is still unclear which phos-
phorylation sites contribute to the Mms4 phospho-shift, we investi-
gated the effect of rtt107D on individual phosphorylation sites
in our mass spectrometry data. Appendix Fig S7A and B shows
SILAC-based comparisons of Mms4 phosphorylation sites in WT
and rtt107D cells, expressing Mus81-Mms4 from endogenous
(Appendix Fig S7A) or high-copy promoters (Appendix Fig S7B).
The overexpression set-up allowed us to quantify phosphorylation
at (S/T)(S/T) motifs, and we found that double phosphorylation of
several of these sites was reduced (Appendix Fig S7B), although the
change was much smaller compared to cells lacking DDK. On the
other hand, while we could not detect higher order phosphorylated
Mms4 peptides using endogenous Mus81-Mms4, we could detect an
effect of Rtt107 on several other sites (T209, S241 and S268, and to
a lesser extent S286; Appendix Fig S7A), which were also deregu-
lated after Cdc5 inhibition (Fig 3A and C). These data are thus
consistent with Rtt107 promoting efficient DDK and Cdc5 phospho-
rylation of Mms4.
Therefore, we tested whether Rtt107 would affect the mitotic
activation of Mus81-Mms4. We immunopurified Mus819myc-
Mms43FLAG from WT and rtt107D cells that were arrested in mitosis
and found that Mus81-Mms4 activity on a nHJ substrate was
reduced in the rtt107D background (Fig 7A and Appendix Fig S7C).
Furthermore, in the background of deficient DDK (cdc7D bob1-1),
additional mutation of rtt107D did not lead to a further defect in








































Figure 6. The Rtt107 scaffold tethers DDK and Cdc5 to Mus81-Mms4 independently of Slx4 and Dpb11.
A Rtt107, but not Slx4, is required for DDK and Cdc5 interaction with Mus81-Mms4. Mms43FLAG pull downs from mitotically arrested cells as in Fig 1A, but specifically
comparing interactions of Mus81-Mms4 in WT, slx4D, rtt107D and slx4D rtt107D mutant backgrounds.
B Rtt107 interacts with Cdc7. Two-hybrid interaction was tested using Gal4-BD-Rtt107 constructs and Gal4-AD-Cdc7 or Gal4-AD-Dbf4 constructs. Interaction between
Gal4-BD-Cdc5 and Gal4-AD-Dbf4 serves as positive control.
C Rtt107 interacts with Mus81-Mms4, DDK and Cdc5 independently of Slx4. Rtt1073FLAG co-IPs from untagged control, WT or slx4D cells arrested in mitosis were
probed for indicated proteins.
D Rtt107 interacts with Mus81-Mms4 independently of the Mms4-Dpb11 interaction. SILAC-based Mms43FLAG pull down in WT and mms4-S201A cells reveals changes
in the Dpb11 association, but not in Rtt107, Slx4, Cdc5 or DDK binding. Plotted are the H/L ratios of two experiments including label switch.
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Mus81-mediated cleavage (Appendix Fig S7D). Therefore, we
conclude that Rtt107 is required for full mitotic activation of Mus81-
Mms4 and that it works at least in part through cell cycle kinases
such as DDK.
In order to test whether such a defect in Mus81-Mms4 activation
would translate into a shifted balance of JM removal pathways, we
measured rates of crossover and non-crossover formation in the
absence of Rtt107. We observed a reduction in crossover rates in
the rtt107D mutant indicating a shift in the balance of JM removal
pathways (Fig 7B). The decrease was mostly visible in one class of
recombinants (Fig 7B, “red”) and is smaller compared to the pheno-
type of a mus81D or a mms4-8A mutant (Ho et al, 2010; Fig 4F),
consistent with a stimulatory but non-essential role of the Rtt107
scaffold in Mus81-Mms4 function. These data thus provide the first
mechanistic insight of how the interaction of the mitotic Mus81-
Mms4 complex with the scaffold proteins influences Mus81
function, as Rtt107 facilitates DDK and Cdc5 tethering, full mitotic
phosphorylation of Mms4 and activation of Mus81-Mms4.
Discussion
Activation of Mus81-Mms4 during mitosis is critical for the response
to DNA damage, in particular to process repair intermediates that
may arise from DSBs and stalled replication forks (Matos et al,























Figure 7. Rtt107 is required for efficient Mus81-Mms4 activation in mitosis.
A Mus81-Mms4 purified from mitotic rtt107D cells is less active compared to Mus81-Mms4 from WT cells. In vitro resolution activity of Mus819myc-Mms43FLAG purified
from WT or rtt107D cells is tested on a nHJ substrate (see Appendix Fig S7C for control Western blot). Right panel: quantification of cleavage products from three
independent experiments (mean ! SD). Left panel: representative gel picture.
B The rtt107D mutant leads to a reduction in crossover formation. Recombination assay as in Fig 4F. Note that the rtt107D mutant particularly affects crossover
formation in the red class (long conversion tracts), while no significant defect could be observed in the red/white and white class (mean ! SD).
C Hypothetical model of Mus81-based JM resolution. Upper panel: cell cycle regulation of JM removal pathways, indicating Mus81 activation in mitosis. Lower panel:
physical interactions of Mus81-Mms4 and its regulatory complex in mitotic cells. Grey arrows indicate physical interactions; green arrows specifically indicate kinase–
substrate interactions. Genetic data indicate a hierarchy of molecular events leading to Mus81 activation. (1) DDK, Cdc5 and CDK (not shown) phosphorylate Mms4.
(2) Rtt107 binds to DDK and Cdc5 and—in a phosphorylation-dependent manner—associates with Mus81-Mms4. This interaction is either direct or could potentially
depend on bridging effects by DDK and Cdc5. Rtt107 promotes the stable interaction of DDK and Cdc5 with Mus81-Mms4 and thus full phosphorylation of Mms4 and
Mus81 activation. (3) Upon Mms4 phosphorylation, two scaffold proteins, Rtt107 and Dpb11, bind independently to Mus81-Mms4. Both proteins can also bind to Slx4
enabling two alternative connections of Slx4 with Mus81-Mms4.
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& Branzei, 2013). Previously, this regulation was shown to critically
depend on phosphorylation by the cell cycle kinases CDK and Cdc5
(Matos et al, 2011, 2013; Gallo-Fernández et al, 2012; Saugar et al,
2013; Szakal & Branzei, 2013), but also involve the formation
of a multi-protein complex comprising several scaffold proteins
(Gritenaite et al, 2014). Here, we not only identify a new cell cycle
kinase to be crucial for this regulation—DDK—but moreover show
that the two regulatory pathways—cell cycle kinase phosphorylation
and scaffold complex formation—are connected by Rtt107 (see
Fig 7C for a hypothetical model). Rtt107 association depends on
active cell cycle kinases and Mms4 phosphorylation, but in turn
Rtt107 is required for stable DDK and Cdc5 association with the
Mus81-Mms4 complex, as well as full phosphorylation of Mms4 and
mitotic activation of Mus81. This study thus extends our mechanistic
understanding of the regulatory framework that controls cell
cycle-regulated JM resolution.
Interestingly, our work shows that for its function as a regulator of
Mus81-Mms4 DDK must act interdependently and as a complex with
Cdc5. DDK and Cdc5 have been shown to interact physically (Miller
et al, 2009; Chen & Weinreich, 2010), but until now DDK was viewed
to antagonize mitotic functions of Cdc5 (Miller et al, 2009). In
contrast, in meiosis I DDK and Cdc5 are known to cooperate in order
to promote chromosome segregation and jointly phosphorylate the
monopolin and cohesin subunits Lrs4 and Rec8, respectively, as well
as the meiotic regulator Spo13 (Matos et al, 2008). We now provide
the first example for a joint DDK and Cdc5 substrate in the mitotic cell
cycle, suggesting that cooperation between DDK and Cdc5 could be a
more widespread phenomenon than previously anticipated. The
apparent antagonism between DDK and Cdc5 in the regulation of
mitotic exit (Miller et al, 2009), a canonical Cdc5 function, could be
explained if DDK targeted Cdc5 to a specialized subset of substrates
rather than to substrates involved in mitotic exit. It is also interesting
to note that we could detect significant DDK binding to Mus81-Mms4
only after cells finished S phase (Fig 2A). Therefore, the role of DDK
in Mms4 phosphorylation is clearly post-replicative and further
challenges a simplified view of DDK as an S-phase kinase (Matos
et al, 2008). It will therefore be interesting to see whether additional
DDK substrates during mitosis can be identified and whether DDK
collaborates with Cdc5 for their phosphorylation as well.
Mus81-Mms4 has previously been shown to be cell cycle-regulated
and Mms4 to be a critical CDK and Cdc5 phosphorylation
target (Matos et al, 2011; Gallo-Fernández et al, 2012). We add
DDK to this already complex regulation. Our data clearly show that
phosphorylation of (S/T)(S/T) motifs is critical for Mus81-Mms4
function. The hypomorphic phenotype of the mms4-8A mutant
(Fig 4C, D and F) is likely due to additional DDK phosphorylation
sites either on Mms4 or perhaps even on Mus81. Importantly, DDK
does not appear to establish the timing of Mms4 phosphorylation in
mitosis, as Cdc5 still seems to be the limiting factor for this temporal
control in undisturbed cell cycles (Fig EV1B). However, the fact that
activation of Mus81-Mms4 depends on the activity of several
kinases makes it a coincidence detector that integrates the activity
of several cell cycle regulators. Therefore, it can be envisioned that
there are specific cellular conditions under which DDK activity
becomes limiting for Mus81-Mms4 activation. Notably, DNA
damage checkpoint kinases are known to phosphorylate DDK and
counteract its function during S phase (Weinreich & Stillman, 1999;
Lopez-Mosqueda et al, 2010; Zegerman & Diffley, 2010). Therefore,
it can be speculated that the checkpoint acts as a negative regulator
of Mus81-Mms4 activation via inhibition of DDK. Such regulation
could therefore explain how the presence of DNA damage restricts
Mus81 activity towards replication intermediates (Matos et al, 2011,
2013; Saugar et al, 2013; Szakal & Branzei, 2013; Gritenaite et al,
2014), suggesting that cell cycle and checkpoint pathways converge
in the regulation of Mus81.
A second layer of Mus81 regulation relies on the formation of a
multi-protein complex, which assembles specifically in mitosis and
contains Mus81-Mms4, DDK, Cdc5 and Slx4 as well as the scaffold
proteins Dpb11 and Rtt107 (Gritenaite et al, 2014). We are only
beginning to understand the mechanism whereby this scaffold
complex influences Mus81 function. Here, we show that Rtt107, but
not Dpb11 or Slx4, promotes the stable association of DDK and
Cdc5 with Mus81-Mms4 (Fig 6), suggesting that one function of the
multi-protein complex is to promote efficient Mus81-Mms4 phos-
phorylation. Conversely, our new data as well as our previous work
(Gritenaite et al, 2014) show that phosphorylation by cell cycle
kinases also regulates the formation of the multi-protein complex.
In particular, Rtt107 association with Mus81-Mms4 depends
strongly on DDK and Cdc5 (Fig 2E and Appendix Fig S2A). A direct
interaction of Rtt107 with Mus81-Mms4 seems the most plausible
interpretation of our data, although we currently cannot exclude
that Rtt107 may facilitate the interaction of DDK and Cdc5 with
Mus81-Mms4 without a direct interaction. A possible phosphoryla-
tion dependence of Rtt107 binding to the complex could thus
originate from Mms4 phosphorylation generating a binding site for
Rtt107 [e.g. for Rtt107 BRCT domains (Li et al, 2012)].
Importantly, Rtt107 is in turn required for stable binding of DDK
and Cdc5 (Fig 6A and Appendix Fig S6A). Via tethering the kinases,
Rtt107 regulates the phosphorylation of specific Mms4 sites and is
required for full Mus81 activation (Fig 7A and Appendix Fig S7A
and B). The interdependence between Rtt107 and Cdc5/DDK
phosphorylation therefore suggests that Rtt107 may be part of a
signal amplification mechanism, which ensures efficient
Mus81-Mms4 phosphorylation and activation. Mechanistically,
Rtt107-dependent stimulation of Mms4 phosphorylation thus resem-
bles a kinase priming mechanism. It is entirely possible that other
kinase priming mechanisms for either Cdc5 or DDK are at work in
the Mms4 phosphorylation cascade, although the in vitro kinase
assays with full-length proteins did not provide support for such a
mechanism (Fig 1B, and Appendix Fig S1C and D). Altogether, it
seems plausible to speculate that Rtt107-dependent and Rtt107-
independent amplification mechanisms are involved in generating a
switch-like activation of Mus81 in mitosis.
Furthermore, Rtt107 can also bind to Slx4 (Ohouo et al, 2010).
There are thus two BRCT-containing scaffold proteins—Dpb11
(Gritenaite et al, 2014) and Rtt107—that could bridge between
Mus81-Mms4 and Slx4. Interestingly, our data with different mms4
mutants suggest that either one of these BRCT scaffold proteins is
sufficient to connect Slx4 and Mus81-Mms4 [Figs 6D and EV3; note
that the rtt107D mutant (Appendix Fig S6A) is difficult to interpret
in this regard as it also leads to defects in Slx4 phosphorylation and
the Slx4-Dpb11 interaction (Ohouo et al, 2010)]. This redundancy
may thus explain the modest phenotype of the mms4-S201A mutant
that is deficient in the Mms4-Dpb11 interaction (Fig 5C).
Several aspects of Mus81-Mms4 regulation are conserved
throughout eukaryotic evolution. The HJ resolution activity of
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Mus81-Eme1 in mammalian cells is cell cycle-regulated (Matos et al,
2011; Wyatt et al, 2013). Mus81-Eme1 furthermore binds to Slx4
and forms multi-protein complexes (Fekairi et al, 2009; Muñoz
et al, 2009; Svendsen et al, 2009; Castor et al, 2013; Wyatt et al,
2013), albeit these complexes may have a different organization to
that in yeast. Therefore, it will be interesting to explore in the future
if in human cells DDK is also required for activation of Mus81-Eme1
and if this mechanism may contribute to the anti-tumorigenic activ-
ity of DDK inhibitors (Montagnoli et al, 2008).
Materials and Methods
All yeast strains are based on W303 and were constructed using
standard methods. Plasmids were constructed using the In-Fusion
HD cloning kit (Clontech Laboratories), and mutations were intro-
duced by site-directed mutagenesis. A summary of all yeast strains
used in this study can be found in the Appendix Table S2.
Cell cycle synchronization was achieved using alpha-factor (G1),
hydroxyurea (S), or nocodazole (mitosis). DNA content was
measured by flow cytometry with a BD FACSCalibur system using
SYTOX green to stain DNA.
Co-immunoprecipitations of yeast extracts were performed on
anti-FLAG agarose resin (Sigma) for 2 h with head-over-tail rotation
at 4°C as previously described (Gritenaite et al, 2014). After bead
washing, proteins were eluted by 3X FLAG-peptide (Sigma), precipi-
tated and separated on 4–12% Bis-Tris gels. For SILAC-based mass
spectrometry, cells were labelled with heavy-isotope-labelled lysine
(Lys6 or Lys8), and proteins were digested with Lys-C. Mass spec-
trometry data were analysed using MaxQuant (Cox & Mann, 2008).
Yeast two-hybrid assays, genetic interaction assays, in vitro
kinase assays and peptide binding assays were performed as
described previously (Pfander & Diffley, 2011; Gritenaite et al, 2014).
Nuclease assays were done as described (Matos et al, 2011,
2013). Briefly, Mus819myc was immunopurified from mitotically
arrested cells and mixed with 50-Cy3-end-labelled nicked Holli-
day junctions. After incubation at 30°C for the indicated times, the
reaction was stopped by proteinase K and SDS for 1 h at 37°C. Prod-
ucts were separated by 10% PAGE, and cleavage efficiency was
normalized to the level of immunoprecipitated Mus819myc.
Unspecific nHJ cleavage in untagged controls was subtracted in the
quantifications.
DSB-induced recombination assays were performed as described
(Ho et al, 2010). Diploids harbouring I-SceI under the control of the
GAL promoter were grown in adenine-rich raffinose medium and
arrested in mitosis. Nuclease expression was induced by addition of
galactose for 2.5 h. Cells were plated on YPAD and replica plated on
YPAD + Hyg + Nat, YPAD + Hyg, YPAD + Nat, SC-Met, SC-Ura and
SCR-ADE + Gal media after 3–4 days to classify recombination events.
Detailed experimental procedures are available in the Appendix.
Data availability
Mass spectrometric datasets are available at EBI PRIDE. DDK and
the Rtt107 scaffold promote Mus81-Mms4 resolvase activation
during mitosis (2015). PXD005356.
Expanded View for this article is available online.
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Mus81'Mms4! forms! a! complex! in!mitosis!with! kinases! and! scaffold! proteins,! and! is! a!
target!to!phosphorylation!by!these!kinases.!!
(A)(SILAC'based!quantification!of!Mms43FLAG!pulldowns! in!untagged!vs!MMS43FLAG!cells!
after! G2/M! arrest! with! nocodazole.! H/L! ratios! from! two! label'switch! experiments!
without! ratio! count! cut'off! are! plotted.! #,! as! the! only! protein! of! the! analysis! Dpb11!
displayed!exclusively!peptides!that!were!derived!from!the!Mms43FLAG!IP!samples,!but!not!





(C)! Kinetic! in! vitro! kinase! assay.! Purified,! immobilized! Mus81'Mms4! is! either! mock!
treated! or! treated! with! CDK! in! a! non'radioactive! priming! step,! and! incubated! with!
purified!DDK!(upper!panel)!or!Cdc5!(lower!panel).!Samples!were!taken!after! indicated!
time!points.!!
(D)( Mus81'Mms4! in! vitro! phosphorylation! is! independent! of! DKK! and/or! CDK! pre'
phosphorylation.!Purified,! immobilized!Mus81'Mms4! is! incubated! in!an! in!vitro!kinase!














(D)( Cdc5! association! with! Mus81'Mms4! is! dependent! on! DDK! activity.! Mms43FLAG!
pulldown!as!in!Fig.!1A.!Cells!were!cultivated!and!arrested!in!mitosis!at!RT.!Inhibition!of!
DDK! was! achieved! by! using! the! cdc791! allele! and! shifting! cells! to! permissive!
temperature!(38!°C)!for!the!indicated!time.!!
(E)! Effect! of! DDK! and! Cdc5! mutants! on! Cdc5! substrates.! Phosphorylation! of! Cdc5!
substrates! Ulp2! and! Scc1! (and! as! control! Mms4)! was! tested,! indicated! by! their!
phosphorylation! shift! in! 7%! Tris'Acetate! gels! in! untagged,!WT,! cdc59as1! and! cdc7∆!
backgrounds.!Western! blot! analysis! of! Ulp29myc! and! Scc19myc! whole'cell! extracts! from!
alpha'factor'! (G1)! or! nocodazole'arrested! (G2/M)! cells.! Cdc5! was! inhibited! by!
treatment!with!15!µM!CMK!for!1!h.!!





Summary! of! Mms4! phosphorylation! sites.! Shown! is! the! Mms4! primary! amino! acid!








(A)! Endogenous! Mus813FLAG'Mms4! purified! from! mitotically! arrested! cells! shows!
increased!activity! compared! to!non'phosphorylated! recombinant!protein!expressed! in!
yeast.!Left!panel:!Western!blot!analysis! for!quantification!of!bead'bound!protein! levels!
of!Mus81! (endogenous! and! recombinant)! compared! to! increasing! amounts! of! soluble!













(E)( DDK! is! required! for! mitotic! activation! of! Mus81'Mms4.! Resolution! assay! using! a!
replication! fork! (RF)! substrate! and! Mus819myc'Mms43FLAG! purified! from! mitotically!




Dpb11! interacts!with! the!N'terminal! region! of!Mms4! and! its! binding! is! dependent! on!
CDK!activity.!!
(A)! Dpb11! binds! to! a!minimal! interacting! fragment! of!Mms4! comprising! the! residues!
101'230.! Two'hybrid! analysis! of! GAL4'BD! fused! to!Dpb11! and!GAL4'AD! fusions!with!
Mms4!or!Mms4!fragment!constructs!(left!panel).!Expression!of!constructs!was!verified!
by!western!blot!analysis!(right!panel).!!




(C)(A!defect! in! the!Dpb11'Mms4! interaction! introduces!only! a!minor!defect! in!Mus81!






(A)( Formation! of! the! Mus81'Mms4! complex! depends! on! Rtt107.! SILAC'based!
quantification!of!Mms43FLAG!pulldowns!in!WT!vs!rtt107∆!cells.!Plotted!are!the!H/L!ratios!
of!two!experiments!including!label'switch.!!





(A,B)! Rtt107! influences! the! phosphorylation! of! specific! Cdc5'dependent!
phosphorylation! sites.! SILAC'based! MS! analysis! of! Mms4! phosphorylation! after!
purification! of! endogenously! expressed! Mus81'Mms43FLAG! (A)! or! of! Mus813FLAG'
Mms4His10'Strep2!expressed!from!the!pGAL1910!promoter!(B).!!
(C)!Western!blot! analysis!of!Mus819myc! IP! samples! that!were!used!as! inputs! for! the! in!
vitro!for!resolution!assay!of!Fig.!7A.!!
(D)(RTT107!deletion!does!not!lead!to!a!further!reduction!in!Mus81!activity!in!the!cdc7∆!
background.( Resolution! assay! using! a! nicked! HJ! substrate! and! Mus819myc'Mms43FLAG!
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The	 genetic	 experiments	 in	 Fig.	 4D-E,	 5C,	 and	 EV2A,B,D	 were	 performed	 in	 a	 W303	
RAD5+	 background	 to	 exclude	 any	 effect	 from	 a	 partial	 defect	 of	 the	 rad5-535	 allele.	
Two-hybrid	analyses	were	performed	in	the	strain	PJ69-7A	(James	et	al.,	1996).	
S.	 cerevisiae	 strains	were	 prepared	 by	 genetic	 crosses	 and	 transformation	 techniques.	
Deletion	 of	 particular	 genes	 and	 endogenous	 protein	 tagging	 were	 performed	 as	
described	 (Knop	 et	 al.,	 1999).	 Correct	 integrations	 were	 checked	 by	 genotyping	 PCR.	
Denaturing	 cell	 extracts	 were	 prepared	 by	 alkaline	 lysis	 and	 TCA	 precipitation.	 The	
























































































































































































































































































































































































































































































































































































Proteins	 were	 detected	 using	 specific	 antibodies:	 rabbit-anti-Dpb11	 (BPF19,	 Pfander	
lab),	rabbit-anti-Slx4	(2057,	Pfander	 lab),	goat-anti-Cdc5	(sc-6733,	Santa	Cruz),	rabbit-
anti-Cdc7	(Diffley	lab),	rabbit-anti-Clb2	(sc-9071,	Santa	Cruz),	goat-anti-Dbf4	(sc-5705;	
Santa	 Cruz),	 rabbit-anti-FLAG	 (F7425,	 Sigma),	 mouse-anti-myc	 (05-724,	 clone	 4A6;	








h	 at	 37	 °C.	 Next,	 cells	 were	 treated	 with	 proteinase	 K	 (200	 µl	 Tris	 buffer	 +	 20	 µl	
proteinase	 K	 (10	 mg/ml	 in	 50%	 glycerol,	 10	 mM	 Tris	 pH	 7.5,	 25	 mM	 CaCl2)	 and	
incubated	 for	 30'	 at	 50	°C.	 After	 centrifugation	 cells	were	 resuspended	 in	 500	 µl	 Tris	
buffer.	 Before	 measuring	 the	 DNA	 content,	 samples	 were	 sonified	 (5'';	 50%	 CYCLE;	







MOPS,	 50	mM	 Tris-base,	 1.025	mM	 EDTA,	 0.1%	 SDS,	 adjusted	 to	 pH	 7.7).	 To	 resolve	
phosphorylation	 shifts	 of	 Mms4	 in	 Fig.	 EV1,	 and	 of	 Ulp29myc	 or	 Scc19myc	 (Fig.	 S2E),	
protein	 samples	 were	 separated	 in	 7%	 Novex	 NuPAGE	 Tris-Acetate	 precast	 gel	
(ThermoFisher)	with	Tris-Acetate	buffer	 (50	mM	Tris-base,	50	mM	Tricine,	0.1%	SDS,	
adjusted	to	pH	8.24).	
After	 electrophoresis,	 proteins	 were	 transferred	 to	 a	 nitrocellulose	 membrane	





Pierce	ECL	western	blotting	substrate	 (ThermoFisher)	according	 to	 the	 instructions	of	





and	 pGBD-C1.	 To	 assay	 for	 an	 interaction	 between	 the	 proteins,	 respective	 plasmids	
were	 transformed	 into	 competent	PJ69-7A	cells.	Transformants	were	 spotted	 in	 serial	
dilution	 (1:5)	 either	 on	 SC-Leu-Trp	 plates	 (control)	 or	 on	 SC-Leu-Trp-His	 plates	
(selection)	and	incubated	at	30	°C	for	2-3	days.	Cells	from	the	control	plates	were	then	




Cell	 pellets	 were	 re-suspended	 in	 1	ml	 pre-cooled	 H2O	 and	 incubated	 with	 150	 µl	 of	
freshly	prepared	lysis	solution	(1.85	M	NaOH,	7.5%	beta-mercaptoethanol)	at	4	°C	for	15	
min.	 Then,	 the	 lysate	 was	 admixed	 with	 150	 µl	 55%	 trichloroacetic	 acid	 (TCA)	 and	
incubated	 at	 4	 °C	 for	 10	 min.	 After	 centrifugation	 and	 careful	 aspiration	 of	 the	
supernatant,	the	precipitated	proteins	were	re-suspended	in	50	µl	HU-buffer	(8	M	urea,	
































SILAC	 experiments	 with	 high-copy	 expression	 of	 MUS81-MMS4,	 overexpression	 was	
induced	by	addition	of	2%	galactose	for	2	h	after	nocodazole	arrest.	
Lysates	 were	 prepared	 by	 harvesting	 cells	 in	 equal	 amounts	 after	 growth	 under	 the	
indicated	 conditions.	 After	 co-IP,	 eluted	 proteins	 from	 light	 and	 heavy	 cultures	 were	
pooled,	TCA	precipitated	and	separated	on	a	4-12%	NuPAGE	Bis-Tris	gel	 (Invitrogen).	
The	 gel	was	 stained	with	 GelCode	 Blue	 (Thermo	 Scientific).	 The	 gel	 lane	was	 excided	
into	 ten	 slices	 and	 peptides	were	 analyzed	 by	 LC-MS/MS	 after	 in-gel	 Lys-C	 digestion.	
Samples	 were	 measured	 on	 an	 LTQ-Orbitrap	 and	 analyzed	 using	 MaxQuant	 (Cox	 &	
Mann,	2008).		
For	 analysis	 of	 proteins	 (Fig.	 S1A,	 2E,	 S2A,	 EV3A,	 6D,	 S6A),	 log2	 values	 of	 H/L	 ratios	
from	two	label-switch	experiments	without	ratio	count	cut-off	were	plotted	against	each	
other.		
For	analysis	of	phosphorylation	sites	 from	endogenous	protein	 levels	 (Fig.	3A-B,	S7A),	
H/L	 ratios	 for	 Mms4	 peptides	 were	 calculated	 from	 the	 corresponding	 H	 and	 L	
intensities	of	MS	evidences	and	plotted	in	their	 log2	values	against	the	 log10	values	of	
the	 peptide’s	 overall	 intensity.	 Evidences	 of	 non-phosphorylated	 Mms4	 peptides	 are	




phosphorylated	 (detected	 phosphorylation	 probability	 >0.7).	 Phosphorylated	 peptides	
matching	 the	 Cdc5	 consensus	 site	 are	 coloured	 in	 blue.	 Numbers	 indicate	 the	
phosphorylated	 residue	 in	 the	 depicted	 peptide.	 An	 asterisk	marks	 peptide	 evidences	




peptide’s	 intensity.	 Depicted	 are	 phosphorylated	 peptides	 only.	 Peptides	 were	 sorted	
into	categories	according	to	their	phosphorylation	status.	Putative	DDK	target	sites	were	
differentiated	into	the	categories	pSpS	(red),	pSS	(orange)	or	SpS	(yellow),	in	which	the	
respective	 residues	 of	 the	 (S/T)(S/T)	 motif	 were	 phosphorylated	 (detected	
phosphorylation	 probability	 >0.7).	 Phosphorylated	 peptides	 matching	 the	 Cdc5	
consensus	 site	 are	 coloured	 in	 blue.	 All	 other	 phosphorylated	 peptides	 are	marked	 in	
grey.	Bars	depict	the	mean	of	the	ratios	of	the	respective	category.	
Protein	purification	
CDK	was	 expressed	 in	E.	 coli	 BL21	 pRIL	 cells	 (Agilent).	Mus81-Mms4,	 DDK	 and	 Cdc5	




FLAG3MUS81	 and	 GST-HIS10-STREP2MMS4	 were	 cloned	 under	 the	 control	 of	 the	 GAL1,10	




4x107	 cells/ml)	were	 harvested,	washed	 and	 resuspended	 in	 a	 small	 volume	 of	 A500	
buffer	 (40	mM	Tris-HCl	pH	7.5,	500	mM	NaCl,	20%	glycerol,	0.1%	NP-40,	1	mM	DTT)	
containing	phosphatase	and	protease	inhibitors	and	mechanically	disrupted.	The	frozen	
lysate	 was	 resuspended	 in	 2	 volumes	 of	 A500,	 cleared	 by	 ultracentrifugation	 and	
incubated	 with	 anti-FLAG	 M2	 agarose	 beads	 (Sigma)	 for	 1	 h	 at	 4	 °C.	 After	 extensive	
washing	of	 the	beads	 in	A500,	Mus81-Mms4	was	dephosphorylated	by	treatment	with	




(Qiagen).	 The	 column	 was	 washed	 with	 A500	 buffer	 containing	 increasing	
concentrations	 of	 imidazole	 up	 to	 50	 mM,	 and	 finally	 Mus81-Mms4	 was	 eluted	 with	
A500	containing	300	mM	imidazole.	The	eluate	was	dialyzed	extensively	against	A500,	
and	 stored	 in	 aliquots	 at	 -80	 °C.	 Protein	 concentrations	 were	 determined	 using	 the	
Bradford	 assay	 (BioRad)	 and	 on	 Coomassie-stained	 PAGE	 gels	 using	 BSA	 as	 the	
standard,	which	also	confirmed	absence	of	phosphorylation-dependent	electrophoretic	




To	 generate	 CDK2/cycA∆N170	 complex,	 GSTCDK2	 and	 His6cycA∆N170	 were	 expressed	
separately.	 Bacteria	 with	 either	 expression	 plasmids	 were	 grown	 in	 1	l	LB	 medium	
supplemented	with	antibiotics	to	mid-log	phase.	Both	cultures	were	cooled	down	on	ice	
for	 5	 min	 to	 increase	 chaperone	 expression	 followed	 by	 addition	 of	 1	 mM	 IPTG	 and	
incubation	for	20	h	at	20	°C.	Cells	were	pelleted	and	resuspended	in	40	ml	lysis	buffer	
(300	mM	NaCl,	20	mM	HEPES	pH	7.6,	5	mM	β-mercaptoethanol,	0.01%	NP-40,	100	µM	
AEBSF,	 1x	 complete	 protease	 inhibitor	 cocktail	 EDTA-free)	 followed	 by	 lysis	 with	 an	
EmulsiFlex-C3	 system	 for	 three	 rounds	 at	 1,000	 bar.	 Cell	 debris	 was	 spun	 down	 at	
140,000	g	for	45	min.	To	allow	complex	formation	between	both	subunits,	extracts	were	
pooled	 and	 incubated	 for	 45	 min.	 For	 glutathione	 affinity	 chromatography,	 1	 ml	 bed	





40)	and	 incubated	 together	with	250	U	GST-PreScission	protease	 (MPIB	Core	Facility)	
for	 18	 h.	 The	 eluate	 was	 then	 adjusted	 to	 300	 mM	 NaCl	 and	 6	 mM	 imidazole	 for	
subsequent	Ni-NTA	affinity	chromatography.	Here,	a	bed	volume	of	1	ml	equilibrated	Ni-
NTA	 Agarose	 (Qiagen)	 was	 added	 to	 the	 eluate	 and	 incubated	 for	 1	 h.	 Beads	 were	
subsequently	 washed	 four	 times	 with	 15	 CV	 wash	 buffer	 (300	 mM	 NaCl)	 +	 6	 mM	
imidazole	 and	 five	 times	with	 2	 CV	wash	buffer	 (300	mM	NaCl)	 	 +	 6	mM	 imidazole	 +	
5%	glycerol.	Elution	was	then	performed	with	wash	buffer	(300	mM	NaCl)	 	+	250	mM	










pellet	was	 resuspended	 in	1	volume	of	 lysis	buffer	 (500	mM	NaCl,	100	mM	HEPES	pH	
7.6,	0.1%	NP-40,	10%	glycerol,	2	mM	β-mercaptoethanol,	400	µM	PMSF,	4	µM	aprotinin,	
4	 mM	 benzamidin,	 400	 µM	 leupeptin,	 300	 µM	 pepstatin	 A,	 4x	 complete	 protease	
inhibitor	cocktail,	EDTA-free)	and	frozen	drop-wise	in	liquid	nitrogen.	Frozen	cell	drops	
were	crushed	using	a	freezer/mill	system	(Spex	Sample	Prep).	Cell	powder	was	thawed	
on	 ice	 and	 centrifuged	 at	 >185,000	 g	 for	 1	 h.	 The	 clear	 phase	 was	 recovered	 and	
incubated	 with	 1	 ml	 bed	 volume	 of	 anti-FLAG	M2	 resin	 (Sigma)	 equilibrated	 in	 lysis	
buffer.	 After	 2	 h	 of	 incubation,	 the	 resin	 was	 washed	 five	 times	 with	 10	 CV	 of	 wash	
buffer	 (500	 mM	 NaCl,	 100	 mM	 HEPES	 pH	 7.6,	 0.1%	 NP-40,	 10%	 glycerol,	 2	 mM	 β-
mercaptoethanol).	Two	elution	steps	were	performed	by	adding	1	CV	0.5	mg/mL	3FLAG	
peptide	 in	 wash	 buffer	 and	 incubation	 for	 30	 min.	 Obtained	 fractions	 were	 pooled,	
brought	to	a	conductivity	of	10	mS/cm	(100	mM	salt)	and	subjected	to	anion	exchange	





DDK	 was	 purified	 as	 described	 by	 Gros	 et	 al.	 with	 modifications	 (Gros	 et	 al.	 2014).	
YFZ021	cells	were	grown	in	10	l	YP	medium	+	2%	raffinose	at	30	°C	until	mid-log	phase	




aprotinin,	 4	 mM	 benzamidin,	 400	 µM	 leupeptin,	 300	 µM	 pepstatin	 A,	 4x	 complete	





mM	 HEPES	 pH	 7.6,	 0.1%	 NP-40,	 10%	 glycerol,	 2	 mM	 β-mercaptoethanol).	 For	 λ-
phosphatase	treatment,	beads	were	resuspended	 in	1	CV	wash	buffer	+	2	mM	MnCl2	+	
900	U	λ-phosphatase	(New	England	Biolabs)	and	incubated	for	1	h	at	30	°C	in	a	tabletop	
thermoshaker.	Beads	were	 recovered	and	bound	DDK	was	 eluted	 twice	with	1	CV	0.5	
mg/ml	 3FLAG	 peptide	 in	wash	 buffer	 for	 30	min.	 Elutions	were	 pooled,	 concentrated	
using	a	Vivaspin	500	MWCO	50.000	(GE	healthcare)	and	fractionated	by	size	exclusion	
chromatography	using	a	Superdex	200	GL	10/300	column	(GE	healthare,	equilibrated	in	
wash	 buffer)	 over	 1.2	 CV.	 DDK	 containing	 fractions	 were	 pooled,	 brought	 to	 a	
conductivity	 of	 10	 mS/cm	 (100	 mM	 salt)	 and	 fractionated	 by	 anion	 exchange	












with	 binding	 buffer-100	 (100	mM	Hepes	 pH	7.6,	 100	mM	KOAc,	 10%	glycerol,	 0.02%	
NP-40,	2	mM	β-mercaptoethanol)	and	once	with	kinase	buffer	 (10	mM	HEPES	pH	7.6,	
100	mM	KOAc,	 50	mM	β-glycerophosphate,	 10	mM	MgCl2,	 2	mM	β-mercaptoethanol),	
and	aliquoted.	Residual	buffer	was	removed.		
Priming	 phosphorylation	 reactions	were	 performed	 by	 addition	 of	 10	 pmol	 (of	 each)	
kinase	and	started	by	addition	of	2	or	10	mM	(Fig.	1B,	S1C)	ATP.	For	samples	without	








For	 kinetic	 analysis	 of	 the	 phosphorylation	 reactions	 (Fig.	 S1C),	 the	 second	 kinase	
reaction	was	upscaled	to	100	µl	and	20	µl	samples	were	taken	at	indicated	time	points.		



















5’-Cy3-end-labelled	 nHJs	 or	 RFs	 11.	 Reactions	 were	 incubated	 for	 the	 indicated	 times	
with	gentle	rotation	at	30	°C	and	stopped	by	addition	of	5	µl	10	mg/ml	proteinase	K	and	
2%	 SDS,	 and	 further	 incubation	 at	 37	 °C	 for	 1	 h.	 Loading	 buffer	 was	 added	 and	
fluorophore-labelled	 products	 were	 separated	 by	 10%	 PAGE,	 and	 analyzed	 using	 a	






cultures	 reached	 an	 OD600	 of	 0.5.	 Cells	 were	 arrested	 with	 nocodazole	 and	 I-SceI	
expression	was	induced	by	adding	galactose	to	a	final	concentration	of	2%.	After	2.5	h	
cells	were	plated	onto	YPAD	(YPD	+	10	mg/l	Adenine),	incubated	for	3-4	days	and	then	
replica	 plated	 onto	 YPAD+Hyg+Nat,	 YPAD+Hyg,	 YPAD+Nat,	 SC-Met,	 SC-Ura,	 and	 SCR-
ADE+Gal	 media	 to	 classify	 recombination	 events.	 The	 different	 classes	 depicted	 arise	
from	repair	of	DSBs	by	either	short	tract	or	long	tract	gene	conversion	which	produces	
ade2-n	 or	 ADE+	 recombinants,	 respectively	 (white	 class:	 two	 short	 tract	 conversions;	
red	 class:	 two	 long	 tract	 conversions;	 red/white	 class:	 one	 short	 and	 one	 long	 tract	
conversion).	 Within	 the	 distinct	 classes	 CO	 events	 are	 measured	 by	 the	 number	 of	
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Figure EV1. Cdc5 restricts Mms4 hyperphosphorylation to mitosis.
A Overexpression of CDC5 in S phase results in premature Mms4 hyperphosphorylation. Western blot analysis of Mms49myc, Cdc5 and Dbf4 from whole-cell extracts
(upper panel) and FACS data (lower panel). Cells were arrested in G1 (with alpha-factor), S phase (with HU) or G2/M phase (with nocodazole). After arrest, CDC5GFP
overexpression was induced by addition of 2% galactose for the indicated time to cells harbouring an additional copy of GFP-tagged CDC5 under the GAL1 promoter.
Samples were run in 7% Tris-acetate gels.
B Mms4 hyperphosphorylation by CDC5 overexpression in S phase is reduced in HU-treated cells. Western blot analysis of Mms49myc and Cdc5 from precipitated whole-
cell extracts (upper panel) and FACS data (lower panel) of cells arrested in G1 (with alpha factor) or G2/M phase (with nocodazole), or released to S phase (with or
without HU). CDC5GFP overexpression was induced for 30 min by addition of 2% galactose to cells harbouring an additional copy of GFP-tagged CDC5 under the GAL1
promoter. Note that upon CDC5 overexpression cells are partially defective in bulk replication. Samples were run in 7% Tris-acetate gels.
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Figure EV2. Phenotypic analysis of Mms4 variants deficient in (S/T)(S/T) phosphorylation sites.
A, B The mms4-8A mutation or lack of Cdc5-DDK interaction does not lead to a synthetic hypersensitivity towards MMS in the yen1D background. Spotting assay as in
Fig 4D and E.
C–E Additional mutation of 4 additional (S/T)(S/T) motifs in the background of the mms4-8A mutant (mms4-12A) leads to a reduction in the Mms4 phosphorylation
shift (C), increases the hypersensitivity to MMS in the sgs1∆ background (D) and shows a slightly but not significantly decreased activity of Mus81-Mms4 (E). (C)
Mms43FLAG pull down as in Fig 1A, but in G2/M-arrested cells in untagged, WT, mms4-12A and mms4-8A backgrounds. Asterisk marks a cross-reactive band. (D)
Spotting assay as in Fig 4D and E. (E) Resolution assay using a nHJ substrate and Mus819myc-Mms43FLAG purified from mitotically arrested WT, mms4-8A or mms4-
12A cells. Lower panel: Western blot samples of anti-myc IPs.
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Figure EV3. A defect in the phosphorylation of Mms4 (S/T)(S/T) sites
(mms4-8A) causes reduced association of Cdc5, DDK and Rtt107 with
Mus81-Mms4.
SILAC-based quantification of Mms43FLAG pull downs in WT vs. mms4-8A cells.
Plotted are the H/L ratios against peptide intensity
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of	 the	 catalytic	 activity	 in	 M-phase	 is	 thought	 to	 protect	 cells	 from	 unwanted	 cleavage	 of	
replication	 fork	 structures	 during	 S-phase	 (Matos	 et	 al.,	 2013,	 Blanco	 et	 al.,	 2014,	 Szakal	 and	












knowledge	 about	 the	 timing	 of	Mus81-Mms4	 function	 (Bittmann	 et	 al.,	 2020).	 Furthermore,	 I	
contributed	to	the	discovery	of	an	additional	layer	of	regulation	occurring	on	Mus81-Mms4	in	M-




Cell	 cycle	 tags	 can	 be	 a	 valuable	 tool	 to	 study	 cell	 cycle	 regulation	 of	 proteins	 and	 we	 have	


























This	 fact	 made	 it	 impossible	 to	 compare	 phenotypes	 arising	 from	 the	 restriction	 to	







one	 single	 cell	 cycle	 tag	 construct	 is	 therefore	 extremely	 difficult	 and	 would	 profit	 from	
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complementary	data	derived	from	additional	cell	cycle	tag	constructs	restricting	to	other	cell	cycle	
phases.	Additionally,	the	limited	number	of	a	single	cell	cycle	tag	per	cell	cycle	phase	did	not	allow	
to	 adjust	 peak	 expression	 levels,	 for	 example	 to	 the	 level	 of	 the	 endogenous	 protein.	 As	 the	
expression	level	of	a	cell	cycle-tagged	protein	is	dictated	by	the	corresponding	cell	cycle	tag,	cell	
cycle-restricted	 expression	 with	 the	 Clb6-,	 Clb2-	 and	 Sic1-tag	 can	 lead	 to	 over-	 or	 under-
expression	 compared	 to	 the	 endogenous	 protein	 levels	 (Figure	 7).	 In	 this	 case	 an	 observed	
phenotype	can	be	the	consequence	of	either	the	differing	protein	level	or	the	restriction	of	the	
protein	to	a	certain	cell	cycle	phase	and	is	therefore	difficult	to	be	interpreted.		
	 In	 summary,	 the	 limiting	 number	 of	 three	 cell	 cycle	 tags	 with	 fixed	 expression	 levels	
extremely	minimized	 the	potential	of	 the	 cell	 cycle	 tag	 system	and	we	 therefore	attempted	 to	
overcome	these	limitations	by	introducing	an	increased	number	of	cell	cycle	tags	which	would	
allow	 to	 restrict	 expression	 with	 adjusted	 protein	 levels.	 The	 flexibility	 in	 the	 adaption	 of	
expression	 levels	would	 thereby	not	only	allow	to	derive	complementary	data	 in	different	cell	
cycle	phases	but	also	to	compare	the	effects	of	the	restriction	to	the	endogenous	scenario.	
1.2 An	advanced	cell	cycle	tag	toolbox	





promoter	 sequences	 to	 influence	 protein	 expression	 by	 reduced	mRNA	 stability	 and	 reduced	
translation	rates,	respectively	(Fig.	1A,	(Bittmann	et	al.,	2020)).	Together	these	attempts	resulted	











cell	 cycle	 tag	 involves	 the	 production	 and	 degradation	 of	 the	 protein	 in	 a	 relatively	 short	
timeframe.	A	cell	cycle-tagged	protein	is	therefore	not	expressed	with	constant	level	throughout	
that	cell	cycle	phase	but	will	display	reduced	expression	at	 the	borders	of	 the	cell	cycle	phase	
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compared	to	its	peak	expression	during	that	cell	cycle	phase.	The	overall	adaptation	of	expression	













The	 validity	 of	 this	 strategy	 becomes	 apparent	with	 the	 example	 of	 the	Mus81-Mms4	
endonuclease.	 In	 order	 to	 achieve	 cell	 cycle-restricted	 “low”	 and	 “high”	 expression,	 we	 have	
created	two	sets	of	cell	cycle-restricted	Mus81-Mms4	variants:	Slow-Mus81-Mms4/Mlow-Mus81-




sensitivity	 Slow	 vs.	 Shigh	 and	 Mlow	 vs.	 Mhigh;	 Fig.	 3A,B,	 (Bittmann	 et	 al.,	 2020)).	 The	 different	
tendencies	 between	 the	 “low”	 and	 “high”	 set	 of	 tags	 underline	 the	 importance	 of	 using	 two	
complementary	sets	of	cell	cycle	tags	to	facilitate	interpretations	originating	from	over-	or	under-
expression	during	the	restricted	cell	cycle	phase.	In	detail,	when	using	the	“low”	set	of	cell	cycle	
tags	 we	 observed	 a	 slight	 DNA	 damage	 sensitivity	 for	 Mlow-Mus81-Mms4	 (Fig.	 3A,	 4B,	 4E,	
(Bittmann	 et	 al.,	 2020))	 (note	 that	 defects	 in	 Mus81-Mms4	 function	 lead	 to	 DNA	 damage	
sensitivity).	As	we	did	not	observe	such	a	defect	when	using	Mhigh-Mus81-Mms4	(Fig.	3B,	D,	F,	4C-
E,	 (Bittmann	 et	 al.,	 2020)),	we	 set	 out	 to	 understand	 how	 this	 defect	 in	Mlow-Mus81-Mms4	 is	
caused	and	performed	further	control	experiments	which	showed	that	this	defect	is	due	to	under-
expression	 of	 Mlow-Mus81-Mms4	 in	 M-phase.	 Without	 these	 control	 experiments	 and	 the	
complementary	 Mhigh-Mus81-Mms4	 we	 would	 have	 interpreted	 the	 observed	 DNA	 damage	
sensitivity	 of	 Mlow-Mus81-Mms4	 as	 insufficient	 function	 of	 Mus81-Mms4	 during	 M-phase.	
Consequently,	we	would	have	suggested	an	additional	function	of	Mus81-Mms4	in	other	cell	cycle	
phases	 (e.g	 S-phase).	 Using	 both	 “low”	 and	 “high”	 expressing	 constructs	 thus	 helped	 to	 avoid	
misinterpretations	based	on	expression	levels.	









Figure	8:	The	 “high”/”low”	strategy	of	 the	advanced	cell	 cycle	 tag	 toolbox.	 Considering	 the	dynamic	nature	of	
expression	from	a	cell	cycle	tag,	expression	levels	will	not	be	constant	throughout	the	restricted	cell	cycle	phase.	While	
(a)	adjustment	of	peak	expression	levels	to	endogenous	protein	levels	(dotted	line)	will	lead	to	under-expression	at	cell	









With	 the	 advancements	 of	 the	 new	 cell	 cycle	 tag	 toolbox	 we	were	 able	 to	 efficiently	 restrict	















stalled	 replication	 forks	 is	 thus	 timely	 uncoupled	 and	matches	with	 the	 timeframe	of	 its	 high	
catalytic	activity.	
	 Given	 the	 observed	 functional	 overlap	 of	 M-tagged	 Mus81-Mms4	 with	 Sgs1	 (Fig.	 3E,	
(Bittmann	et	al.,	2020)),	we	conclude	that	our	data	are	well	described	by	a	model	where	Mus81-
Mms4	functions	as	a	post-replicative	resolvase.	The	resolvase	function	of	Mus81-Mms4	generally	




2002,	 Bastin-Shanower	 et	 al.,	 2003).	 The	 strong	 synthetic	 phenotype	 observed	 for	 S-tagged	






of	 Mus81-Mms4	 during	 S-phase	 (Fig.	 3D,	 (Bittmann	 et	 al.,	 2020))	 thereby	 providing	 further	
evidence	for	a	role	as	post-replicative	resolvase.	The	structures	requiring	resolution	by	Mus81-
Mms4	 appear	 to	 arise	 during	 HR-dependent	 repair	 of	 stalled	 replication	 forks	 based	 on	 our	
observations	made	in	the	context	of	replication	fork	stalling	by	MMS,	HU,	CPT	or	transcription-




2020)).	 Replication	 fork	 stalling	 has	 been	 shown	 to	 induce	 JMs	 like	D-loops	 or	HJs	 in	 an	HR-
dependent	manner	(Liberi	et	al.,	2005,	Branzei	et	al.,	2008,	Giannattasio	et	al.,	2014,	Branzei	and	
Szakal,	2016)	 thereby	providing	a	possible	 substrate	 for	 the	mitotic	 function	of	Mus81-Mms4.	
While	Mus81-Mms4	was	generally	 implicated	in	the	resolution	of	such	replication	derived	JMs	
before	(Xiao	et	al.,	1998,	Interthal	and	Heyer,	2000,	Boddy	et	al.,	2001,	Mullen	et	al.,	2001,	Doe	et	




process	 of	 break-induced	 replication	 (BIR)	 (Munoz-Galvan	 et	 al.,	 2012,	 Roseaulin	 et	 al.,	 2008,	





parts	of	 the	 template	chromosome	will	be	copied	(Kramara	et	al.,	2018).	BIR	 in	 the	context	of	
replication	 has	 the	 advantage	 of	 limiting	 this	mutagenicity	 by	 re-installing	 semi-conservative	











late	 timing	 of	 Mus81-Mms4	 function	 during	 BIR	 would	 thereby	 be	 similar	 to	 what	 has	 been	








replication	 fork	 stalling	 in	 budding	 yeast	 –	 as	 resolvase	 or	 during	 BIR	 –	 we	 cannot	 formerly	




MUS81	 in	 replication	 fork	 restart	 by	 cleaving	 stalled	 replication	 forks	 (Hanada	 et	 al.,	 2007,	
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Regairaz	et	al.,	2011,	Franchitto	et	al.,	2008,	Shimura	et	al.,	2008).	While	in	principal	the	reduced	
formation	of	DSBs	in	MUS81	deficient	cells	might	also	be	the	consequence	of	an	indirect	effect	and	
thus	 would	 not	 constitute	 an	 S-phase	 function	 of	 MUS81,	 it	 still	 raises	 the	 possibility	 of	
mammalian	MUS81	having	additional	functions	outside	of	M-phase.	A	critical	point	to	consider	
when	 comparing	 Mus81	 function	 in	 the	 yeast	 and	 mammalian	 system	 are	 differences	 in	 the	
regulatory	mechanisms.	While	the	overall	cell	cycle	regulation	and	specific	upregulation	of	the	
catalytic	activity	are	conserved,	 the	control	of	mammalian	MUS81	 involves	additional	 features	
such	as	the	presence	of	two	regulatory	subunits,	EME1	and	EME2,	compared	to	the	single	Mms4	
subunit	in	yeast	(Ciccia	et	al.,	2003).	This	leaves	room	for	the	speculation	that	the	additional	EME2	
subunit	might	 provide	mammalian	 cells	 with	 an	 additional	 layer	 of	 control	 that	 would	 allow	
MUS81	to	fulfil	specific	functions	in	S-phase	and	would	offer	an	explanation	for	not	detecting	such	















Mms4	 during	 the	 response	 to	 replication	 fork	 stalling.	 We	 reason	 that,	 due	 to	 the	 overall	
conservation	of	Mus81-Mms4	regulation	in	the	mammalian	system,	a	post-replicative	function	of	
mammalian	MUS81	 is	 also	 likely.	 However,	 the	 implications	 of	MUS81	 in	 DSB	 formation	 and	
proper	replication	progression	(Hanada	et	al.,	2007,	Regairaz	et	al.,	2011,	Franchitto	et	al.,	2008,	
Shimura	 et	 al.,	 2008,	Xing	 et	 al.,	 2015,	 Fu	 et	 al.,	 2015)	 –	 although	possibly	being	 the	 result	 of	
indirect	effects	after	MUS81	depletion	–	emphasize	 the	requirement	of	an	 in	depth	analysis	of	
possible	S-	and	M-phase	functions	in	mammalian	cells	similar	to	our	study	in	budding	yeast.	









	 From	 previous	 studies	 we	 know	 that	 the	 catalytic	 activity	 of	 Mus81-Mms4	 becomes	
upregulated	specifically	during	M-phase	(Matos	et	al.,	2011,	Matos	et	al.,	2013,	Gallo-Fernandez	




as	 the	 incorporation	 of	Mus81-Mms4	 into	 a	 complex	 comprising	 the	 scaffold	 proteins	Dpb11,	
Rtt107	and	Slx4-Slx1	(Gritenaite	et	al.,	2014).	In	(Princz	et	al.,	2017)	we	were	thereby	able	to	add	
an	additional	kinase	–	DDK	–	to	this	already	intricate	regulatory	network	and	shed	light	on	the	
interplay	of	 the	different	kinases	and	scaffold	proteins.	As	a	 result,	we	could	attribute	 several	
features	 to	 the	 regulation	 of	 Mus81-Mms4	 that	 are	 typically	 associated	 with	 switch-like	
transitions.	




For	 the	 DDK-dependent	 phosphorylation,	 peptide	 based	 phosphorylation	 assays	 furthermore	
revealed	a	possible	stimulatory	effect	of	priming	phosphorylation	by	CDK	(Fig.	1C,	Princz	et	al.,	
2017)	 which	 would	 connect	 the	 action	 of	 all	 three	 kinases.	 Together,	 the	 three	 kinases	
phosphorylate	Mms4	at	multiple	sites	(Fig.	3,	Princz	et	al.,	2017;	(Matos	et	al.,	2011))	and	seem	to	
do	so	in	a	cooperative	manner.	
	 Second,	 we	 observed	 a	 positive-feedback	 loop	 during	 the	 concerted	 multi-site	
phosphorylation	of	Mms4	integrated	by	the	Rtt107	scaffold.	The	binding	of	Rtt107	to	Mms4	is	
thereby	indispensable	for	the	binding	of	Cdc5	and	DDK	(Fig.	6A,	Princz	et	al.,	2017).	In	turn,	Rtt107	
binding	depends	on	prior	phosphorylation	by	 the	 two	kinases	 (Fig.	2E,	S2A,	EV3,	Princz	et	al.,	
2017)	 thus	 implying	 an	 interdependency	 between	 Rtt107	 binding	 and	 Cdc5/DDK-dependent	
phosphorylation	which	could	be	part	of	a	signal	amplification	mechanism	(Princz	et	al.,	2017).	
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	 Together,	concerted	multi-site	phosphorylation	and	signal	amplification	are	required	for	
an	efficient	upregulation	of	 the	catalytic	activity	of	Mus81-Mms4	during	M-phase	(Fig.	4,	7A,B,	
Princz	 et	 al.,	 2017).	 Since	 such	 features	 are	 commonly	 associated	with	 switch-like	 transitions	
(Nash	et	al.,	2001,	Salazar	and	Hofer,	2009,	Ferrell	and	Ha,	2014)	we	envision	the	activation	of	
Mus81-Mms4	during	M-phase	beeing	installed	by	a	sharp	and	precise	timer.	Consequently,	this	











	 The	 basis	 of	 this	 hypothesis	 is	 provided	 by	 experiments	 analysing	 the	 influence	 of	
deregulated	 SSE	 activity.	 Indeed,	 these	 studies	 revealed	 that	 premature	 SSE	 activity	 has	 the	
potential	to	lead	to	unscheduled	chromosome	breakage	as	well	as	loss	of	viability	in	response	to	
replication	fork	stalling	(Matos	et	al.,	2013,	Blanco	et	al.,	2014,	Szakal	and	Branzei,	2013,	Duda	et	
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indication	 that	 the	 function	 of	 SSEs	 needs	 to	 be	 restrained	 during	 S-phase	 comes	 from	 the	
interplay	 of	 the	Mus81-Mms4	 regulation	with	 the	DNA	damage	 checkpoint.	 The	DNA	damage	
checkpoint	has	been	shown	to	counteract	Mus81-Mms4	activity	during	S-phase	which	might	help	
to	 avoid	Mus81-Mms4-dependent	 cleavage	 of	 stalled	 replication	 forks.	 This	 is	 achieved	 by	 an	
antagonizing	role	of	the	DNA	damage	checkpoint	during	the	phosphorylation	of	Mms4	by	Cdc5	
(Szakal	and	Branzei,	2013)	and	the	formation	of	the	scaffold	complex	(Slx4-Dpb11-Mus81-Mms4)	
(Gritenaite	 et	 al.,	 2014).	 The	 premature	 activation	 of	 Mus81-Mms4	 observed	 in	 checkpoint	



















into	 a	 general	model	whereby	 the	 processing	 of	 recombination	 intermediates	 follows	 a	well-
ordered	hierarchy	(Figure	9).		
	 A	first	level	of	hierarchy	is	thereby	achieved	by	the	temporal	separation	of	dissolution	and	





the	 cell	 cycle	 (Bizard	 and	 Hickson,	 2014,	 Matos	 and	 West,	 2014,	 Pfander	 and	 Matos,	 2017)	
suggesting	 an	 initial	 dissolution	 of	 JM	 structures	 in	 S-phase	 followed	 by	 a	wave	 of	 resolution	
during	M-phase.	Notably,	a	recent	study	by	 the	Matos	 lab	provides	 first	evidence	that	also	 the	
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Yen1	 (Yen1-ON)	 during	 early	 M-phase	 can	 partially	 rescue	 the	MMS	 sensitivity	 observed	 for	
mus81∆	cells	(Fig.	5B,	(Bittmann	et	al.,	2020))	indicating	at	least	some	degree	of	functional	overlap	












	 To	summarize,	we	would	 like	 to	propose	a	working	model	whereby	 the	removal	of	 JM	
structures	follows	a	three-tiered	hierarchy:	JM	structures	arising	during	the	repair	by	homologous	
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